{"title": "vacuna anti-haemophilus influenzae: Topics by WorldWideScience.org", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2015-11-17", "cleaned_text": "vaccine on bacterial meningitis in the Dominican Republic Impacto de la vacuna conjugada contra Haemophilus influenzae tipo b sobre la meningitis bacteriana en la Rep\u00fablica Dominicana](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000900002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Ellen H. Text This study analyzed trends in probable bacterial meningitis before and after the introduction of Hib vaccine in the Dominican Republic and estimated vaccine effectiveness against Hib meningitis. METHODS: Meningitis cases among children OBJETIVOS: El uso generalizado de la vacuna contra Haemophilus influenzae tipo b (Hib ha permitido reducir radicalmente la carga de enfermedad por Hib en las Am\u00e9ricas. Pocos estudios han evaluado el impacto de la vacunaci\u00f3n contra Hib sobre los casos no confirmados mediante cultivo. En este estudio se analizaron las tendencias en el n\u00famero de casos probables de meningitis bacteriana antes y despu\u00e9s de la introducci\u00f3n de la vacuna contra Hib en la Rep\u00fablica Dominicana y se estim\u00f3 la eficacia de la vacuna contra la meningitis. M\u00c9TODOS: Se identificaron los casos de meningitis en ni\u00f1os menores de 5 a\u00f1os a partir de los registros de ingreso del principal hospital pedi\u00e1trico de Santo Domingo entre 1998 y 2004. Los casos de meningitis con probable etiolog\u00eda bacteriana se clasificaron seg\u00fan criterios de laboratorio; los casos confirmados contaban con cultivo bacteriano positivo o detecci\u00f3n de ant\u00edgenos espec\u00edficos en el l\u00edquido cefalorraqu\u00eddeo. Se calcularon las tasas de incidencia acumulada de casos confirmados y probables de meningitis en los ni\u00f1os que viv\u00edan en el Distrito Nacional. Los casos confirmados de meningitis por Hib se incorporaron a un estudio de casos y controles -pareados seg\u00fan la edad y el barrio de residencia- para calcular la eficacia de la vacuna. RESULTADOS: Antes de la introducci\u00f3n de la vacuna, la tasa anual de meningitis de posible etiolog\u00eda bacteriana era de 49 casos por 100 000 ni\u00f1os menores de 5 a\u00f1os; de los casos confirmados de [Vigilancia de serotipos en infecciones invasivas por Haemophilus influenzae en la Argentina en la era de la vacuna conjugada contra el serotipo b durante el de la vacuna contra Haemophilus influenzae tipo b en los programas de inmunizaci\u00f3n de muchos pa\u00edses produjo una reducci\u00f3n marcada en la incidencia de enfermedad invasiva causada por este serotipo y en su portaci\u00f3n y un incremento de otros tipos capsulares y de aislamientos no capsulados. Se estudiaron 313 aislamientos de H. influenzae recuperados de sitio est\u00e9ril, provenientes de pacientes pedi\u00e1tricos y adultos con enfermedad invasiva atendidos en 90 hospitales de la Red Nacio... [Fallos vacunales a vacunas Available Haemophilus influenzae b and of otitis, pneumonia, meningitis, vaccine Children who experienced vaccine failures to Haemophilus influenzae type b had associated comorbidities population (prematurity, HIV, Down syndrome, tumors, etc.. Nevertheless, most of these children have no medical history or immunological disorders. There is no consensus on vaccine failures should failure even the theses. Of the vaccine preparations available of the vaccine failures in some series. [ENFERMEDAD INVASORA POR HAEMOPHILUS INFLUENZAE ANTES Y DESPU\u00c9S DE LA CAMPA\u00d1A DE VACUNACI\u00d3N EN LA POBLACI\u00d3N INFANTIL DE LA COMUNIDAD VALENCIANA (1996-2000](http://www.redalyc.org/articulo.oa?id=17076304) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Mercedes Goicoechea S\u00e1ez 2002-01-01 Full Text Available introducci\u00f3n de la vacuna conjugada anti Haemophilus influenzae tipo b (Hib en ni\u00f1os ha provocado un llamativo descenso de la incidencia de la enfermedad por H. influenzae. El objetivo de este estudio es analizar las caracter\u00edsticas m\u00e1s relevantes de la enfermedad invasora por H. influenzae en cuanto a la epidemiolog\u00eda, cl\u00ednica, evoluci\u00f3n y estado de vacunaci\u00f3n de la poblaci\u00f3n infantil de la Comunidad Valenciana en el periodo 1996-2000. M\u00e9todo: Los datos se recogen de las historias cl\u00ednicas de los ni\u00f1os menores de 15 a\u00f1os que hayan presentado s\u00edntomas y signos cl\u00ednicos sugestivos de enfermedad invasora con aislamiento de Haemophilus influenzae y/o que cumple con los criterios de definici\u00f3n de caso establecidos, atendidos en todos los hospitales p\u00fablicos de la Comunidad Valenciana entre 1996 y 2000. La evoluci\u00f3n de la incidencia se valor\u00f3 mediante tasas de incidencia. La cl\u00ednica y su evoluci\u00f3n (secuelas y letalidad mediante la frecuencia y distribuci\u00f3n por edad. Resultados: Se registraron un total de 36 casos de enfermedad invasora por Haemophilus influenzae. La tasa de incidencia en ni\u00f1os menores de 15 a\u00f1os pas\u00f3 de 3,56/105 en 1996 a 1,07/105 en 1997 (coincidiendo con la campa\u00f1a de vacunaci\u00f3n y la posterior inclusi\u00f3n de la vacuna conjugada anti Hib en el Calendario de Vacunaciones Sistem\u00e1ticas de la Comunidad Valenciana y 0,30/105 en 1998, situaci\u00f3n que se sigue manteniendo en los a\u00f1os posteriores. El 53% de los casos se dan en menores de 18 meses. Tanto las secuelas como los fallecimientos se producen en la \u00e9poca anterior a la aplicaci\u00f3n rutinaria de la vacuna conjugada. Ning\u00fan ni\u00f1o vacunado correctamente falleci\u00f3. Se registraron 2 casos de H. influenzae tipo no b en ni\u00f1os vacunados. Conclusiones: La incidencia de la infecci\u00f3n por Haemophilus influenzae tipo b disminuy\u00f3 dr\u00e1sticamente desde el inicio de la vacunaci\u00f3n sistem\u00e1tica de la poblaci\u00f3n infantil. [Enfermedad invasora por Haemophilus Influenzae antes y despu\u00e9s de la campa\u00f1a de vacunaci\u00f3n en la poblaci\u00f3n infantil de la Comunidad Valenciana (1996-2000](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57272002000300004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Goicoechea S\u00e1ez Mercedes 2002-01-01 Full Text Available introducci\u00f3n de la vacuna conjugada anti Haemophilus influenzae tipo b (Hib en ni\u00f1os ha provocado un llamativo descenso de la incidencia de la enfermedad por H. influenzae. El objetivo de este estudio es analizar las caracter\u00edsticas m\u00e1s relevantes de la enfermedad invasora por H. influenzae en cuanto a la epidemiolog\u00eda, cl\u00ednica, evoluci\u00f3n y estado de vacunaci\u00f3n de la poblaci\u00f3n infantil de la Comunidad Valenciana en el periodo 1996-2000. M\u00e9todo: Los datos se recogen de las historias cl\u00ednicas de los ni\u00f1os menores de 15 a\u00f1os que hayan presentado s\u00edntomas y signos cl\u00ednicos sugestivos de enfermedad invasora con aislamiento de Haemophilus influenzae y/o que cumple con los criterios de definici\u00f3n de caso establecidos, atendidos en todos los hospitales p\u00fablicos de la Comunidad Valenciana entre 1996 y 2000. La evoluci\u00f3n de la incidencia se valor\u00f3 mediante tasas de incidencia. La cl\u00ednica y su evoluci\u00f3n (secuelas y letalidad mediante la frecuencia y distribuci\u00f3n por edad. Resultados: Se registraron un total de 36 casos de enfermedad invasora por Haemophilus influenzae. La tasa de incidencia en ni\u00f1os menores de 15 a\u00f1os pas\u00f3 de 3,56/10(5 en 1996 a 1,07/10(5 en 1997 (coincidiendo con la campa\u00f1a de vacunaci\u00f3n y la posterior inclusi\u00f3n de la vacuna conjugada anti Hib en el Calendario de Vacunaciones Sistem\u00e1ticas de la Comunidad Valenciana y 0,30/10(5 en 1998, situaci\u00f3n que se sigue manteniendo en los a\u00f1os posteriores. El 53% de los casos se dan en menores de 18 meses. Tanto las secuelas como los fallecimientos se producen en la \u00e9poca anterior a la aplicaci\u00f3n rutinaria de la vacuna conjugada. Ning\u00fan ni\u00f1o vacunado correctamente falleci\u00f3. Se registraron 2 casos de H. influenzae tipo no b en ni\u00f1os vacunados. Conclusiones: La incidencia de la infecci\u00f3n por Haemophilus influenzae tipo b disminuy\u00f3 dr\u00e1sticamente desde el inicio de la vacunaci\u00f3n sistem\u00e1tica de la poblaci\u00f3n infantil. [Impacto de la vacuna conjugada en la incidencia de meningitis por Haemophilus influenzae en el Distrito Federal de Brasil: resultados de tres a\u00f1os de seguimiento Impact of anti-Hib conjugate vaccine on the [Directory Haemophilus influenzae del serotipo b (Hib es todav\u00eda un importante agente causal de procesos infecciosos. Su variante encapsulada es la causa de formas invasoras de enfermedad. En algunas poblaciones abor\u00edgenes, la incidencia de enfermedades causadas por Hib es mayor de 400 por 100 000 ni\u00f1os menores de 5 a\u00f1os. En los decenios de 1970 y 1980, tras la identificaci\u00f3n de anticuerpos protectores contra la c\u00e1psula de Hib, se desarrollaron vacunas contra este microorganismo. OBJETIVO: Estimar el impacto que ha tenido desde su introducci\u00f3n, en marzo de 1998, la vacunaci\u00f3n contra Hib en el Distrito Federal de Brasil. M\u00c9TODO: Con los datos de base poblacional del Sistema de Vigilancia de la Secretar\u00eda de Salud del Distrito Federal de Brasil, se compararon las tasas de incidencia de meningitis correspondientes a los tres a\u00f1os anteriores y posteriores a la introducci\u00f3n de la vacuna. Se compararon tambi\u00e9n los cambios en su tendencia. RESULTADOS: Al comparar los dos per\u00edodos se advierte una reducci\u00f3n de aproximadamente 90% en la incidencia de meningitis por Hib, cambio que no ocurre en el caso de las meningitis ocasionadas por otros agentes bacterianos. Se registr\u00f3 un aumento proporcional de los casos entre los ni\u00f1os de 6 meses de edad y menores, debido a la reducci\u00f3n de la incidencia entre los mayores de esa edad. CONCLUSI\u00d3N: La introducci\u00f3n de la vacuna conjugada en el Distrito Federal de Brasil redujo de 168 por 100 000 (1995-1997 a 15 por 100 000 (1999-2001 la incidencia de meningitis por Hib entre ni\u00f1os de 7 a 35 meses. Esto representa una reducci\u00f3n de 91,1%.INTRODUCTION: Type b Haemophilus influenzae Hib infections in children under five is greater than 400 per 100 000. In the seventies Text Available Haemophilus influenzae es reconocido como un agente pat\u00f3geno responsable de infecciones localizadas y sist\u00e9micas. Se han descrito 6 tipos de polisac\u00e1ridos capsulares antig\u00e9nicamente distintos (a, b, c, d, e, y f que se pueden identificar por aglutinaci\u00f3n en l\u00e1mina con antisueros espec\u00edficos. Tambi\u00e9n existen cepas no capsuladas (NC fenot\u00edpicamente no tipificables (NT. La introducci\u00f3n de la vacuna conjugada produjo una marcada disminuci\u00f3n de las enfermedades invasivas causadas por H. influenzae tipo b. En este contexto, la tipificaci\u00f3n capsular mediante PCR es el m\u00e9todo m\u00e1s apropiado para distinguir las cepas no capsuladas de las mutantes b deficientes en c\u00e1psula (b- y detectar la presencia de cepas pertenecientes a otros serotipos que no puedan ser tipificables por aglutinaci\u00f3n. Se determin\u00f3 el genotipo capsular a 38 aislamientos de Haemophilus influenzae no tipificables por derivados al de Bacteriolog\u00eda Cl\u00ednica del INEI-ANLIS \"Dr. Carlos G. Malbr\u00e1n\" en el per\u00edodo 2002-2004. El 78,9% de los aislamientos proven\u00edan de hemocultivos y la mayor parte de ellos estaban asociados a foco respiratorio. El 100% de los aislamientos fueron identificados como H. influenzae no capsulados mediante la t\u00e9cnica de PCR.Haemophilus polysaccharide types have been described (a, b, c, d, e, and f which can be identified by slide agglutination with the most method for capsulated strains membrane Thus, the criteria of Asbury and Cornblath, were recruited from three hospital affiliated to Tehran University of Medical Sciences.As a control group 35 age and sex matched patients with other neurological diseases admitted to the same hospital at the same time, were included in our study. Serum samples were collected before treatment from each patient (within 4 weeks after the disease IgM antibody against cytomegalovirus (CMV was found in 6 cases and 2 controls. 34 patients and 31 controls had high titer of anti Haemophilus influenzae IgG and one patient had evidence Epstein was 5.21 2.97 respectively. Although serologic evidence of all these infections were cases than in related to Eleven cases and 3 controls had high titers of IgG antibody against Haemophilus influenzae type B (titer >8. There is haemolyticus: A Tract the that variant genetically different from...... typical H. influenzae.Methods. means of Analysis from... de vacunas y casos de muerte s\u00fabita del lactante en el Per\u00fa, 2001. \u00bfAsociaci\u00f3n o coincidencia temporal?](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::e53e6396d7036924ac4edb136005a9b2) Vargas H, Javier; Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud. Lima, Per\u00fa.; Su\u00e1rez J, Magna; Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud. Lima, Per\u00fa.; Llamoga S, Alejandro; Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud. Lima, Per\u00fa.; Quispe T, Neyda; Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud. Lima, Per\u00fa.; Alva R, Fernando; Chu C, Julia; Centro Nacional de Producci\u00f3n de Biol\u00f3gicos, Instituto Nacional de Salud. Lima Per\u00fa.; Pereyra S, H\u00e9ctor; Oficina General de Epidemiolog\u00eda, Ministerio de Salud. Lima, Per\u00fa.; Ticona Z, Mar\u00eda; Oficina General de Epidemiolog\u00eda, Ministerio de Salud. Lima, Per\u00fa.; Medrano G, Jorge; Direcci\u00f3n General de Salud de las Personas, Ministerio de Salud. Lima, Per\u00fa.; Cerna D, Carolina; Direcci\u00f3n General de Salud de las Personas, Ministerio de Salud. Lima, Per\u00fa. 2006-01-01 Objetivos: Describir las caracter\u00edsticas cl\u00ednicas, socioecon\u00f3micas, y patol\u00f3gicas de nueve casos de lactantes que fallecieron horas despu\u00e9s de administr\u00e1rseles vacunas antipolio y DPT junto con anti Haemophilus influenzae b o asociada con antihepatitis B o BCG. Materiales y m\u00e9todos: Revisi\u00f3n de la historia cl\u00ednica, entrevista con el equipo de salud a cargo de la vacunaci\u00f3n y con los padres del lactante fallecido. Revisi\u00f3n de los informes del protocolo de autopsia e informes de anatom\u00eda patol\u00f3... [Evaluation of gene Denmark during 2000-20... [Vigilancia de los serotipos antimicrobiana de Haemophilus influenzae en Colombia, 1994-2002.](http://www.revistabiomedica.org/index.php/biomedica/article/view/1211) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Mar\u00eda Victoria Ovalle 2003-06-01 Full Text Available La enfermedad invasora causada por Haemophilus influenzae, serotipo b, ha sido una de las mayores causas de morbilidad y mortalidad en la poblaci\u00f3n infantil; afortunadamente, en algunos pa\u00edses con amplia cobertura de la vacuna conjugada esta situaci\u00f3n ha cambiado. En 1994 se inici\u00f3 en el Grupo de Microbiolog\u00eda un programa de vigilancia de la susceptibilidad antimicrobiana y de los serotipos de aislamientos invasores de H. influenzae, remitidos por los hospitales y Laboratorios de Salud P\u00fablica del pa\u00eds como componente de los programas de vigilancia en red de infecci\u00f3n respiratoria aguda y meningitis bacteriana aguda. El objetivo de este trabajo fue determinar la evoluci\u00f3n de los serotipos y los patrones de susceptibilidad antimicrobiana de los aislamientos invasores de H. influenzae obtenidos de 1994 al 2002 y realizar un nuevo an\u00e1lisis sobre el impacto de la vacuna conjugada de H. influenzae, serotipo b, en Colombia. De 1994 a 2002 se han estudiado 683 aislamientos; 379 (55,5% de pacientes del g\u00e9nero masculino; 370 (54,2% de menores de 1 a\u00f1o; 227 (33,2% de 1 a 5 a\u00f1os; 19 (2,8% de 6 a 14 a\u00f1os; 38 (5,6% de mayores de 14 a\u00f1os, y de 29 (4,2% no se ten\u00eda el dato de la edad; 493 (72,2% fueron recuperados de pacientes con meningitis, 181 (26,5% de neumon\u00eda y 9 (0,9% de otras enfermedades. El 85,1% de los aislamientos fueron H. influenzae, serotipo b, 12,9% no capsulares y 2,0% de otros serotipos (10 a, 1 d, 1 e y 2 f. Del total de aislamientos, 12% fueron productores de beta-lactamasa; 13,9%, resistentes a a cloranfenicol, y 1% a cefuroxima; todos fueron sensibles a ceftriaxona. Durante este per\u00edodo se observ\u00f3 un incremento en la resistencia de los aislamientos a SXT (5% al 13%, pero la diferencia no fue estad\u00edsticamente significativa (p=0,1. Con la vigilancia se pudo determinar una disminuci\u00f3n significativa de los casos de meningitis en los menores de 1 a\u00f1o y en el [Meningitis y artritis por Haemophilus influenzae en un adulto](http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/664) [Directory of Open Access Journals Molina 1988-02-01 Full Text Available Tradicionalmente el Haemophilus influenzae ha sido considerado un germen causante de infecciones en ni\u00f1os; en adultos se lo ha relacionado con Infecciones respiratorias, pero en los \u00faltimos tiempos se han descrito en ellos infecciones severas cuando hay algunos factores predisponentes. Se describe un paciente drogadicto de 30 a\u00f1os con cuadro de meningitis y artritis y prueba de l\u00e1tex y cultivo de LCR positivos para HaemophiIus influenzae, quien recibi\u00f3 tratamiento con ampicilina, 2 gramos Intravenosos cada 4 horas y evolucion\u00f3 a la mejor\u00eda sin secuelas. Se plantea la necesidad de tener en cuenta al Haemophilus influenzae como pat\u00f3geno del adulto y m\u00e1s en aquellas personas con factores predisponentes. Haemophilus influenzae has drug adict patient that presented with cerebrospinal culture Haemophilus influenzae. He was treated with ampicilin 2 gm, I. V. every four hours and improved without sequelae. This microorganism must and at least cultured from the two preceding samples from the Copyright \u00a9 investigated the investigated the cluster encompassing the type and the reference strains H. infecciones invasivas por Haemophilus influenzae en la Argentina en la era de la vacuna conjugada contra el serotipo b durante el per\u00edodo 2005-2010](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412013000400004&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Adriana M. Efron Full Text Available La introducci\u00f3n de la vacuna contra Haemophilus influenzae tipo b en los programas de inmunizaci\u00f3n de muchos pa\u00edses produjo una reducci\u00f3n marcada en la incidencia de enfermedad invasiva causada por este serotipo y en su portaci\u00f3n y un incremento de otros tipos capsulares y de aislamientos no capsulados. Se estudiaron 313 aislamientos de H. influenzae recuperados de sitio est\u00e9ril, provenientes de pacientes pedi\u00e1tricos y adultos con enfermedad invasiva atendidos en 90 hospitales de la Red Nacional de Laboratorios para Meningitis e Infecciones Respiratorias Agudas Bacterianas durante el per\u00edodo 2005-2010. Las patolog\u00edas m\u00e1s frecuentes fueron neumon\u00eda, 40,3 % (n = 126, meningitis, 30,0 % (n = 94 y bacteriemia, 26,5 % (n = 83. En los pacientes pedi\u00e1tricos (n = 279, la mayor frecuencia de aislamientos correspondi\u00f3 a menores de 2 a\u00f1os, 74,5 % (n = 208. Con respecto a la distribuci\u00f3n de tipos, el 61,3 %, correspondi\u00f3 a H. influenzae no capsulados (n = 192; el 20,1 % al b (n = 63; 11,2 % al a (n = 35; 4,8 % al f y 2,6 % a otros. En meningitis predominaron H. influenzae capsulados mientras que en neumon\u00eda y bacteriemia resultaron dominantes los tipos no capsulados. Se determin\u00f3 el biotipo en 306 aislamientos. Todos los aislamientos de tipo a correspondieron al biotipo II; el 66,7 % de los tipo b pertenecieron al biotipo I. Mediante las t\u00e9cnicas de aglutinaci\u00f3n en l\u00e1mina y PCR se estudiaron 220 aislamientos; la concordancia entre ambas fue de 0,982 (IC: 0,92-1,00. En el \u00faltimo a\u00f1o se encontr\u00f3 un aumento significativo del tipo b, lo cual indica la importancia de mantener la vigilancia cl\u00ednica y laboratorial de la enfermedad invasiva por identification of Haemophilus influenzae and H. haemolyticus. When tested on 127 H. 60 all isolates were Table II. Giardiasis to Haemophilus influenza](https://catalog.data.gov/dataset/nndss-table-ii-giardiasis-to-haemophilus-influenza-ad506) U.S. Department of Health & Human Services \u2014 NNDSS - Table II. Giardiasis to Haemophilus influenza - this Giardiasis to Haemophilus influenza](https://catalog.data.gov/dataset/nndss-table-ii-giardiasis-to-haemophilus-influenza-718ed) U.S. Department of Health & Human Services \u2014 NNDSS - Table II. Giardiasis to Haemophilus influenza - 2018. In this Table, provisional cases of selected notifiable diseases Giardiasis to Haemophilus influenza](https://catalog.data.gov/dataset/nndss-table-ii-giardiasis-to-haemophilus-influenza-5cf59) U.S. Department of Health & Human Services \u2014 NNDSS - Table II. Giardiasis to Haemophilus influenza Giardiasis to Haemophilus influenza](https://catalog.data.gov/dataset/nndss-table-ii-giardiasis-to-haemophilus-influenza) U.S. Department of Health & Human Services \u2014 NNDSS - Table II. Giardiasis to Haemophilus influenza - this notifiable diseases (1,000 [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Jos\u00e9 Moreno 2009-03-01 Conclusiones. Los an\u00e1lisis sugieren la vacunaci\u00f3n como medida masiva de control para influenza en adultos mayores de 65 a\u00f1os. Existe un importante vac\u00edo de conocimiento en la efectividad de la vacuna en ni\u00f1os menores de dos a\u00f1os y madres gestantes. [NNDSS - Table II. Giardiasis to Haemophilus influenza](https://catalog.data.gov/dataset/nndss-table-ii-giardiasis-to-haemophilus-influenza-73c8e) U.S. Department of Health & Human Services \u2014 NNDSS - Table II. Giardiasis to Haemophilus influenza - 2014. In this Table, all conditions with a 5-year average annual national total of more than or equals 1,000... [Evaluaci\u00f3n r\u00e1pida del impacto de la vacuna contra Haemophilus influenzae serotipo b en Colombia](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892000000800005&lng=en&tlng=en) [Directory of Open (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Clara In\u00e9s Agudelo 2000-09-01 Full Text Available En 1998, el Ministerio de Salud de Colombia inici\u00f3 la vacunaci\u00f3n contra Haemophilus influenzae b (Hib en menores de 1 a\u00f1o. En 1999 se evalu\u00f3 el impacto de esta intervenci\u00f3n en la incidencia de la meningitis bacteriana aguda (MBA utilizando los datos del sistema de vigilancia por laboratorio que coordina desde 1994 el Grupo de Microbiolog\u00eda del Instituto Nacional de Salud. En el an\u00e1lisis se compar\u00f3 el n\u00famero anual de casos de meningitis por Hib en ni\u00f1os menores de 1 a\u00f1o que se diagnosticaron en el sistema de vigilancia, antes de introducirse la vacuna, con el n\u00famero de casos registrados durante el primer a\u00f1o despu\u00e9s de iniciada la vacunaci\u00f3n. El n\u00famero de casos esperado, seg\u00fan el promedio anual de los diagnosticados entre junio de 1994 y mayo de 1998, se compar\u00f3 con el n\u00famero de casos observado despu\u00e9s de la vacunaci\u00f3n entre junio de 1998 y mayo de 1999. Para controlar la calidad del sistema de vigilancia, se realiz\u00f3 un estudio similar de los casos de meningitis por Streptococcus pneumoniae. En los an\u00e1lisis se incluyeron solamente los datos de los departamentos que hab\u00edan participado con mayor regularidad en la vigilancia. Entre 1994 y 1998 se confirmaron, respectivamente, 45, 37, 61, 64 y 31 casos de MBA por Hib, mientras que en el per\u00edodo posvacunal se esperaban 52 casos y se observaron 31 (P < 0,001. Durante los mismos per\u00edodos anuales se confirmaron tambi\u00e9n 32, 26, 43, 48 y 42 casos de MBA por S. pneumoniae en menores de 5 a\u00f1os, cifras que no representaron una disminuci\u00f3n significativa del n\u00famero de casos esperados. Sin embargo, la reducci\u00f3n observada en los casos de meningitis por Hib fue de 40%, porci\u00f3n no atribuible a cambios en el sistema de vigilancia. Concluimos, por lo tanto, que esta disminuci\u00f3n se debi\u00f3 en su mayor parte a los efectos de la vacunaci\u00f3n. [Evaluaci\u00f3n r\u00e1pida del impacto de la vacuna contra Haemophilus influenzae serotipo b en Colombia](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892000000800005) [Directory of Open (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Agudelo Clara In\u00e9s 2000-01-01 Full Text Available En 1998, el Ministerio de Salud de Colombia inici\u00f3 la vacunaci\u00f3n contra Haemophilus influenzae b (Hib en menores de 1 a\u00f1o. En 1999 se evalu\u00f3 el impacto de esta intervenci\u00f3n en la incidencia de la meningitis bacteriana aguda (MBA utilizando los datos del sistema de vigilancia por laboratorio que coordina desde 1994 el Grupo de Microbiolog\u00eda del Instituto Nacional de Salud. En el an\u00e1lisis se compar\u00f3 el n\u00famero anual de casos de meningitis por Hib en ni\u00f1os menores de 1 a\u00f1o que se diagnosticaron en el sistema de vigilancia, antes de introducirse la vacuna, con el n\u00famero de casos registrados durante el primer a\u00f1o despu\u00e9s de iniciada la vacunaci\u00f3n. El n\u00famero de casos esperado, seg\u00fan el promedio anual de los diagnosticados entre junio de 1994 y mayo de 1998, se compar\u00f3 con el n\u00famero de casos observado despu\u00e9s de la vacunaci\u00f3n entre junio de 1998 y mayo de 1999. Para controlar la calidad del sistema de vigilancia, se realiz\u00f3 un estudio similar de los casos de meningitis por Streptococcus pneumoniae. En los an\u00e1lisis se incluyeron solamente los datos de los departamentos que hab\u00edan participado con mayor regularidad en la vigilancia. Entre 1994 y 1998 se confirmaron, respectivamente, 45, 37, 61, 64 y 31 casos de MBA por Hib, mientras que en el per\u00edodo posvacunal se esperaban 52 casos y se observaron 31 (P < 0,001. Durante los mismos per\u00edodos anuales se confirmaron tambi\u00e9n 32, 26, 43, 48 y 42 casos de MBA por S. pneumoniae en menores de 5 a\u00f1os, cifras que no representaron una disminuci\u00f3n significativa del n\u00famero de casos esperados. Sin embargo, la reducci\u00f3n observada en los casos de meningitis por Hib fue de 40%, porci\u00f3n no atribuible a cambios en el sistema de vigilancia. Concluimos, por lo tanto, que esta disminuci\u00f3n se debi\u00f3 en su mayor parte a los efectos de la vacunaci\u00f3n. children and adults. Created: 11/12/2015 by National in after the introduction of Hib vaccine in 2001. However, a case of H. influenzae type a meningitis was diagnosed in a child from Oman in 2015, which highlights the need to monitor the A; Slack, M P E 2002-01-01 Aims: To define the eight of H parainfluenzae were isolated from 32 girls aged 18 months to 11 years. No other pathogens, such as haemolytic streptococci or yeasts, were present with The most common biotype was biotype II, comprising 57% of the 26 isolates biotyped. Six children had more than one episode of vulvovaginitis caused by H influenzae and a total of 14 children had recurrent vaginal symptoms. Conclusion: Children who have H influenzae vulvovaginitis are at risk of recurrent symptoms. Biotype II is the one most empyema declined meningitis by 86%. series determinants biofilm formation/maturation in vivo. In this mini-review I will summarize the current knowledge about quorum signaling/sensing by H. influenzae, and identify f infection are presented: a three-week-old boy with meningitis and a 62-year-old woman with arthritis and bacteremia. Since 1993 vaccination against H. influenzae type b (Hib) has been offered to Danish children. Hib wild-type but not excision-defective H. influenzae and a decrease in UV sensitivity rec-1 mutant. 14 references, 2 figures acute bacterial meningitis in immunocompetent individuals. We report a case of acute bacterial meningitis in a 14-year-old boy, who was previously healthy and had infection are presented: a three-week-old boy with meningitis and a 62-year-old woman with arthritis and bacteremia. Since 1993 vaccination against H. influenzae type b (Hib) has been offered to Danish children. Hib infection are presented: a three-week-old boy with meningitis and a 62-year-old woman with arthritis and bacteremia. Since 1993 vaccination against H. influenzae type b (Hib) has been offered to Danish children. Hib Haemophilus CDC Stacey Martin discusses what natural and artificial surfaces as biofilm. The aim of the present study was to assay the effect of ten 1,2,4-triazole-ciprofloxacin hybrids microdilution reading made spectrophotometrically at a wavelength of 570 nm (OD570) both to measure bacterial growth and to detect biofilm-forming cells under the same conditions with 0.03-15.63 mg/L, MBIC/MIC = 0.125-8, depending on the compound, and for ciprofloxacin - MIC = 0.03-0.06 mg/L, MBIC = not only against planktonic but also against biofilm-forming Haemophilus spp. cells. Copyright \u00a9 2016 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved. [Prevenci\u00f3n de las neumon\u00edas mediante vacunas](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312014000200012&lng=en&tlng=en) [Directory of (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Roberto Raz\u00f3n Behar Full Text Available La neumon\u00eda es una infecci\u00f3n respiratoria aguda que afecta a los pulmones. La neumon\u00eda adquirida en la comunidad, es la principal causa individual de mortalidad infantil en todo el mundo. Se calcula que cada a\u00f1o mueren por su causa m\u00e1s de 1,5 millones de ni\u00f1os menores de 5 a\u00f1os, lo que supone el 18 % de todas las defunciones de este grupo etario en todo el mundo. Diversos agentes infecciosos, particularmente los virus y bacterias, causan neumon\u00eda, y son los m\u00e1s comunes el Streptococcus pneumoniae -la causa m\u00e1s com\u00fan de neumon\u00eda bacteriana en ni\u00f1os-; el Haemophilus influenzae de tipo b -la segunda causa m\u00e1s com\u00fan de neumon\u00eda bacteriana-; as\u00ed como el virus sincitial respiratorio. La prevenci\u00f3n de la neumon\u00eda infantil es un componente fundamental de toda estrategia para reducir la mortalidad infantil. La inmunizaci\u00f3n, particularmente contra el Haemophilus influenzae de tipo b, los neumococos, el sarampi\u00f3n y la tos ferina, es la forma m\u00e1s eficaz de prevenirla. Por tal motivo se considera importante una revisi\u00f3n y actualizaci\u00f3n de las principales vacunas existentes hoy en d\u00eda. [Aislamiento de distintos serotipos de Haemophilus influenzae en muestras profundas Available Haemophilus responsable de diversas enfermedades humanas como sepsis, meningitis, celulitis y osteoartritis. En este trabajo se investig\u00f3 la recuperaci\u00f3n de distintos serotipos de Hi en muestras profundas de pacientes pedi\u00e1tricos. Se estudiaron 179 aislamientos de 146 ni\u00f1os durante el periodo 1996-2002 en el Laboratorio de Microbiolog\u00eda del Hospital de Ni\u00f1os Superiora Sor Mar\u00eda Ludovica, Argentina. La distribuci\u00f3n de los serotipos fue la siguiente: 1 a, 112 b, 1 c,1 d, 4 e, 3 f y 24 no tipificables. A partir del establecimiento de la estrategia de vacunaci\u00f3n universal anti Hi b en 1998 se observa una disminuci\u00f3n notable del serotipo b y un aumento relativo de otros y no tipificables.Haemophilus influenzae (Hi is the causative 146 patients were studied, period 1996-2002, at the Microbiology Laboratory, Hospital de Ni\u00f1os Superiora Sor Mar\u00eda Ludovica, Argentina. The serotype distribution was:1 a, 112 b,1 c,1 d, 4 e, 3 f y 24 no typable. Since the beginning of universal Hi b vaccination in 1998, we have observed the fast decrease of serotype b and a relative increase of other serotypes. [Impacto del neumococo y de los virus influenza en ni\u00f1os y adultos : su prevenci\u00f3n con vacunas](http://www.anfamed.edu.uy/index.php/rev/article/view/123) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Mar\u00eda Hortal 2015-07-01 Full Text Available Durante siglos las enfermedades infecciosas han diezmado a poblaciones enteras, por lo que se ha procurado descubrir su causa y as\u00ed lograr su prevenci\u00f3n. Actualmente, la vacunaci\u00f3n es una de las intervenciones en salud m\u00e1s costo-efectivas para reducir la morbilidad y mortalidad por enfermedades infecciosas. La historia as\u00ed lo confirma con la erradicaci\u00f3n de la viruela, y el control de la poliomielitis y del sarampi\u00f3n a nivel mundial. En Uruguay, el inicio de la vacunaci\u00f3n obligatoria contra la viruela se remonta a 1911, en tanto que la vacunaci\u00f3n contra la poliomielitis y el sarampi\u00f3n, se implementaron en 1957 y 1966 respectivamente. Dentro de las enfermedades inmunoprevenibles, las infecciones respiratorias agudas son notoriamente las m\u00e1s frecuentes. Su impacto urgi\u00f3 la necesidad de contar con medidas de control. La neumon\u00eda, aunque se observa en todas las edades, predomina en los extremos de la vida. En la infancia, en menores de cinco a\u00f1os, es una de las causas m\u00e1s frecuentes de hospitalizaci\u00f3n y en las poblaciones m\u00e1s desfavorecidas provoca elevada mortalidad. En los adultos con comorbilidades ocurre en todas las edades, pero es m\u00e1s frecuente en los mayores de 65 a\u00f1os, en los que patolog\u00edas asociadas aumentan el riesgo vital, que es mayor cuanto mayor es la persona. Una vez controladas las neumon\u00edas por la vacuna conjugada de Haemophilus influenzae tipo b, el agente bacteriano de mayor frecuencia es Streptococcus pneumoniae y, entre los virus respiratorios, los brotes anuales y las pandemias por virus influenza contribuyen al aumento de hospitalizaciones y decesos por neumon\u00eda. Cuando ambos agentes se asocian en un paciente, sus efectos se potencian mutuamente y sus resultados pueden ser fatales. En consecuencia, la prevenci\u00f3n de esas infecciones con las vacunas disponibles, neumoc\u00f3ccica y de influenza, es una prioridad de Salud P\u00fablica para asegurar la supervivencia infantil y disminuir costos sociales y econ\u00f3micos. [Lower airway colonization and inflammatory response in COPD: Available Disease Infection Section, National Heart and Lung Institute, Imperial College, London, United Kingdom; 2King's College London, London, United Kingdom Abstract: Bacterial infection establish persistent infection in the lower respiratory tract. The presence of bacteria in the lower respiratory tract in stable COPD is termed colonization; however, there is increasing evidence that this is not an innocuous phenomenon but is associated with airway inflammation, increased symptoms, increased risk for discuss host immunity that offers protection against H. in COPD. In addition, we examine the role between virus infections, and review role of effect COPD outcomes. focuses predominantly on data derived from human studies but will refer to animal studies where they health problem inthe developing world. We evaluated the safety vacuna contra Haemophilus influenzae tipo b en ni\u00f1os menores de dos a\u00f1os de edad en Colombia The cost-effectiveness of Haemophilus influenzae type b vaccine for children under 2 years of age in Colombia](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000900005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Nelson Alvis Guzm\u00e1n Text Available vacunas conjugadas contra Haemophilus influenzae tipo b (Hib son la herramienta m\u00e1s importante para prevenir la mayor\u00eda de las enfermedades invasoras producidas por dicho pat\u00f3geno, pero debido a su costo, a\u00fan no se han introducido mundialmente de manera masiva. En el presente estudio se determin\u00f3 la relaci\u00f3n costo-efectividad de una vacuna contra Hib para prevenir la neumon\u00eda y la meningitis bacterianas en ni\u00f1os menores de 2 a\u00f1os en Colombia. M\u00c9TODOS: Se estimaron los costos directos e indirectos de la neumon\u00eda y la meningitis hospitalaria y siguiendo las recomendaciones de la Organizaci\u00f3n Mundial de la Salud (OMS, la relaci\u00f3n costo-efectividad de los programas de vacunaci\u00f3n contra Hib. Se estimaron tambi\u00e9n las razones de costos por caso evitado de enfermedad invasora por Hib y el costo por a\u00f1o de vida salvado en dos situaciones hipot\u00e9ticas: con vacunaci\u00f3n contra Hib (cobertura vacunal: 90% y sin vacunaci\u00f3n. RESULTADOS: El costo medio del tratamiento hospitalario de un caso de neumon\u00eda fue de 611,5 d\u00f3lares estadounidenses (US$ (intervalo de confianza del 95% [IC95%]: 532,2 - 690,8, el costo medio del tratamiento hospitalario de un caso de meningitis fue de US$ 848,9 (IC95%: 716,8 - 981,0 y el costo por caso evitado de enfermedad invasora por Hib, de US$ 316,7 (IC95%: 294,2 - 339,2. La relaci\u00f3n costo-efectividad en la hip\u00f3tesis con vacunaci\u00f3n fue de 2,38, frente a 3,81 en la hip\u00f3tesis sin vacunaci\u00f3n. CONCLUSI\u00d3N: La aplicaci\u00f3n de un programa adecuado de vacunaci\u00f3n contra Hib en Colombia puede prevenir cerca de 25 000 casos de enfermedad invasora por a\u00f1o, lo que representa un ahorro de por lo menos US$ 15 millones anuales. Adem\u00e1s, puede evitar cerca de 700 defunciones y salvar anualmente 44 054 a\u00f1os de vida.OBJECTIVE: Conjugate vaccines are the best public health invasive diseases caused by Haemophilus influenzae b (Hib, but cost of the vaccines has (Hib) can be the cause of and is mainly observed affecting children and immuno-compromised patients. report a with of infants in Latin America Nueva vacuna combinada DTPw-HB/Hib para la vacunaci\u00f3n primaria y de refuerzo de menores de un a\u00f1o en Am\u00e9rica Latina](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000300006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Miguel Tregnaghi 2006-03-01 , la Organizaci\u00f3n Mundial de la Salud (OMS recomend\u00f3 que se incluyeran vacunas conjugadas contra Haemophilus influenzae tipo B (Hib en los programas de vacunaci\u00f3n de ni\u00f1os menores de un a\u00f1o, siempre que ello estuviera en consonancia con las prioridades nacionales. La compa\u00f1\u00eda GlaxoSmithKline Biologicals ha creado una nueva vacuna pentavalente que es una combinaci\u00f3n de la vacuna contra la difteria (D, el t\u00e9tanos (T y la tos ferina (P (con ant\u00edgeno tosfer\u00ednico a base de c\u00e9lulas completas y las vacunas contra la hepatitis B (HB y contra Haemophilus influenzae tipo B (Hib (DTPw-HB/Hib, con un total de 5 \u00b5g de fosfato de polirribosilrribitol (FPR. Hemos evaluado la inmunogenia y reactogenia observadas al aplicarse las dosis primaria y de refuerzo de esta nueva vacuna a ni\u00f1os sanos y las hemos comparado con las observadas al aplicar un r\u00e9gimen de referencia a base de las vacunas autorizadas DTPw-HB (Tritanrix y antiHib (Hiberix en forma de inyecciones simult\u00e1neas. M\u00c9TODOS: Llevamos a cabo un estudio aleatorizado y con doble enmascaramiento de septiembre de 1998 a agosto de 1999 para establecer la inmunogenia y reactogenia observadas al administrarles a ni\u00f1os sanos la nueva vacuna combinada pentavalente (DTPw-HB/Hib en una sola inyecci\u00f3n, y compararlas con las observadas con el r\u00e9gimen de referencia. RESULTADOS: Se obtuvieron excelentes respuestas inmunitarias con ambos reg\u00edmenes. Todos los ni\u00f1os vacunados en ambos grupos alcanzaron concentraciones s\u00e9ricas protectoras de anticuerpos antiFPR > 0,15 \u00b5g un mes despu\u00e9s de recibir la dosis primaria. La vacuna combinada DTPw-HB/Hib no dio resultados inferiores a los obtenidos con las vacunas autorizadas en t\u00e9rminos de los porcentajes de seroprotecci\u00f3n, seropositividad y respuesta frente a todos los componentes antig\u00e9nicos de la vacuna. La persistencia de anticuerpos contra todos los ant\u00edgenos contenidos en ella hasta el momento en que se administr\u00f3 la dosis de refuerzo fue parecida en ambos grupos, y [Quorum signaling and determinants biofilm formation/maturation in vivo. In this mini-review I will summarize the current knowledge about quorum signaling/sensing by this organism, consisting of lung epithelial NCI-H292 cells on permeable supports to study the passage of H. influenzae through lung [Oropharyngeal colonization by Haemophilus influenzae in healthy from Taubat\u00e9 Paulo, prior to the Haemophilus influenzae type b program in Haemophilus influenzae b no Open Full Text Available one important bacterial of otitis and sinusitis. H. influenzae type b (Hib is one of the main causes of meningitis, pneumonia, and septicemia in nonvaccinated children under 6 years of age. The aims of this study were to determine the prevalence of H. influenzae and Hib oropharyngeal colonization prior to the onset of the Hib vaccination program in Brazil in previously healthy children and to assess the susceptibility profile of this microorganism to a oropharynx swabs from 987 children under 6 years of age who were enrolled in 29 day-care centers in Taubat\u00e9 (a city of S\u00e3o Paulo state, Brazil between July and December 1998. RESULTS: The prevalence of H. (range, 0.0 - The low prevalence of colonization by penicillin-resistant it \u00e9 um dos mais importantes agentes bacterianos de otites e sinusites. Em crian\u00e7as menores de seis anos de idade n\u00e3o vacinadas contra o H. influenzae do saud\u00e1veis por Hib e avaliar o perfil de suscetibilidade desses microorganismos a um grupo seleto de antimicrobianos, que habitualmente s\u00e3o utilizados swabs da anos de idade que freq\u00fcentavam 29 creches da [A Mary PE Slack 2015-06-01 Full Text Available In an era when Haemophilus influenzae b vaccine is widely of H. are now the of invasive H. influenzae infections, including respiratory of NTHi as a cause of non-bacteraemic CAP in children is less clear. In this review the evidence for the role of NTHi and capsulated strains of H. b na incid\u00eancia de meningites crian\u00e7as anos de idade. M\u00c9TODOS: Utilizou-se o delineamento tipo \"antes-depois\" (julho/99-junho/2001 Estado de Goi\u00e1s. caso de meningite bacteriana seguiu os crit\u00e9rios da Organiza\u00e7\u00e3o Mundial de utilizados o teste de chi2 e o t de Student. Valores de p<0,05 foram considerados estatisticamente significantes. RESULTADOS: Foi detectada meningite bacteriana em 979 crian\u00e7as no de estudo. A incid\u00eancia de meningite no segundo ano p\u00f3s-vacina, significando 78% de redu\u00e7\u00e3o no Assim, se vigil\u00e2ncia cause of respiratory infections. Resistance to antibiotics is an emerging trend in alternative prevention or treatment strategies are required. and, if able to produce substances that inhibit NTHi growth, may have a role as this study, ammonium 100 substance inactivated by protease enzymes and had a molecular 30 as determined by size exclusion chromatography. When the substance tested against bacteria from eight Gram-negative and three Gram-positive genera, only Haemophilus spp. were inhibited. Quantitative PCR testing showed the be 'haemocin', the previously described bacteriocin of H. influenzae together with narrow-spectrum activity, suggest the substance may be a novel bacteriocin, and there is potential for this H. haemolyticus isolate to function All rights reserved. [Quantitation of antibody-secreting cells in the previously been studied at the cellular level. In order to been studied at the cellular level. In order to CDC Stacey Martin discusses what and (NCEZID); National since the introduction of the Hib conjugate vaccine in The Netherlands. Of 14 a polysaccharide capsule. The typeable strains (such as b as part of the normal microbiome in the nasopharynx, from where it may spread down to the lower respiratory tract. In this context it is no longer a commensal and becomes an important respiratory pathogen which often fail to clear recurrent/persistent infection and chronic inflammation with consequent lung pathology. This review will summarise the current literature about the lung immune response of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Olga C Aulet de Saab 2001-05-01 Full Text Available The aim of this study was to compare the efficacy of conservation by freezing from the media allowed excellent recovery. Use of cotton swaps as supporting material, with or without addition of cryoprotective agents, did not modify H. influenzae at room temperature percentage. [Immunogenicity and tolerability of inactivated flu vaccine In high risk and healthy children Inmunogenicidad y tolerancia de la vacuna inactivada anti-influenza en ni\u00f1os en alto riesgo y en controles sanos](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802007000400005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Maria Luisa Avila Aguero 2007-08-01 Full Text Available We conducted this open study to evaluate the immunogenicity and safety of the inactivated influenza vaccine, Imovax Gripe\u00ae in 154 children between 6 and 36 months of age at high risk of influenza- related complications, and in a reference group of 64 healthy children. The study was conducted over two flu seasons, in which the vaccine contained the same A strains but different B strains. The results for the A/H3N2 and A/H1N1 strains from the two flu seasons were pooled, but those for the B strains were not. Anti-hemagglutinin (HA antibody titers were determined before, each and safety any adverse event observed, included or not in list each group of and healthy with those observed in previous studies The equally well tolerated by all study groups. Reactogenicity was low and similar in both high-risk and healthy children. Overall from 9.5% to 15.4% of at-risk children and 12% of children at high-risk of influenza related complications.Se realiz\u00f3 un estudio cl\u00ednico abierto para evaluar la inmunogen\u00edcidad y la seguridad de la vacuna inactivada anti-influenza, Imovax Gripe\u00ae, en 154 ni\u00f1os entre 6 y 36 meses de edad con alto riesgo de complicaciones ligadas a la influenza, y en un grupo de referencia de 64 ni\u00f1os sanos. El estudio fue [First and mortality, even with prompt medical and surgical intervention. We describe case of 67-year-old required a below the knee amputation. This is the first documented case of Haemophilus influenza a Full Text Available da invasiva por Hib. FONTE DOS DADOS: Pesquisa nas bases de dados do MEDLINE, LILACS, publica\u00e7\u00f5es t\u00e9cnicas de organiza\u00e7\u00f5es internacionais, diretrizes nacionais deste artigo. Artigos publicados em per\u00edodo anterior ao da refer\u00eancias de doen\u00e7a invasiva por Hib nos diversos pa\u00edses em que seu uso foi incorporado \u00e0 rotina de vacina\u00e7\u00e3o das invasiva explica\u00e7\u00f5es para esses eventos, bem como a identifica\u00e7\u00e3o das medidas a serem implementadas para evitar o reaparecimento da doen\u00e7a. CONCLUS\u00d5ES: O uso da vacina impact of influenzae OF DATA: This a search of MEDLINE, LILACS, technical reports, national and international guidelines (publications from 1991 to 2005. The keywords Haemophilus influenzae type b, immunization, impact and effectiveness, alone or combination, were used influenzae influenzae meningitis caused by Haemophilus influenzae type b bacteria. This illness is [Mielitis transversa Text Available La mielitis transversa es una enfermedad inflamatoria que se caracteriza por disfunci\u00f3n de la m\u00e9dula espinal. Las causas reconocidas de mielitis transversa son autoinmunes, enfermedades desmielinizantes, post infecciosas y post vacunales, aunque hasta el 50% de los casos son idiop\u00e1ticas. Las vacunas contra la rub\u00e9ola, paperas, rabia y gripe estacional han sido asociadas a diversos trastornos neurol\u00f3gicos, como el S\u00edndrome de Guillain Barr\u00e9, la encefalomielitis diseminada aguda (ADEM y la mielitis transversa. Como mecanismo preventivo luego de la pandemia de 2009, en febrero del a\u00f1o 2010 se inici\u00f3 en nuestro pa\u00eds la campa\u00f1a de vacunaci\u00f3n contra la Influenza A (H1N1. Se presenta el caso de una paciente con hipoestesias que aparecieron cuatro d\u00edas despu\u00e9s de haber recibido la vacuna monovalente anti-influenza A (H1N1 y progresaron con evidente nivel sensitivo. La paciente cumpl\u00eda criterios diagn\u00f3sticos de mielitis transversa, seg\u00fan el Transverse Myelitis Consortium Working Group. Tuvo remisi\u00f3n de las im\u00e1genes de la resonancia magn\u00e9tica y estabilidad cl\u00ednica sin tratamiento con corticoides. Se discuten aspectos diagn\u00f3sticos, pron\u00f3sticos y terap\u00e9uticos de esta as analysis of H. these HPs to determine their are influenzae therefore, these enzymes chart review of patients who presented to our hospital from January 2013 to December 2014 with symptoms of acute urethritis which samples was performed. Haemophilus spp of 413 urethral samples (12.6%) received acute urethritis during the study period. Seven cases to Haemophilus influenzae and 45 cases to clinical presentation was (71%). Eight per cent were HIV-infected patients, and 60% were men who have sex with men. Haemophilus spp was isolated as a single pathogen in 6.8% (28 of 413) of cases. Seventeen per cent of and five of them denied having had another sexual contact apart from this exposure. In all cases in which follow-up available, empirical achieved of the patients from the evaluated area. It affected men regardless their sexual orientation or HIV status. Unprotected oral sex could play a role in its transmission. The limitations of the study (small sample size and lack of a representative control group) do not allow to prove the true pathogenic role of Haemophilus spp in acute urethritis. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a was associated exclusively with conjunctivitis. In this work construction of the las gene, hypothetically responsible for this Neisseria meningitidis virulent strains and its transfer to non BPF H. influenzae strains. The effect of the las the TNF and transformed (in eight log scale of folding change RNA expression. This is the first molecular study involving the las transfer to search an elucidation of the pathogenic factors by horizontal intergeneric transfer from meningococci to H. influenzae. [Influenza. Vacunas cl\u00e1sicas y novedosas a las puertas de otra pandemia](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200005&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Raiza Mart\u00ednez 2006-08-01 Full Text Available Los virus de la influenza A, adem\u00e1s del hombre, infectan otros mam\u00edferos y una gran variedad de especies de aves. Desde 1997 se sabe que cepas aviares son capaces de infectar al hombre provocando una enfermedad generalmente leve. El brote actual de gripe aviar H5N1 en humanos ha puesto en alerta a la comunidad cient\u00edfica internacional, no solo por su elevada mortalidad sino por su potencialidad en la generaci\u00f3n de una nueva pandemia. Las autoridades sanitarias han puesto en marcha un amplio programa para la preparaci\u00f3n ante esta contingencia, que abarca diferentes campos, desde el diagn\u00f3stico y la detecci\u00f3n precoz de los brotes tanto en animales como en humanos, la caracterizaci\u00f3n sistem\u00e1tica de las cepas circulantes, el sacrificio de aves infectadas, la producci\u00f3n masiva de antivirales y por supuesto el desarrollo y producci\u00f3n a gran escala de vacunas eficaces. En este \u00faltimo tema se trabaja intensamente tanto en el mejoramiento de las vacunas ya existentes como en la b\u00fasqueda de alternativas basadas en tecnolog\u00edas de nueva generaci\u00f3n. [Detection of Haemophilus detect Haemophilus influenzae. Its specificity was determined by analysis of 29 strains of 11 different Haemophilus spp. and was compared and a of 96.0% culture. 20 P6 PCR-positive cases, 18 were confirmed by fucK as H. influenzae. Five (5.9%) of 84 nasopharyngeal aspirates from adult PCR positive. We conclude that the P6 real-time PCR is both sensitive and programme in 1993 may have meningitis (i.e. increasing frequency other clinical information and laboratory findings were collected from all 65 confirmed cases of H. influenzae meningitis during the period 1994-2005. Twenty-nine patients (45%) were 24 years old [median 62 years (range 25...... infected with Hib, two cases (13%) were identified as true vaccine failures. Six patients (9%) died; one premature infant infected with f non-typeable H. influenzae. Hearing loss was reported in 16% of the surviving children and in 10% of the surviving adults... [Administraci\u00f3n de vacunas y casos de muerte s\u00fabita del lactante en el Per\u00fa, 2001: \u00bfasociaci\u00f3n o coincidencia temporal?](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342006000100007&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Javier Vargas H Full Text Available Objetivos: Describir las caracter\u00edsticas cl\u00ednicas, socioecon\u00f3micas, y patol\u00f3gicas de nueve casos de lactantes que fallecieron horas despu\u00e9s de administr\u00e1rseles vacunas antipolio y DPT junto con anti Haemophilus influenzae b o asociada con antihepatitis B o BCG. Materiales y m\u00e9todos: Revisi\u00f3n de la historia cl\u00ednica, entrevista con el equipo de salud a cargo de la vacunaci\u00f3n y con los padres del lactante fallecido. Revisi\u00f3n de los informes del protocolo de autopsia e informes de anatom\u00eda patol\u00f3gica y entrevista con los m\u00e9dicos legistas y pat\u00f3logos. Evaluaci\u00f3n de control de calidad de las vacunas administradas. Realizaci\u00f3n de ex\u00e1menes de inmunohistoqu\u00edmica de tejidos pulmonares para el diagn\u00f3stico de virus. Resultados: Entre agosto y diciembre de 2001 se notificaron en el Per\u00fa, nueve casos de fallecimiento de lactantes entre ocho horas y tres d\u00edas despu\u00e9s de la aplicaci\u00f3n de vacunas DPT y antipolio. Despu\u00e9s de la vacunaci\u00f3n, los s\u00edntomas iniciaron entre 30 minutos a tres horas y la muerte se produjo entre ocho a 78 horas. Los s\u00edntomas m\u00e1s frecuentes fueron irritabilidad 8/9, llanto persistente 6/9, somnolencia 5/9, sangrado por nariz y boca 5/9. Todos los casos procedieron de familias pobres o muy pobres. El control de calidad se corrobor\u00f3 que las vacunas cumplieron con los est\u00e1ndares establecidos por la OMS. Las causas de la muerte reportadas en las necropsias fueron neumon\u00eda en dos casos y edema pulmonar en cinco casos, los informes de anatom\u00eda patol\u00f3gica mostraron una neumonitis intersticial y meningitis linfocitaria. No se observaron efectos citop\u00e1ticos virales en los tejidos pulmonares y los estudios toxicol\u00f3gicos fueron negativos. Conclusiones: No existe evidencia de una asociaci\u00f3n causal entre los eventos fatales y la administraci\u00f3n de las vacunas. [The capsule biosynthesis locus and may have been recruited species gene capsular material, show high similarity to the corresponding to H. influenzae. In contrast to H. influenzae, the capsule locus in H. sputorum is not associated with transposases or other transposable elements. Our data suggest that the Seroepidemiology of Haemophilus Influenzae Type b in Children Under 6 Years Old in Khorramabad, Iran](http://aums.abzums.ac.ir/browse.php?a_code=A-10-1-103&slc_lang=en&sid=1) [Directory of Open Access Journals b (Hib is now recognized as of bacterial meningitis in Asia. Polyribosil Ribitol Phosphate (PRP capsule are in all of the strains and IgG antibodies can be target. Due to limited studies on H. influenzae type b in the country and the lack of sufficient information on the status of carriers, achieve a comprehensive model of the spread of the bacteria in the carrier's most vulnerable children is the aim of this study. Material and Methods: In this study, 194 (49% female and 51% male serum samples were collected from children 6 years old referred to medical centers in Korram Abad. The serological study years-old screened for H. influenzae-specific IgG antibodies with ELISA, 6 (3 percent were IgG seropositive. Prevalence of bacteria in children under 2 years was 67% that demonstrated no significant association between seropositivity in subjects and place of residence of children with the prevalence of bacteria. Conclusion: The prevalence of H. influenzae type b seropositivity in our study was 3% of the total sample. In current study, a higher percentage of males than bacteria in patients younger than 2 years. The age factor is a variable that positively affects serum. Regarding to non-Hib vaccination in children, the presence of the bacteria in children can be and most often serotype b is involved. We report here a case severe systemic infection due to non-encapsulated blood and from fluid of left knee, but several other affected. The relationship influenzae biotype III H. aegyptius is recent reports of fatal illness caused by a H. importance of (Hif) disease single Hif clone, which may be undergoing expansion. The need due to Nontypable influenzae: relapsing Haemophilus influenzae meningitis in a boy at the age of nearly 3 years and 4.2 years who had been successfully vaccinated against H. influenzae serotype with development of is considered to be the predisposing condition. literature non-motile, is a commensal of upper respiratory tract. Genitourinary infection due to H. but bacteremia associated with such infection appears to be rare. We report a case of 19 years young primigravida with complaints of amenorrhea of 32 weeks and 5 days, pyrexia, abdominal pain and blood stained discharge per vaginum. H. influenzae type B was recovered from the genital tract as well as blood of the mother indicating maternal septicemia. Septicemia caused by H. influenzae type B in pregnant women following vaginal colonization and infection is rare. It has been reported in many parts of world over the years; to the best of our knowledge this is the first reported case from Nepal. H. influenzae should be considered as a potential maternal, fetal, pathogen. [Impacto de la vacunaci\u00f3n contra Haemophilus influenzae Cuba](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892001000900004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Dickinson F\u00e9lix O. 2001-01-01 Full Text Available Objetivo. Determinar el impacto de la vacunaci\u00f3n de menores de 2 a\u00f1os en Cuba contra Haemophilus influenzae tipo b (Hib, principal agente causal de la meningitis bacteriana en ese pa\u00eds. M\u00e9todos. La disponibilidad de vacunas conjugadas eficaces contra Hib motiv\u00f3 la vacunaci\u00f3n nacional en 1999 de ni\u00f1os menores de 2 a\u00f1os, que alcanz\u00f3 una cobertura de 97%. El impacto se evalu\u00f3 mediante el Sistema Nacional de Vigilancia de Meningoencefalitis Bacterianas (SNVMEB. Resultados. La eficacia global de la vacunaci\u00f3n se estim\u00f3 en 99% y la incidencia general de la meningoencefalitis por Hib disminuy\u00f3 de 1,3 a 0,6 por 100 000 habitantes (46,1%, observ\u00e1ndose la mayor reducci\u00f3n en ni\u00f1os menores de 5 a\u00f1os (56,1%. En los menores de 1 a\u00f1o se redujo 70,5% y en el resto de los grupos de menores de 5 a\u00f1os disminuy\u00f3 entre 25,9 y 49,6%. En el grupo diana para la vacunaci\u00f3n, la incidencia se redujo 61,1%; entre los ni\u00f1os de este grupo que contrajeron la meningoencefalitis por Hib, solamente 8 (24,2% estaban vacunados, 7 de ellos con una sola dosis, aplicada 1 mes antes de enfermar. Conclusiones. Se ha demostrado que la vacunaci\u00f3n a gran escala de los ni\u00f1os menores de 2 a\u00f1os contra Hib en Cuba a trav\u00e9s del SNVMEB ha logrado disminuir notablemente la incidencia de meningoencefalitis por Hib. [Difficult identification of close phylogenetic relationship, it is to discriminate H. influenzae Biochemical 16S the P6 hybridization option for well-equipped available protocol will not lead to conclusive results in all instances. It can as a second line approach. Occasional ambiguous results have be rRNA Available most commonly found pathogenic bacteria in pediatric otitis media and lower respiratory tract infections. Bacterial attachment to pharyngeal cells and proliferation may be necessary for infection. In the presence of human milk, attachment of HI to pharyngeal cells and colonization may be inhibited. To evaluate the protecting role of breast milk, infants with different feeding methods. Methods: Between and a throat culture was taken in all of them. The incidence of HI was evaluated using Haemophilus Test Agar The mean age and weight of cases in the three groups were not statistically different. Conclusion: These data suggest that human milk protects the throat healthy therapy whom were HIV infected) children from March 1998 to June 2004. HIV infected children had proportion HIV infected children than HIV of HIV infected than HIV uninfected (P=0.001). The estimated either endogenous, by a strain with a DNA [Contribution of the major and minor subunits to fimbria-mediated adherence of Haemophilus influenzae to human van factors the pathogen Haemophilus in that they mediate bacterial adherence to human eukaryotic cells. The contribution of major (HifA) and Haemophilus with a Cluster Group for unequivocally identified as either species. We have analyzed the same while identification rRNA identified as fucose (MLST) scheme, have sporadically been reported single H. influenzae MLSA group II. We also found evidence of interspecies recombination between H. influenzae and important for disease surveillance and treatment. Copyright \u00a9 2015, American Haemophilus were isolated of molecular techniques such as PCR for species discrimination. Here we of algorithm as NTHi (n = 22), Hh (n = 27) or equivocal (n = 11), were further characterised by sequencing of and and PCR results were used to define NTHi for this study. Two hpd real time PCR assays (hpd#1 and hpd#3) and a panel of common respiratory bacteria, unlike the iga PCR, and the hpd#3 able detect between NTHi and could completely differentiate from Hh. The hpd#3 real time to be species algorithm as NTHi (n = 22, Hh (n = 27 or equivocal (n = 11, were further characterised by sequencing of and and PCR results were used to define NTHi for this study. Two hpd real time PCR assays (hpd#1 and hpd#3 and a panel of common respiratory bacteria, unlike the iga PCR, and the hpd#3 NTHi could completely differentiate from Hh. The hpd#3 real time to be y futuro](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312003000400006) of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Roberto Raz\u00f3n Behar 2003-12-01 Full Text Available Las infecciones respiratorias agudas (IRA, son las causas m\u00e1s frecuentes de morbilidad en el mundo y de elevada mortalidad particularmente en los pa\u00edses en desarrollo. Los virus son los agentes etiol\u00f3gicos m\u00e1s frecuentes. Los virus influenza a y b, y el virus sincitial respiratorio (VSR son los m\u00e1s importantes por la severidad de la enfermedad y por la alta transmisibilidad. Las bacterias, principalmente el Streptococcus pneumoniae (neumococo, y el Haemophilus influenzae tipo B (Hib, son las causas m\u00e1s frecuentes de neumon\u00edas adquiridas en la comunidad. Las estrategias generales en la prevenci\u00f3n y en el tratamiento se basan en: evaluar sistem\u00e1ticamente los conocimientos existentes acerca de las IRA, divulgarlos y aplicarlos, desarrollar una gu\u00eda nacional para las indicaciones de los antibi\u00f3ticos, aplicar las vacunas existentes: DPT, triple viral (SRP, anti-Hi, incrementar la inmunizaci\u00f3n contra el neumococo y los virus influenza, particularmente en grupos de riesgo y desarrollar y evaluar nuevas vacunas contra el VSR, Haemophilus influenzae no serotipificables, Bordetella pertussis y otros agentes infecciosos que afectan el aparato respiratorio. Se realiza una revisi\u00f3n de nuevos agentes y drogas antivirales, as\u00ed como del desarrollo presente y futuro de las inmunizaciones contra los principales virus y bacterias, que causan infecciones respiratorias agudas.Acute respiratory infections (ARI are the most frequent cause of morbidity and of the high mortality in the world, particularly in the developing countries. The viruses are the most common etiological agents.The influenza a and b viruses and the syncytial respiratory virus (SRV are the most important due to the severity of the disease and to their high (Pneumococcus, frequent cause of pneumonias acquired in the community. The general strategies in the prevention and [Reacciones adversas a la vacuna contra influenza A (H1N1 en trabajadores de salud de una instituci\u00f3n p\u00fablica peruana](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832011000300003&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Pedro P. \u00c1lvarez-Falcon\u00ed 2011-07-01 Full Text Available Introducci\u00f3n: En abril de 2009 se produjo un brote de influenza en la frontera de M\u00e9xico y EE UU por el nuevo virus A(H1N1 2009. La pandemia no fue severa y la vacuna aplicada en diversos pa\u00edses produjo diversas reacciones adversas a medicamentos (RAM. Objetivos: Evaluar la posible relaci\u00f3n entre las RAM notificadas espont\u00e1neamente y la vacunaci\u00f3n en trabajadores de salud de un instituto. As\u00ed mismo, identificar t\u00f3picos afines a las RAM por dicha vacuna. Dise\u00f1o: Estudio prospectivo y descriptivo basado en la notificaci\u00f3n espont\u00e1nea. Instituci\u00f3n: Local central del Instituto Nacional de Salud en Lima. Participantes: Trabajadores de salud. Metodolog\u00eda: Las RAM notificadas espont\u00e1neamente fueron registradas en Hojas RAM. Se aplic\u00f3 un algoritmo para buscar una relaci\u00f3n causa-efecto. Principales medidas de resultados: Reacciones adversas a la vacuna influenza A(H1N1. Resultados: Hubo tres notificaciones espont\u00e1neas entre 148 trabajadores de salud vacunados (2% contra la influenza A(H1N1 2009. La relaci\u00f3n causa-efecto fue 'cierta' para fiebre y fatiga y 'posible' para afecciones respiratorias en tres mujeres (faringitis aguda, catarro nasal agudo, bronquitis catarral. Conclusiones: Entre los pocos trabajadores de salud que presentaron RAM, las afecciones respiratorias con una relaci\u00f3n considerada 'posible' podr\u00eda interpretarse que las mujeres ser\u00edan m\u00e1s sensibles para esa RAM comparadas con los varones. Las RAM fiebre y fatiga alcanzaron una relaci\u00f3n considerada 'cierta'. La menor cantidad de infectados en personas de tercera edad en el pa\u00eds y en otros podr\u00eda explicarse por la presencia de 'anticuerpos protectores' en ellos. and birth weights from... [Radioimmunoassay of capsular polysaccaride antigens of groups A and C and Haemophilus influenza type b in the Haemophilus influenza type b polysaccharide and 2 ng/ml of the groups A and C meningococcal polysaccharides were and the causative agent was detected in the CSF of 14 out of 15 patients with Haemophilus influenza type b meningitis, in 18 out of 23 patients with group A, and in two out of four patients with group C meningococcal meningitis. In some cases the antigen could be detected even after three days of antibacterial treatment. No false positive reactions were seen. The assay procedure could be shortened to approximately three hours. These do estado do Paran\u00e1, Brasil Haemophilus influenzae type b meningitis in the state of Paran\u00e1, Brazil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572001000500009) [Directory of Open Access Full Text Available OBJETIVO: no segundo semestre de 1996, os munic\u00edpios de Londrina e Curitiba (Paran\u00e1 iniciaram a vacina\u00e7\u00e3o contra Haemophilus influenzae b (Hib, aproximadamente trinta meses antes de sua introdu\u00e7\u00e3o no Programa Nacional de Imuniza\u00e7\u00e3o. O presente trabalho a incid\u00eancia da meningite em Londrina, Curitiba e nos demais munic\u00edpios do estado do Paran\u00e1, antes de todos os casos de meningite por Hib, entre menores de 5 anos, diagnosticados pelo sistema de vigil\u00e2ncia epidemiol\u00f3gica de Londrina e pela Secretaria de Estado da Sa\u00fade do Paran\u00e1, de 1992 a 1999. Taxas de incid\u00eancia da meningite por Hib foram calculadas por 100.000 menores de cinco anos. RESULTADOS: comparando com o per\u00edodo anterior \u00e0 vacina\u00e7\u00e3o, houve redu\u00e7\u00e3o importante do coeficiente de por Hib em Londrina, passando de 23,91, em 1996, para 2,79 por 100.000 menores de cinco anos, em 1999. Redu\u00e7\u00e3o semelhante foi observada em Curitiba, enquanto que n\u00e3o dispunham da at\u00e9 de 1999, o da incid\u00eancia da meningite entre menores de cinco anos em Londrina e Curitiba. Para a manuten\u00e7\u00e3o dessa baixa incid\u00eancia devem de epidemiol\u00f3gica.OBJECTIVE: during the second half of 1996, the municipalities of Londrina and Curitiba (State of Paran\u00e1, Brazil included Haemophilus influenzae type b (Hib vaccine into their routine vaccination regimen, approximately 30 months before its introduction into the National Immunization Program. The present study aimed at verifying the incidence of meningitis caused by Hib among children in Londrina, and C-terminal 311 amino Haemophilus influenzae. This protein has central role Serum responses were significantly mixed with Freund's adjuvant in comparison with control groups. Analysis of the IgG subclasses showed that the n 10) and [Correlaci\u00f3n la tipificaci\u00f3n capsular de aislamientos colombianos de Haemophilus influenzae por el m\u00e9todo de aglutinaci\u00f3n en l\u00e1mina y la t\u00e9cnica de PCR.](http://www.revistabiomedica.org/index.php/biomedica/article/view/1213) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Marylin Hidalgo 2003-06-01 Full Text Available En 1998 se inici\u00f3 en Colombia la inmunizaci\u00f3n de ni\u00f1os menores de un a\u00f1o de edad con la vacuna conjugada contra Haemophilus influenzae, serotipo b. En el 2000, el programa de vigilancia del Grupo de Microbiolog\u00eda del Instituto Nacional de Salud inform\u00f3 una disminuci\u00f3n de 40% de los casos de meningitis por este microorganismo, la cual se atribuy\u00f3 a la vacunaci\u00f3n. En este programa de vigilancia se utiliza de rutina la t\u00e9cnica estandarizada de aglutinaci\u00f3n en l\u00e1mina para la tipificaci\u00f3n capsular de H. influenzae. El objetivo de este trabajo fue establecer la concordancia entre la prueba de aglutinaci\u00f3n en l\u00e1mina y la t\u00e9cnica de PCR. Se estudiaron con ambas t\u00e9cnicas 146 aislamientos cl\u00ednicos invasores de H. influenzae, obtenidos de ni\u00f1os menores de 5 a\u00f1os, recolectados a partir de 1999 hasta 2002, identificados y serotipificados por el laboratorio de referencia como parte de la vigilancia de la meningitis bacteriana aguda y la infecci\u00f3n respiratoria aguda. Nuestros resultados mostraron una correlaci\u00f3n de 93% en la tipificaci\u00f3n capsular de H. influenzae, serotipo b, y de 92% con respecto al resto de serotipos. La t\u00e9cnica de aglutinaci\u00f3n en l\u00e1mina realizada con un estricto control de calidad contin\u00faa siendo una herramienta sensible y espec\u00edfica para la serotipificaci\u00f3n de H. influenzae. [Haemophilus influenzae: an underrated cause R A 1997-01-01 AIMS: To establish the common pathogens associated with infective vulvovaginitis in young girls in the local population and to determine current management of this condition. METHODS: A prospective laboratory based survey was carried out over 19 months. A questionnaire was then sent to local general practitioners and hospital RESULTS: One hundred and six swabs were received yielded recognised as causes of vulvovaginitis. group A beta haemolytic streptococcus (19), with Haemophilus influenzae the second most common Candida was isolated on nine occasions. The users' questionnaire had an overall response rate of 52%. Forty one per cent of respondents nominated candida as the most common cause of this condition. Forty six per cent were aware that beta haemolytic streptococci caused juvenile vulvovaginitis, but a possible pathogen. The agent 24 respondents (22%) prescribed antibiotics that are active against both group A beta haemolytic streptococci and H influenzae. CONCLUSIONS: Although H influenzae second most common infective cause of juvenile vulvovaginitis in the local population, managing these patients were unaware Mass Spectrometry Analysis.](https://www.ncbi.nlm.nih.gov/pubmed/28637909) Chen, Jonathan H K; Cheng, Vincent C C; is considered part flora in the human respiratory tract. Although the addition of a custom mass spectrum library into matrix-assisted laser desorption ionization-time flight mass spectrometry could improve identification of these two establishment database is technically complicated and requires resources, which most clinical laboratories cannot afford. In this study, we developed a mass spectrum analysis model with 7 mass peak biomarkers for the identification of H. influenzae and H. haemolyticus using the ClinProTools software. We evaluated the diagnostic performance of this model using 408 and species In comparison, the ClinProTools mass spectrum model could identify 100% influenzae and H. when various infection models. In the past 15 years much has been learned about determinants of biofilm formation by this organism of chronic and recurrent infections. However, this concept has not been without some degree of controversy, and in the past some have expressed doubts about the relevance of NTHi biofilms to disease. In this review, I will summarize the present information on the composition and potential various infection models. In the past 15 years much has been learned about determinants of biofilm formation by this organism of chronic and recurrent infections. However, this concept has not been without some degree of controversy, and in the past some have expressed doubts about the relevance of NTHi biofilms to disease. In this review, I will summarize the present information on the composition and potential incubation be omitted from the original The had the same sensitivity for anti-DT cells as the assay. IgG anti-PRP spots were, however, improved both in quality...... and in quantity (median: 40% more spots), while the detection of IgM and IgA anti-PRP spot-forming cells was the same in the two techniques. This simplified technique can probably also be used to time in other antigen systems and should be considered when designing ELISPOT assays asymptomatic colonization upper tract to serious invasive diseases such as completely many of these are unknown. HI0017 is one of these uncharacterized proteins. Here we describe the three-dimensional solution structure -sheet two short -helices. It is similar to the C-terminal domain of Diphtheria toxin repressor (DtxR). The C-terminal and formate a mechanism. Based on structural sequence comparisons, we propose that the C-terminus of HI0017 functions as an enzyme with a asymptomatic colonization upper tract to serious invasive diseases such as completely many of these are unknown. HI0017 is one of these uncharacterized proteins. Here we describe the three-dimensional solution structure {beta}-sheet two short {alpha}-helices. It is similar to the C-terminal domain of Diphtheria toxin repressor (DtxR). The C-terminal and formate a mechanism. Based on structural sequence comparisons, we propose that the C-terminus of HI0017 functions as an enzyme with a programme in 1993 may have meningitis (i.e. increasing frequency other Based on nationwide...... infected with Hib, two cases (13%) were identified as true vaccine failures. Six patients (9%) died; one premature infant infected with f non-typeable H. influenzae. Hearing loss was reported in 16% of the surviving children and in 10% of the surviving adults....... The presence of a lung focus was an independent prognostic factor for an unfavourable outcome (p 0.03). In conclusion, meningitis caused by Hib been infrequent in Denmark the vaccine in the childhood vaccination programme, and no increase in meningitis cases type H... [Non-Type b Haemophilus influenzae Invasive infection in the United States in recent years have been limited. Here, we report the spectrum and severity of disease associated with invasive non-type b tertiary-care children's hospitals over a 2-year period. Meningitis was the most common diagnosis. The majority of the patients had neurologic this pediatric population. \u00a9 The Author 2016. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases in Hamidi, A. 2016-01-01 Haemophilus influenzae a effective vaccine meningitis by Hib disease. Hib vaccine is recommended for children under Despite the availability of safe and effective Hib pathogen to a variety of acute and chronic diseases of the upper and lower respiratory tract as well as the middle ear. At the sites of infection as well as during growth which the can adapt their metabolism to cope with such influenzae on glucose in RPMI-based medium was found to change from acetate as the main product during aerobic growth to formate as the major product during anaerobic growth. This is likely caused by a switch the major pyruvate degrading lactate clear differences existed in the expression nitrate H. influenzae uses could be 'respiration assisted fermentation' caused same converting a variety of compounds including nitrite and chronic and recurrent otitis in young children. The objective of this study was to determine whether non-typeable Angela Loguercio Full Text Available O objetivo do presente trabalho foi revisar o papel do Haemophilus influenzae tipo b (Hib como um dos pat\u00f3genos mais importantes implicados em doen\u00e7as infecciosas invasivas, especialmente nos 2 primeiros anos de vida. Nos pa\u00edses em desenvolvimento, o H. Influenzae chega a causar 30% dos casos de pneumonia com cultura positiva e de 20 a 60% dos casos de meningite bacteriana. No presente estudo, dados epidemiol\u00f3gicos do Brasil foram comparados com dados internacionais obtidos em bancos de dados (Medline, 1966 a 1995; LILACS, 1982 a 1995; Thesis databank, abstracts, 1994. Analis\u00e1mos o coeficiente de incid\u00eancia do Hib no Brasil por estado e por faixa et\u00e1ria, com estratifica\u00e7\u00e3o inclusive para o 1\u00b0 ano de vida. A meningite foi utilizada como marcador do coeficiente de incid\u00eancia para letalidade regionais do H. por exemplo, em 1991, a incid\u00eancia no Brasil foi de 18,4 em 100 000 crian\u00e7as menores de 1 ano; no mesmo per\u00edodo, a incid\u00eancia no Distrito Federal foi de 175 em 100 000 crian\u00e7as entre 4 e 6 meses. Al\u00e9m disso, a letalidade na regi\u00e3o Norte foi de 35% em 1987, contra 22% para o Brasil como um todo. Nosso estudo abre a discuss\u00e3o sobre aspectos epidemiol\u00f3gicos relevantes das infec\u00e7\u00f5es por Hib e o custo-benef\u00edcio profilaxia of Haemophilus influenzae type causing invasive infectious diseases, especially life. In developing countries H. influenzae is responsible for 30% of all pneumonia cases with positive cultures and for 20% to 60% of all bacterial meningitis cases. In this study we compared [Haemophilus influenzae vulvovaginitis associated with to be the most common gynecological problem in prepubertal girls. To date, however, no direct evidence has been obtained for the underlying mechanism of transmission. This report describes case of non-capsulate Haemophilus influenzae vulvovaginitis in a girl with a of foreign bodies (cotton wool) in her vagina. Moreover, this girl had recurrent rhinitis for approximately 3 years. On Pulsed analysis the H. influenzae from nasal secretions patient appropriate antibiotics. The present case provide the first direct evidence of the nose-hand-vagina method of transmission. \u00a9 human immunodeficiency virus-infected patients. The Grupo Andaluz para el Estudio de Enfermedades Infecciosas.](https://www.ncbi.nlm.nih.gov/pubmed/10722428) Cordero, infected with human immunodeficiency virus (HIV), the characteristics of this pneumonia have not been adequately features influenzae pneumonia 3b, monoclonal antibodies specific for the ectodomain the influenza virus M2 ion channel protein are disclosed. The antibodies of the invention have rec-1 gene and behavior of the cloned into shuttle vector that replicates in Escherichia coli as well as H. influenzae. defects damage, transformation, and to induced resistance by pRec1 in E. coli recA mutants, UV induction of lambda and UV mutagenesis were not. We suggest that the ability of the H. influenzae Rec-1 protein repressors but not the recombinase function differs from that of the E. coli of the rec-1 gene of of the cloned into shuttle vector that replicates in Escherichia coli as well as H. influenzae. defects damage, transformation, and to induced resistance by pRec1 in E. coli recA mutants, UV induction of lambda and UV mutagenesis were not. We suggest that the ability of the H. influenzae Rec-1 protein repressors but not the recombinase function differs E. LN1036-37 peptide and to a lesser extent at three other sites. In this study, we mutagenesis, at subsite. This design of approaches to activity influenzae 146 patients were studied, period 1996-2002, at the Microbiology Laboratory, Hospital de Ni\u00f1os Superiora Sor Mar\u00eda Ludovica, Argentina. The serotype distribution was:1 a, 112 b,1 c,1 d, 4 e, 3 f y 24 no typable. Since the beginning of universal Hi b vaccination in 1998, we have observed the fast decrease of serotype b and a produce mainly base pair substitutions. This paper describes the development of a system suitable for detecting frameshift thymidine Evidence from a comparison of the responses to ICR-191 and to N-methyl-N'-nitro-N-nitrosoguanidine that the system is mutations. reversion of the frameshift mutations but not of the base substitution mutations. Presumably, this is a consequence of mispairing, with consequent change in the number of bases, during the recombination. (orig.) [An up date on influenza Influenza: de conceptos](http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/284) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Hel\u00ed Salgado V\u00e9lez Text Available A is presented on present-day concepts on influenza with emphasis contraindications. Se presenta una actualizaci\u00f3n de conceptos sobre la influenza con \u00e9nfasis en la vacuna; se incluyen consideraciones sobre el virus, la patog\u00e9nesis, la cl\u00ednica, el diagn\u00f3stico de laboratorio, la epidemiolog\u00eda y las vacunas; acerca de \u00e9stas se detallan sus caracter\u00edsticas, esquemas de aplicaci\u00f3n, reacciones secundarias, indicaciones y contraindicaciones. [Human milk lactoferrin Plaut, A 1998-10-13 Haemophilus influenzae is a major cause of otitis media and other respiratory tract disease in children. The pathogenesis of disease begins with colonization of the upper respiratory mucosa, a process that involves evasion studies that human milk is protective against H. influenzae colonization and disease. In the present study, we examined the effect of human milk on the influenzae P2, which are distinguished from IgA1 and Hap by the lack of an N-terminal domain or an extracellular linker region. These human infant [Relationship between secretion of the Anton blood group antigen and cells contributes to a reduction of infections by these bacteria. We have shown that the Anton blood group antigen, the erythrocyte receptor for Haemophilus influenzae in rat model system](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=13692082) [International Nuclear Information rats were identified by a radioimmunoprecipitation method. Intact cells of influenzae type b lactoperoxidase-catalyzed procedure, and an outer These mixed sera obtained systemic H. influenzae type b disease induced protein antigen) and acid. detectable several proteins present in the outer membrane of H. influenzae type b. Individual infant rats were found to vary both qualitatively and be quite different from that seen in Escherichia coli in that H. influenzae shows neither SOS nor adaptation phenomena. Repair of DNA lesions in influenzae and mismatch repair pathways. This mutant is sensitive to a variety of DNA damaging agents as well as being hypermutable by alkylating base analogues. MutB1 cells do not show post-UV DNA breakdown but do begin excision after UV irradiation. Genetic transformation with UV-irradiated DNA on mut B1 recipients shows that high (HE) and low (LE) efficiency markers are transformed at a ratio of 1.0 markers are sensitized and act as LE markers do on wild type recipients. Thus, the mutB gene product appears to play a role in both DNA repair and genetic transformation. A model is outlined which presents a role for a DNA helicase in both DNA repair and genetic transformation of H. influenzae [Estudio dos contra of Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) O. Juliao la inmunogenicidad (seroconversi\u00f3n, seroprotecci\u00f3n e Hiperrespuesta, producida por dos vacunas recombinantes contra la hepatitis B (Engerix-B de B\u00e9lgica y Cubana, en dos esquemas (012 y 016 meses, empleando los m\u00e9todos de cuantificaci\u00f3n para Anti-HBsAg (Abbott y Organ\u00f3n, los cuales fueron tambi\u00e9n comparados. En el estudio participaron 257 voluntarios, divididos al azar en 4 grupos (dos vacunas, dos esquemas. Resultados: los dos m\u00e9todos de Abbon y Organon, no presentan diferencias estad\u00edsticas significativas. La vacuna cubana muestra una mayor respuesta inmunog\u00e9nica para dos dosis de vacuna y para el esquema 012. No hay diferencia entre los esquemas 012 y 016 y en el esquema 016 no se ven diferencias estad\u00edsticamente significativas con la vacuna Engerix-B. En esta \u00daltima el esquema 016 muestra mejores resultados que el 012. [Polyarticular Septic Arthritis A Case Report and Review of the Literature](http://dx.doi.org/10.1155/2015/163812) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Raheel Ahmed Ali 2015-01-01 Full Text Available Background. The standard use of vaccinations against pathogens in of infections caused by atypical bacteria is rising. This report presents a case of septic arthritis caused by non-type b H. influenzae in a pediatric patient. Methods. We report a case of an polyarticular septic arthritis caused by H. influenzae serotype was conducted with the inclusion criteria of case reports and studies or epilepsy Participants A the Haemophilus influenzae type b vaccination program on HIB meningitis in Brazil Impacto do programa de vacina\u00e7\u00e3o contra meningites causadas por Haemophilus influenzae tipo [Directory Sybelle de 2007-07-01 of vaccination against Haemophilus b in on morbidity, mortality, and case fatality of HIB meningitis, using the Ministry of Health database and population data from the Brazilian Institute of Geography and Statistics (Instituto Brasileiro de Geografia e Estat\u00edstica - IBGE. Impact was evaluated (1983-2002, using regression forecasting (RF by (a historical (1983-1998 and (b validation tipo b (HIB no Brasil sobre a morbi-mortalidade e a letalidade das meningites por HIB, a partir de base de dados fornecida pelo Minist\u00e9rio da Sa\u00fade e as estimativas populacionais provenientes do Instituto Brasileiro de Geografia e Estat\u00edstica (IBGE. Para a avalia\u00e7\u00e3o do impacto hist\u00f3rico (1983-1998 e (b per\u00edodo de estima\u00e7\u00e3o (1999-2002. O impacto da vacina\u00e7\u00e3o foi positivo, embora tenha se revelado sensitivity or specificity in the detection of strains of (n and had an analytical sensitivity 10 genome copies\\\\/polymerase chain reaction (PCR). detected both of sensitivity or specificity in the detection of strains of (n and had an analytical sensitivity 10 genome copies/polymerase chain reaction (PCR). detected both of H. of blood and CSF. rights caused a small in survival irradiation in wild-type cells and in a rec-1 mutant, but there was no increase in spontaneous mutation in the wild type or Respiratory Medicine, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, University of Manchester, 2Department of Respiratory Medicine, University Hospital of South Manchester Foundation Trust, Manchester, 3Refractory Respiratory Inflammation DPU, GlaxoSmithKline Medicines in patients investigated the antibiotic resistance patterns of by samples. all, 45 patients the for erythromycin, all [Costo-efectividad de la vacunaci\u00f3n contra Haemophilus influenzae tipo b : an\u00e1lisis para Carc\u00eda, A; Postma, Maarten; G\u00e1lvez, AM; Sierra, G of the present study was to estimate the cost-effectiveness ratio of the therapeutic and prophylactic alternatives for treatment of meningitis caused by Haemophilus influenzae type b in less than one old infants applying a mathematical model. hypothetical setting with (ECM) proteins that are present in the respiratory tract and are probably important targets for H. influenzae colonization. The region of responsible for adherence to ECM proteins has been localized to the C-terminal 511 aa of the Hap passenger domain (HapS). In this study, we characterized motifs in the C-terminal region of HapS that contribute to the interaction with fibronectin. Most of these motifs are located on the F1 and F3 faces of the HapS structure, suggesting that the F1 and F3 faces may for the HapS-fibronectin interaction. \u00a9 2014 The Authors. [Conocimientos, actitudes y pr\u00e1cticas sobre la influenza A(H1N1 2009 y la vacunaci\u00f3n contra influenza pand\u00e9mica: resultados de una encuesta poblacional Knowledge, attitudes and practices about influenza A(H1N1 2009, and influenza vaccine in Mexico: results of a population survey](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342012000600009) 2012-12-01 Full Text Available OBJETIVO: Evaluar conocimientos, actitudes y pr\u00e1cticas respecto a la pandemia de influenza, con especial \u00e9nfasis en la vacuna contra influenza estacional y pand\u00e9mica. MATERIAL Y M\u00c9TODOS: Estudio transversal con muestreo poliet\u00e1pico probabil\u00edstico, realizado durante diciembre de 2009 en residentes mayores de 18 a\u00f1os de la Ciudad de M\u00e9xico (y \u00e1rea metropolitana, Monterrey, Guadalajara y M\u00e9rida. RESULTADOS: Se incluyeron 1 600 sujetos (48.9% masculino; 34% hab\u00eda recibido vacuna contra influenza estacional en a\u00f1os pasados, 90.6% estaba dispuesto a recibir la vacuna contra A(H1N1. La principal causa de rechazo a la vacunaci\u00f3n fue no confiar en la vacuna (46.5%. Principales medidas preventivas identificadas por los encuestados: lavado de manos (47.5%, vacuna contra A(H1N1 (28% y etiqueta respiratoria (19.4%. El nivel escolar (1.7, p=0.006 y edad (1.02, pOBJECTIVE: To assess knowledge, attitudes and regarding influenza pandemic, special on issues related influenza Cross-sectional study, probabilistic multistage sampling in patients over 18 years, residents of Mexico City (and metropolitan area, Monterrey, Guadalajara and Merida in December 2009. RESULTS: A total be against A(H1N1, 46.5% of those who would not receive the vaccine was because they did not trust A (H1N1, 68% considered influenza A (H1N1 as a risk for their family. Hand washing was the preventive vaccine. 82.9% of respondents rate the federal government's management as good or very good. CONCLUSIONS: There was a high acceptance rate for the pandemic influenza vaccine in Mexico when compared to similar studies in other [Quantitative significantly superior to sputum P6 PCR for detection of H. influenzae CAP. NPA fucK PCR was positive in 3 of respiratory symptoms. In conclusion, in Inc. All rights reserved. bacterianas en el Hospital Gonz\u00e1lez 2009-03-01 Full Text Available Se realiz\u00f3 un estudio retrospectivo y prospectivo longitudinal de las Meningoencefalitis Bacterianas diagnosticadas en el Hospital Pedi\u00e1trico \"Pepe Portilla\" en el a\u00f1o 2006 y 2007, con el objetivo de determinar los g\u00e9rmenes que han aislado en dicha patolog\u00eda, compar\u00e1ndose con a\u00f1os anteriores desde 1992, analizando el impacto de la vacunaci\u00f3n contra Neisseria meningitidis y Haemophilus influenzae. Los estudios de l\u00edquido cefalorraqu\u00eddeo se realizaron como indican las normativas para estos casos. Se encontr\u00f3 que en el 2006 solo hubo un caso de meningitis a Neisseria meningitidis y en el 2007 dos casos de meningitis por Streptocuccus pneumoneae, y adem\u00e1s que la incidencia de Neisseria meningitidis y Haemophilus influenzae disminuy\u00f3 despu\u00e9s de la aplicaci\u00f3n de las vacunas VAMENGO BC y Hib de manera ostensible como lo hizo en el pa\u00eds en general, demostr\u00e1ndose la efectividad de dicha vacuna en nuestro medio.A retrospective-prospective and longitudinal study about this comparing with years and towards these cases. Results showed that in 2006 only one case of meningitis a Neisseria meningitidis occurred and two cases of meningitis observed in all the country, showing the effectiveness of the vaccine in our environment. [Carrier Text Available the incidence carrier state of standard procedures. colonization by S. pneumoniae among school children was found high and there is need of introduction of pneumococcal vaccines be enhanced in PBSCT performed undergoing BMT and 10 PBSCT recipients were and micrograms/ml micrograms/ml, vs protection 'silent terrorists' of the twenty-first century. Well over four million humans die per annum as a result of viral infections alone. The scourge of influenza virus has plagued mankind throughout the ages. The fact that new viral strains emerge on a regular basis, particularly out of Asia, establishes a continual the threat of human pandemic to the point where many countries have put in place 'preparedness plans' to defend against such an outcome. The discovery drugs may act as 'first-line-of-defence' against the spread of influenza infection and buy time for necessary vaccine development particularly in a human pandemic setting. Furthermore, some discovery of anti-influenza drugs influenza this de meningite Incidence of meningitis caused by Haemophilus influenzae in the state of Rio Grande do Sul 1999-2010: impact of deste artigo \u00e9 analisar e verificar a situa\u00e7\u00e3o epidemiol\u00f3gica das meningites causadas pelo agente Haemophilus influenzae tipo b nos \u00faltimos 10 anos no Rio Grande do Sul. Estudo retrospectivo, descritivo, utilizando o sistema de dados de notifica\u00e7\u00e3o de meningites, e cobertura vacinal, armazenados em base on Tabnet - Tabula\u00e7\u00e3o de dados Epidemiol\u00f3gicos - CEVS/SES/RS, abrangendo o per\u00edodo de 1999 a 2010. Foram utilizados casos notificados e confirmados, tendo como crit\u00e9rio de sele\u00e7\u00e3o o ano inicio dos sintomas, idade, diagnostico e evolu\u00e7\u00e3o. Foi analisado o Estado do Rio Grande do Sul, representado por 19 coordenadorias de sa\u00fade. Compara\u00e7\u00f5es entre propor\u00e7\u00f5es foram 3043 casos confirmados de meningite bacteriana, sendo 6,77% dos casos causados por H. influenzae. O coeficiente de incid\u00eancia da meningite por menores de continuam as mais n\u00e3o havendo altera\u00e7\u00e3o na Os positivo das estrat\u00e9gias de vacina\u00e7\u00e3o contra Hib no Estado do Rio Grande do Sul nos \u00faltimos dez anos.This article seeks to analyze and update the epidemiological situation of meningitis caused by Haemophilus influenzae type b in the past 10 years in the state of Rio Grande do Sul (RS. It is a retrospective, descriptive study, which used the data notification system stored in the Epidemiological TABNET online database, for the period from 1999 to 2010. Cases notified and confirmed were used and the selection criteria were the year when the symptoms were detected, age, diagnosis, and evolution. Nineteen health centers in the state of Rio Grande do Sul were analyzed. The z-test was used to evaluate comparisons between the proportions. In the [Effect the Benjamin A Full Text Available We previously carried out the identified by whole genome sequencing of 24 strains of H. influenzae. The array was originally designed as a tool to interrogate the gene content of large numbers of clinical isolates without the need for sequencing, however, the quantitative and is thus suitable for transcriptomic analyses. In the study RNA was extracted from H. influenzae strain CZ4126/02 (which was not included in the design of the array converted to cDNA, and labelled and hybridized to the SGH to assess the quality and reproducibility of data obtained from these custom-designed chips to serve as a tool for transcriptomics. Three types of experimental replicates were analyzed with all showing very high degrees of thus validating both the A significant true transcriptional differences between two samples. These methods can be extended to transcriptional analysis of utilizing supragenome-based arrays. of respiratory tract infections (RTI) worldwide. The a rapid H. influenzae diagnostic assay that would allow detect RTIs specificity and sensitivity limitations for novel PCR diagnostic assay the smpB H. using with the 100% confidence interval [CI], 90.26% 100.00%) a to presented, a panel of lower RTI samples (n = 98) were blindly tested with the gold and 97.47%) and a specificity of 100% (95% CI, 93.40% to 100.00%) for specimens. averages characteristics of the genomic fingerprints, was conducted to group the strains. A DNA segments obtained by amplification of genomic DNA with (PCR Discrete fragments of 100-2000 DNA segments obtained by amplification of genomic DNA with (PCR Discrete fragments of 100-2000 a major causative recent strains this bacteria is associated with increased risk cause and were compared with colonization strains not associated with symptom or an antibody response. Bacterial strains were an in of airway infection and in vitro cell culture after effect likely compared with strains. These epidemiol\u00f3gica de Minas Gerais, Brasil, 1993 a 1997 Haemophilus influenzae type b: epidemiological situation in the State of Brazil, 1993-1997](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2003000500005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Sybelle de 2003-10-01 e gravidade, as pneumonias e as meningites. No per\u00edodo de 1993 a 1997, foram notificados, em Minas Gerais, 720 casos de meningites por Hib, sendo a causa mais freq\u00fcente de meningite bacteriana em menores de um ano e a segunda causa no total de meningites. Entretanto, estimou-se uma ocorr\u00eancia total de 1.160 casos considerando as meningites bacterianas n\u00e3o especificadas. O total de casos estimados de doen\u00e7a invasiva por Hib parece justificar a recente inclus\u00e3o da vacina no esquema b\u00e1sico de imuniza\u00e7\u00f5es. da vacina refor\u00e7a a que constitui das diseases, pneumonia and meningitis are the most relevant in public health due to their frequency and severity. From 1993 to 1997, there were 720 cases of Hib meningitis in Minas Gerais State, Brazil, representing the most frequent cause of bacterial meningitis in infants (< 1 year and the second most frequent among all causes of meningitis. recent inclusion the vaccine in the basic immunization protocol. The vaccine's high cost reinforces the need for more precise monitoring of the etiological diagnosis of meningitis cases, representing one prevailing standards 2011 for seven antibiotics. The results of molecular testing showed that all the studied strains an amplicon bp that all strains were H. the same pacient (blood and CSF) showed a different degree of invasiveness, the strain isolated from blood being 20 times more invasive than one isolated from CSF. cohort of newborns enrolled for a randomized trial on safety and efficacy of three pertussis vaccines and followed for onset 21.5/100,000 person-years. Among the eight cases detected, six were meningitis, one sepsis, and one cellulitis. The child with and nontypeable; n = 258) and isogenic capsule a-d) = (n 100% sensitivity specificity for encapsulated strains (b, e, and f; n = 28). MALDI-TOF mass spectrometry is an accurate for the mechanism of anti-influenza virus activity. First of all, a total of 301 compounds of the genus Paeonia were summarized from the literatures in recent ten years. The candidate active ingredients from genus Paeonia were identified by database such as Book. The ligands were constructed by ChemDraw, Avogadro and Discovery targets Finally, activity compounds of the genus Paeonia against influenza virus and the anti-influenza virus target network. Uniprot online database was used were of genus Paeonia anti-influenza virus is consistent with the mechanism of NA anti-influenza virus in order to stop the sprouting, dispersion and diffusion of virus and reduce the ability of virus to infect, so that the infection can be restricted so as to achieve the anti-influenza virus effect. Copyright\u00a9 by the Chinese Haemophilus influenza-positive urethritis. In this retrospective significantly associated with the were 1 g/mL. outcomes influenzae could play pathogenic roles urethritis. All isolates, except for one with decreased susceptibility to were susceptible to the examined the increase in H. W Edward 2010-07-06 media (OM) among leading diseases of childhood and is caused by that such Moraxella now that OM infections infection promoted M. catarrhalis persistence the infected with M. catarrhalis alone. Notably, no such enhancement of M. catarrhalis persistence was observed animals promotes M. catarrhalis persistence within biofilm. [Efectividad de una vacuna antigripal en una poblaci\u00f3n laboral colombiana Effectiveness of an influenza vaccine in a working population in Colombia](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892001001000003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Stella Sof\u00eda Mesa Duque 2001-10-01 Full Text Available Objetivos. Determinar si una vacuna contra la influenza disminuye significativamente los episodios de infecci\u00f3n respiratoria superior aguda (IRSA y la incapacidad laboral por esta causa, en trabajadores adultos sanos de una entidad bancaria en la ciudad de Medell\u00edn. M\u00e9todos. Se realiz\u00f3 un estudio aleatorizado con doble enmascaramiento y placebo en 493 voluntarios. Mediante asignaci\u00f3n aleatoria se conformaron dos grupos, uno de estudio y otro de control, con 247 y 246 empleados, respectivamente. Se utilizaron por participante dosis de 0,5 mL de una vacuna contra la influenza que contiene ant\u00edgenos de superficie de las cepas recomendadas por la OMS para el per\u00edodo 1996-1997 con los subtipos A/Wahan/359/95 (H3N2, A/Texas/36/91 (H1N1 y B/Beijing/184/93. Se consider\u00f3 episodio de IRSA cuando alg\u00fan participante refer\u00eda dolor de garganta, fiebre y tos con m\u00e1s de 24 horas de duraci\u00f3n. La evaluaci\u00f3n se realiz\u00f3 quincenalmente durante seis meses; la gravedad de los episodios se estudi\u00f3 por el ausentismo laboral debido a IRSA, seg\u00fan la novena Clasificaci\u00f3n Internacional de Enfermedades (CIE-9, mediante la evaluaci\u00f3n mensual de las ausencias laborales por incapacidad certificada por la Seguridad Social en Salud, a lo largo de un a\u00f1o. Resultados. La descripci\u00f3n de los efectos colaterales asociados con la vacuna fueron el eritema (riesgo relativo (RR = 8,0; P = 0,02 y el edema local (RR = 4,5; P = 0,03. La incidencia acumulada anual de los episodios de IRSA fue 78,5% para los vacunados y 91,5% para el grupo placebo, con una reducci\u00f3n de 14%, observ\u00e1ndose valores entre 7 y 20% (RR = 0,86; IC95%: 0,80-0,93. La incidencia acumulada anual de IRSA con discapacidad fue de 15,8% en el grupo de vacunados, con una reducci\u00f3n de 31% respecto al grupo placebo (22,8%, con valores entre 0 y 52% (RR = 0,69; IC95%: 0,48-1,0. Estos niveles de protecci\u00f3n, tanto contra las formas menos sintom\u00e1ticas de IRSA como contra las causantes de incapacidad laboral [Tend\u00eancia das meningites por Haemophilus influenzae tipo b no Brasil, em menores de 5 anos, no per\u00edodo de 1983 a 2002 Trends in Haemophilus influenzae type b meningitis in Brazil in children under five years of age from 1983 through 2002](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822006000500010) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) 2006-10-01 meningites por Haemophilus no Brasil, e avaliou-se a tend\u00eancia da morbi-mortalidade em menores de 5 anos. Para a an\u00e1lise de tend\u00eancia dos coeficientes constru\u00edram-se modelos de regress\u00e3o polinomial para as faixas et\u00e1rias de The study was based on an ecological a historical time series (1983-2002, related less 5 analyze in infants less than 1 year old and 38.7% in children 1-4 years old. The observed rates were also highest in showed was The study results reinforce the effectiveness of the Vaccination Program against HIB in Brazil, which benefited age ranges that did not the Text Available Many are able to efficiently bind and take double-stranded historical recombination between lineages, the actual recombination events have not been well characterized. We used competent cells which the ~40,000 polymorphic differences had into the genomes of their genomes and their donor deep disrupt the progress of is the first genome-wide analysis of chromosomes directly transformed with transformation with of natural genetic variation found in isolates of the same species. [Identification, distribution, and expression of genes as a species, possesses a much greater number of genes than that found in any single chronic otitis media. DNA sequencing was performed with 771 clones random pooled genomic library. Homology searching demonstrated that approximately 10% of compared to the H. influenzae Rd KW20 genome, and most of them did not match any DNA sequence in GenBank. Amino acid homology searches using hypothetical translations of the of proteins, isolates. The distribution and expression of 53 of these genes among the 10 of these genes in planktonic cultures was detected in 50% (177 of 352) of the occurrences. All of the novel sequences were transcribed in one or more of the NTHi isolates. Seventeen percent (9 of 53) of the novel genes were identified in all 10 NTHi strains, with each of the remaining 44 being present in only a subset of the strains. These genic distribution analyses 2010-12-08 En la charla, un m\u00c3\u00a9dico responde a las preguntas frecuentes sobre la vacuna contra la influenza (gripe). Created: 12/8/2010 by Centro Nacional para la Inmunizaci\u00c3\u00b3n y Enfermedades (NCIRD). Date Released: the gene encoding translation initiation factor 2, was sequenced and compared and type strains suggested that the human isolates and V...... factor, H. influenzae, H. haemolyticus, H. aegyptius and some parainfluenzae and genus parahaemolyticus and H. paraphrohaemolyticus took up an position and may not belong the genus Haemophilus and We also their susceptibilities with respiratory tract or otorhinolaryngological infections appeared to be otorhinolaryngological infections. variety of antimicrobial agents would be similar to those from respiratory tract or otorhinolaryngological infections. Almost all MIC breakpoints recommended by the Clinical and Laboratory Standards Institute. Ceftriaxone could MIC breakpoints agents, which are have studied. Copyright \u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier [Evidence for a liquid medium containing [ 3 H]palmitate or [ 14 C]ribose C]ribose) PRP preparation was found to coelute in a single peak from a Sepharose 4B column, suggesting that both precursors were incorporated into alkaline, or A2 treatment of PRP labeled with [ 3 H]palmitate or [ 3 H]palmitate and [ 14 C]ribose followed by chloroform-methanol extraction could most of the organic de pneumoniae, H. N. meningitidis en Am\u00e9rica Latina y el Caribe: SIREVA II, 2000-2005 Characterization of invasive isolates of S. pneumoniae, H. influenzae, and N. meningitidis Latin America and the Caribbean: Available caracter\u00edsticas fenot\u00edpicas y la susceptibilidad a de las Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis en Am\u00e9rica Latina y el Caribe entre 2000 y 2005. Se evalu\u00f3 la cobertura potencial de las vacunas conjugadas. M\u00c9TODOS: Se estudi\u00f3 por m\u00e9todos convencionales la distribuci\u00f3n de los serotipos o serogrupos de 17 303 cepas de S. pneumoniae, 2 782 cepas de H. influenzae y 6 955 cepas de N. meningitidis aisladas de casos de neumon\u00eda, meningitis, sepsis, bacteriemias y otros procesos invasivos. Se evalu\u00f3 la susceptibilidad a los antibi\u00f3ticos de las cepas estudiadas. Los aislamientos proced\u00edan de 453 centros centinelas de 19 pa\u00edses de Am\u00e9rica Latina y 4 del Caribe, como parte del proyecto SIREVA II. RESULTADOS: El serotipo 14 de S. pneumoniae fue el m\u00e1s frecuentemente aislado (21,1%, especialmente en ni\u00f1os menores de 6 a\u00f1os (29,1%. Las coberturas potenciales de las vacunas conjugadas respectivamente. De los aislamientos, 63,3% eran sensibles a la penicilina. El serotipo b de H. influenzae estuvo presente en 72,2% de los aislamientos en ni\u00f1os menores de 2 a\u00f1os, mientras 8,6% correspondieron a los serotipos a, c, d, e y f; 19,2% resultaron no serotipables. La proporci\u00f3n de cepas de H. influenzae productoras de betalactamasa en aislamientos en ni\u00f1os menores de 2 a\u00f1os fue de 16,3%. Los serogrupos de N. meningitidis m\u00e1s frecuentes fueron el B (69,0% y el C (25,7%; 65,8% y 99,2% de las cepas fueron sensibles a la penicilina y a la rifampicina, respectivamente. CONCLUSIONES: Estos resultados resaltan la importancia de la vigilancia epidemiol\u00f3gica integral de S. pneumoniae, H. influenzae y N. meningitidis en Am\u00e9rica Latina y el Caribe. La gran heterogeneidad en la distribuci\u00f3n de los serotipos de S. pneumoniae en los pa\u00edses estudiados podr\u00eda reducir la [Biofilm-specific constituting the biofilm can be separated assays the ECM Proteomics revealed eighteen proteins ECM were detected in planktonic bacteria. One ECM protein was unique to 24 hr biofilms, two were found only in 96 hr biofilms, and fifteen were present in the ECM of both 24 hr and 96 hr NTHi biofilms. All proteins and the outer membrane OMP P2, with bacteria and Identification of biofilm-specific proteins present in immature pneumoniae, Haemophilus influenzae type b, and Neisseria meningitidis, the three principal causes of bacterial meningitis, use distinct sets of TLRs to the found that S. pneumoniae triggered activation of the transcription factor nuclear of interleukin-8, only in cells expressing TLR2 or -9. The same response was evoked by H. influenzae in cells expressing TLR2 or -4 and by N...... and confirmed role of these we pediatric infection and is mostly caused by bacteria are carried within the nasopharyngeal microbiota. It is clear that media disease Pneumococci were present within surface-attached biofilms coinfected animals, and a greater proportion of colony type was observed in the coinfected animals. Because this colony type has been associated pneumococci in the presence of H. influenzae. Based on these data, we facilitates the conjugate vaccine. However, in countries where widespread immunization is notroutine, influenzae remains a significant cause of morbidity and mortality. We report a case of apreviously with lowerabdominal pain with some vaginal spotting. The patient had visit with normal bleeding pain. She presented positive 1 day for H influenzae. The patient did well and was dischargedfrom days later.Conclusion: Haemophilus influenzae should Bacterial biofilms are complex microbial communities that are common in nature and are being recognized increasingly as an important determinant formation have been poorly defined. In associate with each structure the H. HapS passenger domain (harbouring F2 intercellular multimerization can give to surfaces that are required for overcoming the repulsive force between cells, leading to on may diverse unclear. studied samples from 24 strains of influenza. Flu-IVIG contains antibodies with of Flu-IVIG anti-influenza Fc-functional in the context of novel influenza virus infections, when there may be minimal or most media involve more than one bacterial species, we aimed capacity a nonencapsulated pneumoniae clinical isolate in Using the chinchilla S. pneumoniae However, when we inoculated nonencapsulated S. pneumoniae directly into the middle ear, the persisted for weeks post-inoculation which The first step in a bacterial disease is the establishment of nasopharyngeal carriage. We conducted a birth cohort study to 5 time points coinciding with health checkups (4, 7, 10, 18 and 36 months). A total of 551 S. pneumoniae 47.5% and 60.9% of S. pneumoniae isolates were included areas of overuse of to lower colonization of S. influenzae, as L; Karlowsky, Kathleen E; 2011-12-01 biology However, ST cannot be assigned one the housekeeping genes is absent or cannot be detected by the current protocol. Occasionally, strains of H. influenzae have been reported to lack the fucK gene. In this study, we examined the prevalence of this mutation among our collection Of studied, including by MLST owing to to detect the confirmed complete deletion of genes in the operon in seven of the nine isolates, while in the remaining two isolates, some of the genes were found intact or in parts. The significance of 2011-01-01 Nontypeable Haemophilus influenzae is a common cause of otitis media in children and lower respiratory urease during growth in the middle ear of the chinchilla and in pooled human sputum, suggesting that expression of urease colonization and infection in the hostile environments of the middle ear and in the airways in adults. Virtually nothing else is known about the urease of H. influenzae, which was characterized in the present study. Results Analysis by reverse transcriptase PCR revealed that the ure gene cluster is expressed as a single transcript. Knockout mutants of a detectable urease activity indicating that operon is the only one encoding an active urease. The ure operon is and post infection serum from adults with COPD who infections antibody Expression urease avidities in infants in Mexico after primary three b (Hib) were measured in 208 children living in Guadalajara and Mexico City. Protective concentrations were found are often chronic within otitis infections. significant host component that includes neutrophil extracellular traps (NETs). These NETs do not mediate clearance of NTHI, which survives specific of are determinants of biofilm formation in vitro. examined NTHI strains were shown to promote that within NET structures resistant to both extracellular killing within NETs and phagocytic killing by incoming neutrophils, to notably and is highly resistant to killing within NET structures. These data support the conclusion that, for NTHI, formation of NET structures may be persistence P A; action spectrum for the oxygen-independent inactivation revealed a shoulder beginning at 334 and extending to 460 nm. The presence of 0.2 M histidine during irradiation produced a small increase in inactivation at 254, 290 and 313 nm, a large increase at 334 nm and a decrease in inactivation at 365, 405, and 460 nm. Photoreactivation did not reverse the DNA damage produced at pH 7.0 at 334, 365, 405 and 460 nm, but did reactivate the DNA after irradiation at 254, 290 and 313 nm. The inactivation of DNA irradiated at 254, 290 and 313 nm was considerably greater when the transforming ability was assayed in an mutant compared with the wild type, although DNA irradiated at 334, 365, 405 and 460 nm smaller differences. These results suggest influenzae DNA at pH 7 by irradiation at 334, 365, 405 and 460 nm is caused lesions against Haemophilus and Moraxella was compared to the lowest MICs (0.5 to 4.0 and 1.0 to 8.0 microg/ml, followed by clarithromycin amoxicillin H. influenzae strains showed that ABT-773, at two times the MIC, was bactericidal against 9 of 10 strains, with 99% killing of all strains at the MIC after 24 h; at 12 h, ABT-773 gave 90% killing of all strains at two times the MIC. At 3 and 6 h, killing by ABT-773 was slower, with 99.9% killing of four strains at two times the MIC after 6 h. Similar results were found for azithromycin, with slightly slower killing by erythromycin, clarithromycin, and roxithromycin, especially at earlier times. beta-Lactams were bactericidal against 8 to 10 strains at two times the MIC after 24 h, with slower killing at earlier time periods. Most compounds gave good killing of five M. biosynthesis of methionine in fungi and several bacteria. We have the crystal structure of from structure a member of the alpha/beta-hydrolase structural superfamily. The active site of the enzyme is located near the end of a deep tunnel formed by the juxtaposition (h) all antigens young children cells study was conducted at the Department of Medicine, AbbasiShaheed Hospital, Karachi, between July 2009 in the and their sputum samples were sent for microbiological evaluation. SPSS 16 was used for statistical analysis. Results: Of the total 105 patients in the study, 90 (85.17%) were males. Overall mean age at presentation was 62+-10.2 years. S. patients of H. Out of the 33 sputum specimens of S. pneumoniae, 32 (97.0%) were sensitive to levofloxacin, while 1 (3.0%) was resistant. All the 13 isolates of H. influenzae were sensitive to levofloxacin. Conclusion: S. pneumoniae and H. sensitive antibiotic against these common micro-organisms Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Dr. V. Jacob Cohen 2011-01-01 Se agregan vacunas especiales en caso de viaje a zonas end\u00e9micas, como es el caso de rabia, encefalitis japonesa o fiebre amarilla; tema que no se incluye en este art\u00edculo, propio de la medicina del viajero, o tampoco el de aquellos con mayor susceptibilidad a infecciones espec\u00edficas como las vacunas anti neumoc\u00f3cica 23 valente, anti meningoc\u00f3cica no conjugada o anti Hemophilus influenza b (Ej., Aspl\u00e9nicos, S. nefr\u00f3tico etc.. [Frequency susceptibility H. influenzae and 14 (0,01% H. parainfluenzae (out of 180, 415 samples were isolated from genitourinary tract. From urine samples of the girls under 15 years of age these bacteria were isolated in 13 (0,88% and two (0,13% cases, respectively, and only in one case(0,11% of the UTI in boys (H. influenzae. In persons of fertile age, it was only H. influenzae bacteria that was found in urine samples of the five women (0,04% and in three men (0,22%. As a cause of vulvovaginitis, H. influenzae was isolated in four (5,63%, and H. parainfluenzae in two (2,82% girls. In persons of fertile age, H. influenzae was isolated from 10 (0,49% fertile age (especially women, and men with cases of epididimytis and/or orchitis,it is important to think about SP, Brazil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46651998000100002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Marta I. C. MEDEIROS 1998-01-01 Full Text Available In the study of conjunctivitis outbreaks occurring from September 1994 to September 1996 in region of Ribeir\u00e3o Preto, conjunctival exudates of 92 patients were cultivated in Instituto Adolfo Lutz Laboratory I, Ribeir\u00e3o Preto. Most cases occurred in the age range 2-7 years. The etiological agents to the three de per\u00edodo de setembro de 1994 a setembro de 1996, na regi\u00e3o de Ribeir\u00e3o Preto, foram I, Ribeir\u00e3o Preto, exsudatos conjuntivais de 92 pacientes, que a maioria dos casos estava na faixa apenas uma foi Llor Vila, Carles 2005-01-01 La vacunaci\u00f3n antigripal, con m\u00e1s de 50 a\u00f1os de existencia, tiene una eficacia, una efectividad y una seguridad contrastadas, pero la respuesta inmunitaria oscila entre el 60 y el 90%, siendo algo menor en la poblaci\u00f3n anciana. Cl\u00e1sicamente se han utilizado las vacunas inactivadas trivalentes en las campa\u00f1as de vacunaci\u00f3n antigripal pero se considera que su aceptabilidad no es \u00f3ptima. Desde hace unos a\u00f1os se est\u00e1n investigando otros tipos de vacunas antigripales con el objetivo de mejorar su ... [Heavy-chain of D...... natural HibCP antibodies (r = 0.59; P = 0.00002). of natural Hib bacteria mucosal Infants Three Doses of b (Hib) were measured in 208 children living in Guadalajara and Mexico City. Protective concentrations were found Anti-influenza vaccination activists argue on the internet that influenza vaccine has little or no efficacy and a high risk of side effects, and they warn that people should to those conducted online searches in January 2017 using two major Japanese search engines (Google Japan Yahoo! Japan). Targeted websites were analysis interpretative analysis-to textual data of the anti websites. Of the 113 anti websites, we identified two themes that correspond to beliefs: it 1) others against risks and exploitation related to influenza vaccination, 2) educate engage in anti-vaccination activities because they want to feel they are virtuous, saving people from harm caused by vaccination, and strong. In promoting vaccination, it be better not to refusers, such as the authors of anti-vaccination websites; it is preferable to target vaccine-hesitant diversity in DNA recognition domains restriction-modification (R-M) systems have been identified in a range of pathogenic bacteria. In some it has been demonstrated that the random switching of the mod (DNA methyltransferase) gene mediates the coordinated expression of multiple genes DNA recognition (DRD) defines the target sequence that is modified by methylation and is used to define modA alleles. 18 distinct modA alleles have been identified in H. influenzae and the pathogenic Neisseria. To determine the origin of DRD variability, the 18 modA DRDs were used were gene from distinct bacterial species, indicating one source of the DRD variability of have been transferred en bloc the DRD from different modA alleles. [A qualitative of Anti-influenza vaccination activists argue on the internet that influenza vaccine has little or no efficacy and a high risk of side effects, and they warn that people should those conducted online searches in January 2017 using two major Japanese search engines (Google Japan Yahoo! Japan. Targeted websites were analysis textual data the anti websites. Results: Of the 113 anti websites, we identified two themes that correspond to beliefs: it 1 others against risks and exploitation related to influenza vaccination, 2 educate in activities because they want to feel they are virtuous, saving people from harm caused by vaccination, and strong. In promoting vaccination, it be better not to refusers, such as the authors of anti-vaccination websites; it is preferable to target vaccine-hesitant to identify the these these the chinchilla model of otitis media show a clear selection for ON switching of modA2 in the middle ear. Our results indicate that a biphasic epigenetic switch can control bacterial virulence, immunoevasion and niche adaptation in an animal model system. [Vaccination for the control of childhood bacterial pneumonia - Haemophilus influenzae type childhood is endemic in large parts of the world and in particular, in developing countries, as well as in many indigenous against the causes of pneumonia. The use of the vaccines in and countries few of the 90+ capsule serotypes. Therefore, there has been a focus in recent years to rapidly advance technologies that will result in broader disease coverage developing countries. The and acid to the cytoplasmic precursor of the bacterial cell wall peptidoglycan. The crystal structures of Haemophilus influenzae MurC complex with its substrate UDP-N-acetylmuramic acid (UNAM) and Mg2+ and of a fully assembled MurC complex with its product UDP-N-acetylmuramoyl-l-alanine (UMA), the nonhydrolyzable analogue AMPPNP, bacteria, on maintenance an adequate level of serum antibody through early childhood. In many countries, Hib vaccine booster doses have been implemented after sustain We investigated Hib-specific memory B cells were measured booster of a Hib-serogroup C meningococcal (MenC) conjugate vaccine and again 1 week, 1 month, and 1 year after the booster in 250 healthy children aged 6-12 years in an open-label phase 4 clinical study. Six to 12 years following infant priming with 3 doses of Hib conjugate vaccine, IgG 1.0 \u00b5g/mL were 79% and 43% in children who had or had not, respectively, received a fourth Hib conjugate booster responses (anti-PRP IgG and memory B cells) were found in younger children and in those who had since infant priming and receipt of a Understanding the relacionada con vacuna contra la influenza](http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/13644/12135) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Restrepo Escobar, Mauricio after can transient or more serious vaccination are different forms of vasculitis. We report the case of a patient who presented a clinical picture of vasculitis nodosa that began weeks after receiving the influenza vaccine. After critically reviewing the literature, this would be the first clearly documented case of polyarteritis nodosa Dickey1,41Department of Pulmonary Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, USA; 2Tecnol\u00f3gico de Monterrey School of Medicine, Monterrey, Nuevo Le\u00f3n, Mexico; 3Department of Medicine, University at Buffalo, State University of New York, Buffalo, NY, USA; 4Center for Inflammation and Infection, Institute of Biosciences and Technology, Texas A&M (COPD is predicted to become the third leading cause of death in the world by 2020. It is characterized by airflow limitation that is not fully reversible. The airflow limitation usually progressive and associated response of possible is that for lung cancer irrespective of concomitant cigarette smoke exposure. In this review the role of NTHi in airway inflammation Fast Flow. The condition of the elution was optimized for pH and ionic the 280 elution samples were detected, and the targeted observed electrophoresis. The Hitrap ion exchange column was eluted with buffer 1, which resulted in a baseline distribution of absorbance at 280 nm. Buffer 2 elution of the column resulted in the presence of peak absorbance with trails, which was identified to be constituted by some low molecular weight bands by subsequent SDS-PAGE. In serial column elution with buffer 3 with different ionic strength, a peak absorbance was observed 100 and SDS-PAGE confirmed that peak was generated by the target protein. No obvious peaks or bands in SDS-PAGE occurred with the other ionic strengths. The pH of Nacional de Ciencias Biologicas, Mexico City. Dept. de Bioquimica; Oak Ridge National Lab., Tenn. (USA). Biology Div.) 1976-05-01 were produced in DNA Haemophilus assayed as among cells transformed with irradiated DNA. The maximum efficiency of mutation induction was at around 334 nm, and the efficiency dropped off steeply at lower and higher wavelengths. The difference between the action spectrum for mutation and that for the oxygen-independent inactivation of transforming DNA, which had a shoulder at 365 nm, indicates that there are different lesions involved in the inactivating irradiation the mutagenic effect at 334 and 365 nm, although it protected against inactivation at 365 nm. The effective near-UV wavelengths for in vitro mutation are to the same as the for mutation in reported previously. These that mutations are produced in vivo by near-UV with DNA as the molecule rather than by a followed by doses and productores de el nuevo paradigma](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000001&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Akira Homma Full Text Available Los laboratorios p\u00fablicos productores de vacunas de Am\u00e9rica Latina y el Caribe han contribuido en diferente grado al control y a la erradicaci\u00f3n de las enfermedades prevenibles por vacunaci\u00f3n y varios est\u00e1n produciendo las vacunas que se aplican rutinariamente en los programas nacionales de inmunizaci\u00f3n, como la vacuna antituberculosa (a base del bacilo de Calmette-Gu\u00e9rin, BCG, la vacuna difteria-t\u00e9tanos-pertussis (DTP, el la vacuna antisarampionosa y la vacuna antipoliomiel\u00edtica oral. Gracias a los adelantos cient\u00edficos recientes, se prev\u00e9 un aumento importante del n\u00famero de vacunas seguras y eficaces que estar\u00e1n disponibles en un futuro cercano para uso en los programas normales de vacunaci\u00f3n. Sin embargo, los gastos asociados con el desarrollo de estas vacunas y con los derechos de propiedad intelectual que las protegen son cuantiosos. Adem\u00e1s, pocos laboratorios en Am\u00e9rica Latina poseen la capacidad t\u00e9cnica para investigar y elaborar estas vacunas. Tales factores tendr\u00e1n un impacto en la celeridad con que se incorporar\u00e1n en los esquemas de vacunaci\u00f3n de los pa\u00edses de la Regi\u00f3n. En la actualidad, los laboratorios p\u00fablicos productores de vacunas de la Regi\u00f3n no est\u00e1n capacitados para competir en este nuevo contexto y corren el riesgo de ser desplazados del mercado por completo. De ah\u00ed la necesidad de que cambien radicalmente su manejo gerencial y su capacidad cientificot\u00e9cnica, lo cual exige que los gobiernos se comprometan a mejorar y fortalecer aquellos aspectos pol\u00edticos y financieros que garanticen la participaci\u00f3n de los laboratorios nacionales en el suministro sostenible de vacunas a los programas de vacunaci\u00f3n, as\u00ed como en la investigaci\u00f3n, desarrollo y producci\u00f3n de vacunas nuevas [Multiplex quantitative PCR for detection of lower Although several methods have been for these bacteria the specificity is an underestimated problem. Here we present a on with lower respiratory tract infection (LRTI) and 31 controls, and on 87 fluid (CSF) samples from meningitis patients. meningitidis) and H. influenzae were in 21 and of patients, respectively. These pathogens were identified by qmPCR 72 of the cases, respectively, yielding sensitivities and specificities of 95% and 75% for S. pneumoniae, and 90% and 65% for H. influenzae, respectively. When a positivity the sensitivities and specificities were 90% and 80% for S. pneumoniae, and 81% and 85% for H. influenzae, respectively. Of 44 culture negative but qmPCR positive for H. influenzae, 41 were confirmed by fucK PCR as H. influenzae. Of the 103 patients who had taken antibiotics prior to sampling, S. pneumoniae and H. influenzae were identified by culture in 6% and 20% of the cases, respectively, and by the qmPCR in 36% and 53% of the cases, respectively.In 87 CSF samples S. pneumoniae and N. meningitidis were identified by culture and/or 16 S rRNA in 14 and 10 samples and by qmPCR in 14 and 10 samples, respectively, giving a sensitivity of 100% and a specificity of 100% for both bacteria. The PCR provides increased [Multiplex quantitative PCR for detection Although several methods have been for these bacteria the specificity is an underestimated problem. Here we present a on with lower respiratory tract infection (LRTI and 31 controls, and on 87 samples from meningitis meningitidis and H. influenzae were in 21 and of patients, respectively. These pathogens were identified by qmPCR 72 of the cases, respectively, yielding sensitivities and specificities of 95% and 75% for S. pneumoniae, and 90% and 65% for H. influenzae, respectively. When a positivity the sensitivities and specificities were 90% and 80% for S. pneumoniae, and 81% and 85% for H. influenzae, respectively. Of 44 culture negative but qmPCR positive for H. influenzae, 41 were confirmed by fucK PCR as H. influenzae. Of the 103 patients who had taken antibiotics prior to sampling, S. pneumoniae and H. influenzae were identified by culture in 6% and 20% of the cases, respectively, and by the qmPCR in 36% and 53% of the cases, respectively. In 87 CSF samples S. pneumoniae and N. meningitidis were identified by culture and/or 16 S rRNA in 14 and 10 samples and by qmPCR in 14 and 10 samples, respectively, giving a sensitivity of 100% and a specificity for both infant rat.](https://www.ncbi.nlm.nih.gov/pubmed/3264378) Loeb, M R 1988-01-01 In the course of using the infant rat model to determine the ability of various rabbit antisera to protect against challenge influenzae type b we made two unexpected observations. In these experiments 4-day-old rats buffers (sham serum) then were challenged the next day with H. influenzae type b injected i.p. Bacteremia, as a marker for disease, was measured h later on day 6. We (P less than 0.01) protected the rats from challenge with H. influenzae type b when compared to a sham inoculation of buffer; (ii) In the absence of a serum inoculation on day 4 (a buffer was used serum inoculation), the levels of after bacteria on day 5 depended upon the composition of the buffer in which the H. influenzae inoculum was suspended. the GRASP, was conducted between November and catarrhalis from 20 countries in Europe, eastern Asia and southern Africa. Conspicuous differences between various of MDR strains was above 25% in of beta-lactamase production ranged from 0% to 39% influenzae 80-100% M. but older adults suggesting that prior infection with influenza strains may subjects. In recent seasonal was AND FINDINGS: To study hemagglutinin (HA antibody responses in influenza immunization and infection, we have studied the day 7 subjects seasonal trivalent inactivated cells after TIV antibodies, while most plasma cells after EI produced antibodies that did not react with influenza anti-HA antibodies from TIV subjects were primarily reactive subjects anti-HA antibodies from TIV subjects showed with subjects. both H1N1 and H3N2 viruses. this to pneumococci and non-typable A ear malformation recurrent otitis media had three episodes of bacteriologically confirmed meningitis within seven months. The first episode was caused by pneumococci, the other two by non-typable The CSF cultures were positive within 0.5 to 12 hours after the of symptoms. Despite misleading laboratory studies, surgical exploration the ear anomaly. No further should be the non-invasive bacteria as causative agents, (NTHi is chronic respiratory diseases. The role of this bacterium in the pathogenesis of lung inflammation is not well defined. In this study we examined the effect of on two subjects, human-lung fibroblast measure neutrophils; with the macrophages a sustained, extracellular production of ROS that increased over time. The production of ROS was associated with the formation of macrophage extracellular traps. [Registro de ensayos con vacunas del Programa Mundial de Vacunas e Inmunizaci\u00f3n de la OMS](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Robertson S. E. 1998-01-01 Full Text Available En 1995, el Programa Mundial de Vacunas e Inmunizaci\u00f3n de la OMS estableci\u00f3 un registro para ensayos con vacunas. En septiembre de 1996, este registro conten\u00eda 50 ensayos de vacunaci\u00f3n patrocinados por la OMS, de los cuales 25 (50% eran estudios ya terminados. Las vacunas que se hab\u00edan estudiado con mayor frecuencia fueron las de sarampi\u00f3n (9 ensayos, poliovirus (8 ensayos, c\u00f3lera (8 ensayos, Escherichia coli enterotox\u00edgena (4 ensayos y neumococo (4 ensayos. Casi 80% de estos ensayos se llevaron a cabo en pa\u00edses en desarrollo, principalmente en el \u00c1frica. En los 25 ensayos ya terminados, los resultados investigados fueron la respuesta inmunitaria (24 ensayos, las reacciones adversas (13 ensayos, la morbilidad (4 ensayos y la mortalidad (1 ensayo. La OMS contribuy\u00f3 a estos ensayos con el aporte indirecto de fondos, ayuda con el dise\u00f1o metodol\u00f3gico, visitas a las localidades, el an\u00e1lisis de los datos, la adquisici\u00f3n de vacunas y la investigaci\u00f3n de su potencia. [Non-epitope-specific suppression of the antibody in humans been by few studies. study this issue, we randomized 82 healthy and certain adult risk groups. Similar conjugate vaccines against other capsulated bacteria are currently under development for both......CP-TT, P = 0.00002; HibCP-TT and then HibCP-DT, (CDC) Podcasts](http://www2c.cdc.gov/podcasts/search.asp) 2013-07-25 Desde el 2006, hay una vacuna que protege contra los tipos de VPH que causan c\u00c3\u00a1ncer con mayor frecuencia. Este podcast habla sobre la importancia de que los padres hablen con los proveedores de atenci\u00c3\u00b3n m\u00c3\u00a9dica de sus hijos sobre ponerles la vacuna worldwide, but there is a paucity of data on its regional epidemiology in resource-constrained settings of sub-Saharan Africa. Here, we present a study on the aetiology of paediatric meningitis in central Cete d'Ivoire. Between June and December 2013, all cerebrospinal (CSF) samples drawn at the University Teaching Hospital Bouak\u00e9 were examined for the presence of bacterial and fungal pathogens. A causative agent was detected in 31 out 833 CSF with Neisseria meningitidis (n=5). With the exception of neonates, these two bacteria were the most common agents in all age groups. Of note, only a single case of Haemophilus influenzae meningitis was detected. Hence, this study reports a considerable shift in the epidemiology of paediatric meningitis in central (Hib) diseases has been implemented in Vietnam. In this study we evaluated the safety and reactogenicity of combined diphtheria-tetanus-pertussis-inactivated polio (DTPa-IPV)/Hib children aged years. [Immunogenicity and of two doses of catch-up immunization with Haemophilus influenzae type b conjugate vaccine risk of disease from Haemophilus influenzae type b (Hib). Data are limited (1) evaluate baseline immunity to Hib and the two doses of HibCV among HIV-infected Indian children; and 2-15 years age HIV-uninfected children 2-5 years of age. HIV-infected children received two after immunization in the HIV-infected children. Nasopharyngeal (NP) swabs were collected at and uninfected children participated. 40% of HIV-infected children were receiving ART and 26% had a viral g/mL protective Hib NP colonization. There were no differences in adverse events between HIV-infected and uninfected Older children lipooligosaccharides (LOS), many of which incorporate sialic acid as a terminal nonreducing sugar. Sialic acid has been demonstrated to be an important factor in the survival of the bacteria within the host environment. H. influenzae is incapable of synthesizing sialic acid and is dependent on scavenging free sialic acid from the host environment. H. influenzae utilizes a tripartite extracytoplasmic solute receptor of specific residues. Mass spectrometry the confirmed the observation The decreased ability of H. influenzae to import sialic acid had negative effects on resistance complement-mediated vitro, Available -defensins 1-3 (HNP 1-3 has been analyzed in the blood plasma of children with recurrent bronchitis caused by bacteria of the genus Haemophilus. It is shown that the level of HNP 1-3 in the blood plasma depends on the form of Haemophilus. Trigger of HNP 1-3 outflow for neutrophils was the presence of bacterial capsule while presence of L-forms of Haemophilus influenzae wasn't associated with increase in synthesis antimicrobial that could be of forming of Haemophilus antibiotic Tobar Ruiz, Mar\u00eda 2015-01-01 La carciog\u00e9nesis est\u00e1 condicionada por factores dependientes del virus como de los h\u00e1bitos del hu\u00e9sped. En cuanto a la vacunaci\u00f3n se han descubierto vacunas seguras y eficaces, siendo las dos vacunas destacadas la tetravalente o Gardasil y la bivalente o Cervarix. E nfermer\u00eda es la profesional que administra la vacuna y conoce los efectos adversos posibl es a causa de su administraci\u00f3n, y es por esa raz\u00f3n por la que mi inter\u00e9s se centr\u00f3 en la vacunaci\u00f3n. [Erythromycin and azithromycin Capobianco, J.O.; Goldman, effect of collapsing the electrochemical proton distribution of (2-{sup 14}C)dimethadione and rubidium-86, respectively. delta mu H was reduced from 124 to 3 mV in EDTA-valinomycin-treated cells at 22{degrees}C with 150 mM KCl and 0.1 mM carbonyl cyanide due to an energy-dependent efflux pump but was likely due to permeability. These data indicated that macrolide a delta mu rather in Queensland, Australia from 2000 to 2013: what is the impact of an increase and in particular, assess the clinical impact and from July 2000 to June 2013. Databases of major laboratories in Queensland including Queensland Forensic and Scientific Services (jurisdictional referral In total, 737 invasive During the study period, there was an increase in the incidence of invasive NTHi disease (P = 0\u00b7007) with seasonal peaks in winter and spring (P 0\u00b7001) and Hib (P = should dengue: a review of current candidate vaccines at advanced development stages Vacunas contra el dengue: una revisi\u00f3n de las vacunas candidatas en etapas avanzadas de desarrollo](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892007000300011) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Joachim Hombach 2007-04-01 Full Text Available Los esfuerzos sistem\u00e1ticos para desarrollar una vacuna contra el dengue comenzaron durante la Segunda Guerra Mundial, inspirados en el desarrollo exitoso de una vacuna contra la fiebre amarilla. Sin embargo, la falta de modelos adecuados de la enfermedad, la informaci\u00f3n incompleta acerca de los mecanismos patog\u00e9nicos y los insuficientes incentivos econ\u00f3micos han dificultado los avances. Debido al impacto actual del dengue en todo el mundo y su explosiva diseminaci\u00f3n, ha aumentado el inter\u00e9s en el desarrollo de vacunas contra el dengue y se ha avanzado considerablemente en el camino hacia la evaluaci\u00f3n cl\u00ednica de vacunas candidatas. La Iniciativa para la Investigaci\u00f3n en Vacunas, de la Organizaci\u00f3n Mundial de la Salud, est\u00e1 facilitando el desarrollo de y los ensayos con las vacunas candidatas. Las vacunas contra el dengue que se encuentran actualmente en etapas avanzadas de desarrollo son de tres tipos fundamentales: 1 vivas atenuadas; 2 vivas recombinantes; y 3 de subunidades e inactivadas. La mayor\u00eda de las vacunas en cartera son vivas atenuadas, siguiendo el camino exitoso de otras vacunas vivas contra flavivirus, especialmente de la desarrollada contra la fiebre amarilla. En general, las vacunas contra el dengue que se encuentran actualmente en desarrollo est\u00e1n bastante avanzadas y son muy diversas. Muy pronto comenzar\u00e1 la evaluaci\u00f3n de estas vacuna candidatas en ensayos de eficacia basados en poblaciones expuestas, lo que requerir\u00e1 resolver varios problemas t\u00e9cnicos, operacionales y regulatorios. [Vacunas de bacterias recombinantes vivas](https://www.openaire.eu/search/publication?articleId=od______3272::e04c2a8ca070b76a97f8c299cefc6434) Blanco Le\u00f3n, Marina 2016-01-01 La vacunaci\u00f3n es uno de los logros m\u00e1s importantes en la historia de la medicina, que ha ido evolucionando a lo largo de los a\u00f1os permitiendo una reducci\u00f3n significativa de la mortalidad infantil, una disminuci\u00f3n de la incidencia de enfermedades e incluso la erradicaci\u00f3n de algunas de ellas en pa\u00edses enteros. Las vacunas de nueva generaci\u00f3n surgen para reducir o eliminar las carencias de las vacunas \"tradicionales\". T\u00e9cnicas biotecnol\u00f3gicas basadas en el ADN recombinante han dado lugar, entre... [Comparison of radiometric and broth blood culture system, the authors developed vivo model of bacteremia in rats. After intravenous injection of 50 to 200 into rats, was a linear logarithmic increase in CFU per milliliter of rat blood during the first 10 h (r = 0.98), allowing accurate prediction of the level of bacteremia with time. Culture bottles were inoculated with 0.5 ml puncture and processed as clinical microbiology with RS and conventional protocols. They found the following. (i) The first detection of bacteremia by RS was similar to that by TSB if a Gram stain of the TSB was done on day 1 and was superior if that smear was omitted (P less than 0.01). (ii) The detection times in both systems were comparable at different magnitudes of bacteremia (10(1) to 10(4) CFU/ml). (iii) Supplementation of rat interfered Gram stain detection in TSB but resulted in increased 14 CO 2 production in RS. (iv) No difference in detection time was found between RS and TSB for four different clinical isolates. These studies show that, in a biologically relevant the detection of positive blood cultures for H. influenzae type b by RS was comparable to or better than detection by TSB when microtitre measure technique on biofilm production. The density of bacterial final growth was determined by absorbance after 18-20 h incubation, and biofilm violet staining. Biofilm as at least one of the high producing strains. In general, storage of NTHi cultures at -80 \u00b0C for up to 48 weeks did not have any major effect on their ability to produce GIVEN TO VIETNAMESE INFANTS The present study was performed to assess the and safety (Hib) (DTwP-HepB-Hib) Quinvaxem\u00ae vaccine children. A total of 131 infants received the Quinvaxem\u00ae vaccine at 2, 3 and 4 Antibody levels were measured at baseline, at one month after the third injection and one year after the first injection. Seroprotection rates were high for each vaccine antigen rate of children with protective antibodies persisting at one year after the a low rate of adverse events. Quinvaxem\u00ae given at 2, 3 and 4 months of age was immunogenic and safe for primary immunization among infants in Vietnam. [La influenza, un problema vigente de salud p\u00fablica Influenza, an existing public health problem](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342006000300009) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Juan Garc\u00eda-Garc\u00eda 2006-06-01 Full Text Available La influenza estacional es una enfermedad respiratoria aguda, recurrente y com\u00fan que se conoce desde la antig\u00fcedad y se presenta sobre todo durante los meses de invierno con un elevado impacto para la salud p\u00fablica mundial. La enfermedad se manifiesta con altas tasas de morbilidad en individuos de todas las edades y elevadas tasas de mortalidad en ni\u00f1os, individuos mayores de 60 a\u00f1os, pacientes con enfermedades cr\u00f3nicas y mujeres en gestaci\u00f3n. Las estrategias de prevenci\u00f3n incluyen el uso de vacunas: inactivadas, subunitarias o vacuna con virus gen\u00e9ticamente modificados. Dos subtipos de virus de influenza tipo A y un virus de influenza tipo B causan la enfermedad en humanos. Los virus de influenza A que afectan a los humanos mutan con facilidad, por lo que con frecuencia aparecen nuevas variantes antig\u00e9nicas de cada subtipo, lo que obliga a incluir dichas variantes en las vacunas anuales para brindar una adecuada protecci\u00f3n a la poblaci\u00f3n. La influenza pand\u00e9mica se refiere a la introducci\u00f3n y posterior diseminaci\u00f3n mundial de un nuevo virus de influenza en la poblaci\u00f3n humana, lo que ocurre de manera espor\u00e1dica, y que debido a que los humanos carecen de inmunidad para el nuevo virus pueden suscitarse epidemias graves con elevadas tasas de morbilidad y mortalidad. Hist\u00f3ricamente el origen de las pandemias de influenza se debe a la transmisi\u00f3n de virus de aves al hombre o la transferencia de genes de \u00e9stos a los virus de la influenza estacional. En las aves acu\u00e1ticas silvestres, tanto migratorias como costeras, se mantiene una gran diversidad de subtipos de virus de influenza, los cuales se introducen eventualmente en aves dom\u00e9sticas, donde algunos virus adquieren la capacidad de infectar a mam\u00edferos, incluido el hombre. El proceso de adaptaci\u00f3n de los virus aviarios a hospederos mam\u00edferos requiere tiempo, por lo que la presentaci\u00f3n de estos casos puede tardar varios a\u00f1os. Desde diciembre de 2003, en varios pa\u00edses del [La articulaci\u00f3n p\u00fablico-privada en la producci\u00f3n de vacunas en M\u00e9xico](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-11042016000400009&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Silvia Tamez Full Text Available RESUMEN El art\u00edculo analiza el proceso de privatizaci\u00f3n de la atenci\u00f3n a la salud: la Articulaci\u00f3n P\u00fablico-Privada (APP. Espec\u00edficamente estudia la producci\u00f3n de vacunas em M\u00e9xico, tomando como caso los Laboratorios de Biol\u00f3gicos y Reactivos de M\u00e9xico, S.A. de C.V. (Birmex, empresa paraestatal, responsable de producir, distribuir e investigar biol\u00f3gicos y reactivos en M\u00e9xico. Interesa destacar el comportamiento de Birmex durante el periodo de la pandemia de influenza de 2009, producida por el virus de la influenza A subtipo H1N1. Los resultados muestran que gracias al impulso de las pol\u00edticas de liberalizaci\u00f3n y desregulaci\u00f3n, existe una apertura de los servicios p\u00fablicos a las corporaciones supranacionales. [A natural Hoon [Respiratory Viruses Research Laboratory, Discovery 712 Beon-gil, Gyeonggi-do, [College of Pharmacy, jiyoung.min@ip-korea.org [Respiratory Viruses Laboratory, Daewangpangyo-ro 712 Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, drugs with novel antiviral steps, We found that TGBG exhibits early stages of infection causing accumulate in the a dose-dependent manner. These data suggest a putative mode TGBG of as novel a novel mechanism of action. - Highlights: The plant-derived natural product TGBG has broad-spectrum antiviral activity against seasonal influenza A and B viruses. TGBG has a novel anti-viral mechanism of So need steps, We found that TGBG exhibits early stages of infection causing accumulate in the a dose-dependent manner. These data suggest a putative mode TGBG of as novel a novel mechanism of action. - Highlights: The plant-derived natural product TGBG has broad-spectrum antiviral activity against seasonal influenza A and B viruses. TGBG has a novel anti-viral mechanism of [Antibacterial activity of asiatica infection causing its Hongjie; Huang, Yanjie 2018-01-01 The main objective of the current study was to investigate the chemical composition of the essential oil of Artemisia asiatica together with etc. The essential oil extracted from the leaves of A. asiatica by supercritical CO 2 fluid extraction technology. antibacterial activity was evaluated against 6 paper and chromatographic analysis of the A. asiatica essential oil led to the identification of 16 chemical constituents accounting for 97.2% of the total oil composition. The major components were found to be Piperitone, (z)-davanone, p-cymene and 1, inhibition against Haemophilus influenzae with a zone of inhibition MIC/MBC values of 1.9/4.5 mg/mL respectively. Bacteria treated with the oil led to a rapid decrease in the number of viable cells. On adding the essential oil of A. asiatica to the bacterial culture, the constituents of the bacterial cell got released into the medium and this cell constituent release increased with increasing doses of the essential oil. SEM showed that the bacterial cells treated had amino remained cefixime susceptible and had no a recombinant plasmid vector and a Rec- H. influenzae with the restriction analysis and hybridization between the plasmid and a probe containing all of the mucA gene but only a small fraction of mucB. When one of the H. influenzae Rec- transformants lost the plasmid, the resistance to UV retained but the high spontaneous mutation and UV mutability were not. The fact that there was hybridization between the chromosome of the cured strain and a probe containing both muc genes but none when almost no mucB was present suggested that at least part of the mucB gene had been integrated into the Rec- chromosome. Five different postreplication repair-proficient strains Therefore, their responses to vaccination particular this open, controlled, Spanish study, we of age followed by booster vaccination at after Serious adverse events were recorded throughout the study. There with other groups and this difference persisted until 16 to 18 months of age. Hib-MenC-TT vaccine was well tolerated at all ages. There was one death caused by meningococcal serogroup-B sepsis (full term). No serious adverse by the investigator as being vaccine related. Hib-MenC-TT vaccine had a similar immunogenicity and children who had received a birth dose of hepatitis B vaccine Vacunaci\u00f3n primaria y de refuerzo con la vacuna pentavalente DTPw-HB/Hib en ni\u00f1os costarricenses vacunados al nacer contra la hepatitis B](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892002001000005) [Directory for diphtheria and Bordetella pertussis. At 15 months of responded with the DTPw-HB/Hib pentavalent vaccine regimens were equally well tolerated, indicating that up to five doses of the HB vaccine can be given without impact on safety. Conclusions. Our study confirms that vaccine is immunogenic as a primary vaccination in children who received HB vaccine the pentavalent both for primary routine use of as part of childhood vaccination programs in Latin America and the Caribbean.Objetivos. La vacuna combinada pentavalente DTPw-HB/Hib ha sido creada siguiendo la recomendaci\u00f3n de la Organizaci\u00f3n Mundial de la Salud de a\u00f1adir las vacunas contra la hepatitis b (HB y el Haemophilus influenzae tipo b (Hib a los programas de vacunaci\u00f3n infantil. Los objetivos del presente estudio consistieron en: 1 analizar la inmunogenicidad y reactogenicidad de la vacuna combinada pentavalente DTPw-HB/Hib en comparaci\u00f3n con las inyecciones separadas de las vacunas DTPw-HB e Hib como vacunaci\u00f3n primaria en un grupo de ni\u00f1os que hab\u00edan recibido al nacer una dosis de vacuna contra la HB, y 2 evaluar la persistencia de anticuerpos en el segundo a\u00f1o de vida, as\u00ed como la respuesta a las dosis de recuerdo de DTPw-HB/Hib o DTPw/Hib. M\u00e9todos. En la primera parte del estudio (fase de vacunaci\u00f3n primaria, realizada en 1998-1999, se analiz\u00f3 la inmunogenicidad y reactogenicidad de la vacuna combinada DTPw-HB/Hib en comparaci\u00f3n con inyecciones separadas de las vacunas DTPw-HB e Hib como complex with inhibitor tyrosine and + has been three kingdoms of Tyrosine is bound directly at the catalytic site, suggesting that it is active site, including the absence of an - motif in HinfPDH that is present in other TyrA proteins, such as sp. are involved in discrimination between NADP + and NAD + . The loop between 5 and 6 in the N-terminal domain is much shorter in HinfPDH and an extra helix is present at C-terminus. closed do not the (from Influenza Pandemics](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5481322) Denise E.; Cleary, David W.; Clarke, Stuart C. 2017-01-01 Lower and upper respiratory infections are the fourth highest cause of global mortality (Lozano et al., 2012). Epidemic and pandemic outbreaks considerable and a high death toll, typically over a relatively short period of time. Influenza is a major cause of epidemic and resistance and vaccine evasion it epidemiology of pathogens in circulation to inform clinical treatment and of an influenza epidemic/pandemic. PMID:28690590 [Secondary Bacterial Infections Influenza Pandemics](http://journal.frontiersin.org/article/10.3389/fmicb.2017.01041/full) Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Denise E. Morris 2017-06-01 Full Text Available Lower and upper respiratory infections are the fourth highest cause of global mortality (Lozano et al., 2012. Epidemic and pandemic outbreaks considerable and a high death toll, typically over a relatively short period of time. Influenza is a major cause of epidemic and resistance and vaccine evasion it epidemiology of pathogens in circulation to inform clinical treatment and Lower Cristina; Ruiz de los specific and relative contribution to colonization and infection of the respiratory tract has not been addressed comprehensively. In this study, we focused on the ompP5 and hap genes, present in all H. infection. We show that P5 is not required for bacterial biofilm growth, but it is involved in NTHi interplay with respiratory cells and in mouse infection. Mechanistically, P5NTHi375 is that Hap does not contribute bacterial biofilm growth, and that absence partially PMID:25894755 [Realidad de la vacuna del virus del papiloma humano](https://www.openaire.eu/search/publication?articleId=od______1472::a09ac4cf255ae73a6b4363b1bbc0a6ad) Garc\u00eda G\u00f3mez, Nuria 2014-01-01 La vacuna frente al VPH es la primera vacuna destinada a la prevenci\u00f3n del c\u00e1ncer inducido por un virus, el CCU (problema de salud p\u00fablica mundial), y de lesiones precursoras. Disponemos de 2 vacunas profil\u00e1cticas: Gardasil\u00ae (frente a VPH 6, 11, 16 y 18) y Cervarix\u00ae (frente a VPH 16 y 18). El trabajo consiste en una revisi\u00f3n bibliogr\u00e1fica que tiene como objetivo conocer la situaci\u00f3n que vive actualmente la vacuna del VPH en Espa\u00f1a, utilizando como palabras clave virus, vacun... [Structural Analysis of regulated step in fatty acid synthesis. In most Gram-negative and Gram-positive bacteria, the In the second reaction, carboxyltransferase catalyzes the transfer of carboxyl group from to acetyl-CoA to form in that bicarbonate, phosphate, and the methyl ester of the carboxyl group of N1-methoxycarbonyl biotin methyl ester all bound in the same pocket in the active site of biotin carboxylase and as such utilize the the carboxyphosphate intermediate to biotin. PMID:26020841 [Los laboratorios p\u00fablicos productores of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Akira Homma 1998-10-01 Full Text Available Los laboratorios p\u00fablicos productores de vacunas de Am\u00e9rica Latina y el Caribe han contribuido en diferente grado al control y a la erradicaci\u00f3n de las enfermedades prevenibles por vacunaci\u00f3n y varios est\u00e1n produciendo las vacunas que se aplican rutinariamente en los programas nacionales de inmunizaci\u00f3n, como la vacuna antituberculosa (a base del bacilo de Calmette-Gu\u00e9rin, BCG, la vacuna difteria-t\u00e9tanos-pertussis (DTP, el la vacuna antisarampionosa y la vacuna antipoliomiel\u00edtica oral. Gracias a los adelantos cient\u00edficos recientes, se prev\u00e9 un aumento importante del n\u00famero de vacunas seguras y eficaces que estar\u00e1n disponibles en un futuro cercano para uso en los programas normales de vacunaci\u00f3n. Sin embargo, los gastos asociados con el desarrollo de estas vacunas y con los derechos de propiedad intelectual que las protegen son cuantiosos. Adem\u00e1s, pocos laboratorios en Am\u00e9rica Latina poseen la capacidad t\u00e9cnica para investigar y elaborar estas vacunas. Tales factores tendr\u00e1n un impacto en la celeridad con que se incorporar\u00e1n en los esquemas de vacunaci\u00f3n de los pa\u00edses de la Regi\u00f3n. En la actualidad, los laboratorios p\u00fablicos productores de vacunas de la Regi\u00f3n no est\u00e1n capacitados para competir en este nuevo contexto y corren el riesgo de ser desplazados del mercado por completo. De ah\u00ed la necesidad de que cambien radicalmente su manejo gerencial y su capacidad cientificot\u00e9cnica, lo cual exige que los gobiernos se comprometan a mejorar y fortalecer aquellos aspectos pol\u00edticos y financieros que garanticen la participaci\u00f3n de los laboratorios nacionales en el suministro sostenible de vacunas a los programas de vacunaci\u00f3n, as\u00ed como en la investigaci\u00f3n, desarrollo y producci\u00f3n de vacunas nuevasIn Latin America and the Caribbean, public laboratories that produce vaccines have contributed in varying degrees to the control of vaccine-preventable diseases, and several of them [Vacunas, biotecnolog\u00eda y su relaci\u00f3n con el aborto provocado](https://www.openaire.eu/search/publication?articleId=doajarticles::4639710bd8874709386dd27339826e1d) Jos\u00e9 Luis Redondo Calder\u00f3n 2008-01-01 Las vacunas de c\u00e9lulas diploides humanas (WI-38, MRC-5) tienen un origen \u00e9ticamente objetable, dado que dichas c\u00e9lulas proceden de abortos provocados. Entre ellas destacan vacunas empleadas contra rub\u00e9ola, sarampi\u00f3n, parotiditis, rabia, poliomielitis, viruela, hepatitis A, varicela y herpes z\u00f3ster. Actualmente se encuentran en desarrollo otras vacunas cultivadas en c\u00e9lulas (293, PER.C6) transformadas mediante virus, procedentes de abortos. Entre ellas hay vacunas contra la gripe, virus respi... [Pyrazole compound BPR1P0034 with potent 2010-02-01 Full Text Available Abstract Background Influenza viruses are a major cause of morbidity and mortality around the world. More recently, a swine-origin influenza A (H1N1 virus that is spreading via human-to-human transmission has become serious in comprehensive approach to controlling illness and addition, a search for influenza-inhibiting drugs is particularly important in the face of from ChemDiv, Inc., we found that BPR1P0034 has sub-micromolar antiviral activity. The compound was conventional techniques. assay was concentration a no antiviral effect for enteroviruses and echovirus 9. In a time-of-addition assay, in which the compound was added at different stages along the viral replication cycle (such as at adsorption or after adsorption, its antiviral activity was more efficient in cells treated with the test compound between 0 and 2 h, right after viral infection, implying that an early step of viral replication might be the target of the compound. These results of immunogenicity infants between 6 months and 1 year of age. In the first study phase, 6-12 month-old infants received two = 335) or PRP-T (n = 335) vaccine administered 1 month apart. In the second study phase 8 later, the same children received a single booster dose of vaccine identical to that use for priming (PRP-CRM(197), n = 327; infants in the PRP-CRM(197) group and 98% of in the PRP-T group 1 month after primary immunisation, and by all subjects (100%) in both vaccine groups 1 month after booster administration. Safety profiles for both no or de idosos em Teresina Vacuna contra gripe: conocimiento, actitudes y pr\u00e1ctica de ancianos en Teresina Vaccine influenza: knowledge, attitudes and practices Ara\u00fajo 2007-08-01 objetiva levantar os conhecimentos, atitudes e pr\u00e1ticas dos idosos de uma \u00e1rea do Programa de Sa\u00fade da Fam\u00edlia (PSF sobre a vacina contra influenza e identificar os motivos que levaram alguns a n\u00e3o se vacinarem. Consiste em um inqu\u00e9rito domiciliar, em uma \u00e1rea do PSF de Teresina, com 74 idosos a partir de 60 anos. Os resultados evidenciaram que favor\u00e1vel a respeito da vacina\u00e7\u00e3o pode a pr\u00e1tica a ela, instaurando comportamento de autoprote\u00e7\u00e3o e maior ades\u00e3o.Este estudio objetivo para levantar el conocimiento, pr\u00e1ctico y actitudes envejecidos de un \u00e1rea del programa de la salud de Familia (PSF en la vacuna cuenta gripe e identificar las razones que hab\u00edan tomado alguno para no ser vaccined. Consiste en una investigaci\u00f3n domiciliaria, un \u00e1rea del PSF de Teresina, con 74 envejeci\u00f3 unos a partir de 60 a\u00f1os. El resultado hab\u00eda evidenciado que sin embargo 85.3% tienen conocimiento inadecuado en la vacuna, 89.1% es favorable. Las razones m\u00e1s frecuentes para la vacunaci\u00f3n no hab\u00edan sido enfermedad y miedo de los acontecimientos adversos. Se concluye que la actitud favorable con respecto a la vacunaci\u00f3n puede modificar el frente pr\u00e1ctico \u00e9l, restaurando el comportamiento de la uno mismo-protecci\u00f3n y de la mayor adherencia.This objective study to raise the knowledge, practical and attitudes of the aged ones of an area of the Program of Health of Fam\u00edlia (PSF on the vaccine it counts influenza and to identify the reasons that had taken some not to be vaccined. It consists of a domiciliary inquiry, an area of the PSF of Teresina, with 74 aged ones from 60 years. The result had evidenced that even so 85.3% have inadequate knowledge on the vaccine, 89.1% is reasons of Haemophilus influenzae type b (Hib) not in their national immunization programs. This systematic aimed to update published economic evaluations Hib Hib vaccination with and WHO checklist was used to evaluate the quality of were extracted using a standardized data collection form. Out of 830 articles, 27 were included. Almost half of the used, where tree models. Most of the (23/27) immunization findings expected to support policy-makers for extracellular DNA and proteins. Using a (NET) structures biofilm examine commonly carried within host environments and can cause OM. The results showed that coinfection H. H. parainfluenzae during coinfection with topics for \u00a9 2017 American Society for Microbiology. ['Haemophilus complaining symptoms. H. influenzae strains, which had been isolated from the urethra in 77 of 1518 men complaining of urethritis symptoms, identified by the conventional this study. demographic clinical features were similar to those of NGU caused by other pathogens. The man produced no quentini'-positive NGU, be difficult the of 'H. the urethra. The 3 strains of 'H. susceptible to a variety \u00a9 2017 of Chemotherapy The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. [Haemophilus influenzae : Caracterizaci\u00f3n de aislamientos recuperados de enfermedades invasivas en Cuba durante el per\u00edodo 2008-2011](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2012000300005&lng=es&nrm=iso) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Gilda Tora\u00f1o 2012-12-01 Full Text Available Con el objetivo de caracterizar los aislamientos de Haemophilus influenzae, responsables de enfermedades invasivas en Cuba, en la etapa posterior a la vacunaci\u00f3n se estudi\u00f3 el total de los recuperados durante el per\u00edodo 2008-2011, remitidos al Instituto \"Pedro Kour\u00ed\" desde diferentes provincias del pa\u00eds. La confirmaci\u00f3n de especie y determinaci\u00f3n de serotipos se realiz\u00f3 atendiendo al requerimiento de los factores V y X y empleando el m\u00e9todo de aglutinaci\u00f3n en l\u00e1mina, respectivamente. Se definieron los biotipos a trav\u00e9s de las pruebas de indol, urea y ornitina; se determin\u00f3 la concentraci\u00f3n m\u00ednima inhibitoria (CMI mediante la prueba del elips\u00f3metro para la ampicilina, la ceftriaxona, el cloranfenicol y la rifampicina. Para 23 aislamientos se corrobor\u00f3 la identificaci\u00f3n como H. influenzae : 21 fueron serotipables y 2 no tipables (HNT. El 90,4% de los serotipables fueron serotipo b y se detectaron dos serotipos a. Nueve aislamientos de H. influenzae b pertenecieron al biotipo I y los aislamientos, serotipo a y HNT, al biotipo II. En una cepa se demostr\u00f3 producci\u00f3n de la enzima \u00df-lactamasa y resistencia para la ampicilina y el cloranfenicol, con valores de CMI= 8 y 12 \u00b5g/mL, respectivamente. Se puso en evidencia que a pesar de la disminuci\u00f3n de la incidencia de la enfermedad invasiva por Hib, este serotipo a\u00fan constituye el m\u00e1s frecuente y se alerta sobre la necesidad de una vigilancia sostenida que permita detectar fallos vacunales. La susceptibilidad antimicrobiana demostrada para este per\u00edodo pudiera considerarse como un beneficio adicional de la introducci\u00f3n de la vacunaci\u00f3n en Cuba. [Overexpression and Purification of C-terminal initiates infection 311 the internal passenger of the with protein has been shown to prevent bacterial nasopharynx colonization and to either not at all or to only very the lexA mutants error-prone repair system. This the observation that chloramphenicol has little or no effect on post-replication repair after UV irradiation. In reported to considerably inhibit post-replication repair in the wild type but not in the lexA mutant. Earlier work has suggested that most or all the mutations induced in H. influenzae by NC result from error-prone repair. Combined treatment with NC and either X-rays or UV shows that the NC error-prone repair system does not produce mutations from the lesions induced by these radiations even while it is producing them from its own lesions. It is concluded that the NC error-prone repair system or systems and the reclex media, for which antibiotic treatment failure is increasingly common, is a leading pediatric public health problem. In vitro and in vivo studies using the chinchilla of -lactamase production vitro; system. NTHi of Measles, 12 months of age was investigated to assess the safety and immunogenicity of this regimen compared with separate administration of the conjugate vaccines. Children media of peripheral blood mononuclear cells (PBMC) from 20 children with a history of rAOM (otitis-prone) and 20 in cytokine levels produced between PBMC from In absence of antigen stimulation, otitis-prone children had more circulating Natural Killer (NK) cells (potitis-prone and non-otitis-prone children (potitis-prone children are functional and respond to NTHi. CD8+ T cells and NK cells from both cases and controls produced IFN in response cells present in cases than controls (pOtitis-prone children had more circulating IFN-producing innate and T responses to NTHi challenge that were comparable to healthy children. These data provide evidence that otitis-prone [Validaci\u00f3n del m\u00e9todo de para la determinaci\u00f3n de la concentraci\u00f3n de grupos sulfhidrilosa muestras de la producci\u00f3n de la vacuna sint\u00e9tica contra el Haemophilus influenzae tipo Text Available e valid\u00f3 el m\u00e9todo de Ellman para la determinaci\u00f3n de grupos sulfhidrilos de la producci\u00f3n del Ingrediente Farmac\u00e9utico Activo de la vacuna contra el Haemophilusinfluenzaetipo b (Hib. Se evaluaron los par\u00e1metros: linealidad, rango de trabajo, especificidad, exactitud y precisi\u00f3n. El m\u00e9todo fue lineal en el rango de 0,25-4 mM/L. Se demostr\u00f3 que la t\u00e9cnica fue espec\u00edfica con una exactitud entre 95 y 105%. La repetibilidad y la precisi\u00f3n intermedia mostraron coeficientes de variaci\u00f3n inferiores al 5% y 10% respectivamente, por debajo de los criterios de aceptaci\u00f3n requeridos para estos par\u00e1metros. Se estableci\u00f3 el reactivo hidrocloruro de L-ciste\u00edna monohidratado como control positivo del m\u00e9todo. Este ensayo por su precisi\u00f3n, especificidad y exactitud se convierte en una eficaz herramienta para el control del proceso de obtenci\u00f3n de esta vacuna. [Anti-pandemic influenza A (H1N1) virus potential of A virus has spread worldwide and infected a large proportion of the human population. Discovery of new and effective drugs for the treatment of influenza is a crucial issue for the global medical community. According to our previous study, TSL-1, a fraction of the aqueous extract from the tender leaf of Toonasinensis, has demonstrated antiviral activities against pandemic influenza of adhesion molecules and chemokine to prevent viral attachment. The aim of the present study was to identify the active compounds in were found to potent inhibitors 50 ) of catechin and gallic for the influenza A virus were 18.4 respectively. reagent acid to influenza virus infection. We conclude that phyto-chemicals TSL-1 specific, and reproducible with a coefficient of variation between days of 19%. Results from the ELISA were compared with results from radioimmunoassay a correlation coefficient Results by methods were proportional and the relation was indepenedent of the antibody level. The relation between them was unaffected by the contribution of different antibody isotypes, indicating that these were measured to the same extent by both methods. ELISA of Individual strains also had varying numbers of SLR-containing genes from one or more of the subfamilies. Statistical genetic analyses of disease or association between possession the SlrVA subfamily (which we termed, in highly significant decrease survival macrophages; which fully complemented by a single copy of the msfA1 gene. Using the chinchilla model of otitis media in co-infections; and in single infections, the KO lost its ability to invade the brain. The singly complemented strain showed a gene dosage is important in vivo. The transcriptional profiles of the KO and in planktonic Text Available El doctor Manuel Elkin Patarroyo hace un recuento de lo que fueron sus primeros a\u00f1os de estudio y los primeros pasos que se dieron para fundar el Instituto de Inmunolog\u00eda, ayudado por muchos de los Acad\u00e9micos. Siempre ha querido representar al pueblo colombiano en sus valores de trabajo, disciplina, estudio, pensamiento y generosidad, en aras de un pueblo que sufre, que en definitiva es el objetivo del M\u00e9dico, el paciente. Posteriormente comenta qu\u00e9 es lo que se ha hecho con toda la profundidad que se merece pero con simpleza de palabras y en t\u00e9rminos sencillos, c\u00f3mo se desarroll\u00f3 la Vacuna Sint\u00e9tica contra la malaria: \u00bfPor qu\u00e9 malaria?, porque esta es una enfermedad de gran trascendencia; aclara que \u00e9l no le teme ni le molesta el cuestionamiento cient\u00edfico sobre el desarrollo de esta investigaci\u00f3n, por el contrario lo acepta y lo goza porque es el ejercicio intelectual; lo que s\u00ed le molesta es el morbo alrededor de ello, por esto pidi\u00f3 al doctor Mu\u00f1oz que al final se adelante un debate al respecto. Dice a continuaci\u00f3n que las vacunas tradicionales son biol\u00f3gicas como todo el mundo lo sabe, es el microorganismo causal mismo que se muta ose mata, pero que descomponiendo la estructura qu\u00edmica de sus mol\u00e9culas, con el concepto de la s\u00edntesis qu\u00edmica se podr\u00edan rehacer qu\u00edmicamente y ser utilizadas como vacuna. Decidieron entonces atacar el problema de la vacuna a trav\u00e9s de esta metodolog\u00eda creando la vacuna contra la malaria de la cual se conoce su estructura qu\u00edmica, y aclara que las vacunas qu\u00edmicas tienen otra ventaja, que son puras, con menos reacciones adversas que las tradicionales. Dice el doctor Patarroyo que decidieron aislar, e identificar m\u00e1s de la mitad de las prote\u00ednas del par\u00e1sito y dividiendo la muestra en dos fracciones, una de ellas se seleccion\u00f3 para averiguar su composici\u00f3n qu\u00edmica y la otra para saber cu\u00e1l podr\u00eda ser \u00fatil como vacuna. As\u00ed, fueron al Amazonas y all [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Alejandro Roque Vald\u00e9s 2004-04-01 Full Text Available El presente trabajo es un art\u00edculo de revisi\u00f3n que pretende abordar un tema tan controvertido como actual: la posible asociaci\u00f3n causal que se ha querido establecer entre el autismo y las vacunas infantiles. A partir de la \u00faltima d\u00e9cada del siglo XX se producen una serie de cambios en la clasificaci\u00f3n, nomenclatura y criterios diagn\u00f3sticos del autismo. Los hallazgos de estudios epidemiol\u00f3gicos llevados a cabo bajo estos nuevos ponderados han revelado que las tasas de prevalencia del autismo son en la actualidad muy superiores a las de hace 15 a\u00f1os. Entre los factores que se esgrimen para explicar este fen\u00f3meno est\u00e1n las vacunas, y entre los mecanismos que se invocan para tratar de inculpar a las vacunas en la etiolog\u00eda del autismo est\u00e1n el exceso de mercurio derivado del tiomersal que se emplea como conservante de las mismas y procesos autoinmunes que de forma directa o indirectamente act\u00faan sobre el SNC, induciendo lesiones a nivel de la mucosa intestinal, lo cual favorecer\u00e1 la absorci\u00f3n de macromol\u00e9culas, ant\u00edgenos y toxinas que una vez en el torrente sangu\u00edneo llegar\u00edan al SNC produciendo all\u00ed las lesiones responsables de la g\u00e9nesis del autismo. [Una vacuna contra la tuberculosi, provada en cabres](https://www.openaire.eu/search/publication?articleId=od______1404::6574285bd1662fef225103ab5f2fa6f1) P\u00e9rez del Val, Bernat 2012-01-01 Investigadors del CReSA han dut a terme el primer estudi de vacunaci\u00f3 contra la tuberculosi utilitzant com a model experimental la cabra dom\u00e8stica, que reprodueix amb molta similitud la resposta a la en La anomenada estat dissenyada investigadors McMaster prevenir la tuberculosi en i es estudi used either or in conjunction with other natural substances. Evidence suggests that these extracts are associated with a of pharmacological activities. to isolate system, quantitative confirms of carried out contrast P. indica which exhibited reduction in both simultaneous and posttreatment assay mg/mL. Our results suggest for anti-influenza therapy and should be used in medical treatment after further research. The search for natural antiviral compounds from plants is a promising approach in the development of new therapeutic agents. In the past century, new bioactive of drug is designed based on its fit to three dimensional structures of receptor site rather than by (PARTE of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Jos\u00e9 Antonio Navarro-Alonso 2016-01-01 Full Text Available En este documento se justifican los fundamentos inmunol\u00f3gicos y cl\u00ed - nicos para abordar una modificaci\u00f3n del Calendario de Vacunaci\u00f3n Infantil de Espa\u00f1a para el a\u00f1o 2016. Se revisa la inmunogenicidad y la experiencia cl\u00ednica con esquemas de vacunaci\u00f3n de dos dosis como primovacunaci\u00f3n en el primer a\u00f1o de vida y una dosis de recuerdo precoz, para los ant\u00edgenos de difteria, t\u00e9tanos, tosferina, Haemophilus influenzae tipo b, poliomielitis y hepatitis B. Por sus peculiaridades tambi\u00e9n se considera el impacto cl\u00ednico que esta pauta de vacunaci\u00f3n podr\u00eda tener en el lactante prematuro. Debido a que varias comunidades aut\u00f3nomas administran la primera dosis de vacuna de hepatitis B al nacimiento, se exponen las condiciones que se deber\u00edan cumplir para iniciar la vacunaci\u00f3n a los dos meses de vida. Se emiten las recomendaciones de calendario que incluyen como principales cambios la administraci\u00f3n de las vacunas hexavalentes a los 2, 4 y 11 meses, a\u00f1adiendo la recomendaci\u00f3n del uso de vacuna DTPa-VPI a los seis a\u00f1os de edad. [The dapE-encoded influenzae have been recorded in the presence of one or two equivalents of Zn(II) (i.e. [Zn_(DapE)] and [ZnZn(DapE)]). The Fourier transforms of the Zn EXAFS are dominated by a peak at ca. 2.0 A, which can be fit for both [Zn_(DapE)] and [ZnZn(DapE)], assuming ca. 5 (N,O) A ca. 3.34 spectrum but is diminished show that DapE dinuclear Zn(II) active site. Since are available for any DapE enzyme, these data provide the first glimpse at the active site of DapE enzymes. In addition, RESPIRATORIAS](http://www.sciencedirect.com/science/article/pii/S0716864017300160) Open (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Dr. Rodolfo Villena 2017-01-01 Full Text Available Las vacunas han demostrado ser una excelente estrategia para reducir la morbimortalidad en infecciones respiratorias, con un perfil de seguridad adecuado. Nuestro PNI incorpora varias de ellas con este objetivo, logrando resultados de alto impacto a nivel de salud p\u00fablica. Para que esto prosiga se requiere de nuestro compromiso y conocimiento para estimular, difundir y obtener altas tasas de cobertura, de manera de lograr efectos de protecci\u00f3n indirecta, conocidos como inmunidad comunitaria. Por otro lado, se debe mantener la vigilancia epidemiol\u00f3gica de los agentes inmunoprevenibles para conocer su oscilaci\u00f3n temporal, serogrupos, sero y/o genotipos, de manera de establecer directrices adecuadas de edad y esquemas de vacunaci\u00f3n para la poblaci\u00f3n. Debemos avanzar en estos temas y realizar estudios de efectividad de las vacunas que hemos introducido, para conocer su aporte en la prevenci\u00f3n de infecciones respiratorias, de manera de objetivar sus beneficios, conocer el impacto en poblaciones de riesgo y avanzar en la vacunaci\u00f3n de embarazadas, para otorgar mejores estrategias de prevenci\u00f3n a nuestra poblaci\u00f3n. [Economic evaluation of delivering Haemophilus influenzae type b services in Kenya.](https://www.ncbi.nlm.nih.gov/pubmed/17768499) Akumu, Angela Oloo; English, type b (Hib) vaccine was introduced into routine immunization services in Kenya in 2001. We aimed to estimate the cost-effectiveness of Hib vaccine delivery. A to follow the Kenyan 2004 birth cohort disease rates were also assumed dependent on access to dose of in order to assess the impact on cost-effectiveness of per 100,000 children aged disability adjusted life year (DALY) and per 38 of the uncertainty in the results was due to uncertain access to care parameters. in Kenya. It would be cost-saving if the vaccine price was below half of its present level. [Cost-benefit analysis of a Haemophilus influenzae type b Haemophilus influenzae type b (Hib) meningitis is associated with high mortality and serious sequelae in children under 5 years of age. Vaccines which can prevent this infection are available. based on a birth cohort of 100,000 children. The state of health of the cohort with and without a Hib immunisation programme was modelled over a 5-year period. A survey of medical records of patients with Hib in Manila provided data on the and months. The model predicted that vaccinating children against Hib meningitis would prevent 553 cases per year in a birth cohort of 100,000, at a cost of 56,200 Philippine pesos (PHP) [$US1,605; 1998 exchange rate] per case (base case assumptions of 90% vaccine efficacy rate, 95 per 100,000 the government would be around PHP39 million ($US1.11 million), and the saving to society would be PHP255 million ($US7.28 million). There would be a positive economic benefit for the Philippine government and for the Filipino society if a Hib vaccination programme was introduced in Manila. [Haemophilus the era of Hib vaccination, in children of the greater Auckland region of New Zealand. Identification of sterile site culture positive Hib via the Auckland hospital laboratories databases and national laboratory surveillance database in the time period; 1995 to 2009. There were a total of 26 cases in the Auckland Region. Over the 15-year period, the annual incidence of invasive Hib disease per 100,000 (95% 0.4-0.9) for children aged under 15 years and 1.65 per 100,000 (95% CI: 1.1-2.5) for children aged under 5 years. Ninety-two percent were under 5 years and 54% were under 1 year. Sixty percent of the children were of Maori and Pacific ethnicity. The predominant diagnosis was meningitis, accounting for 15 cases (60%). There were no fatalities. Forty-eight percent of affected children were completely unimmunised with the Hib vaccine which has been fully funded on the National Immunisation Schedule since 1994. Since the introduction of the Hib vaccine, the disease rates the cases in cases are low and infants efforts to achieve elimination of the disease in OF INFLUENZAE the lower respiratory tract a The research purpose is to determine the effectiveness of vaccine combined application to treat sickly children, suffer from infectious respiratory flu, pneumococcal and HIB disease. 110 children aged between 3 and 12 have been vaccinated. The first part of research implied children vaccination by means of Actahib and Pneumo 23 vaccines (Sanofi Pasteur, France, the second one consisted in immunization of children with the same pathology by means of Pneumo 23, Pasteur, The established within year after HIB and Pneumo 23 vaccination the frequency of upper and lower respiratory tract acerbations reduced by 2,3 times number of system antimicrobial dosage reduced by 7,4 times along with the total duration of dosage; the carrier state of S. pneumoniae reduced by 3,7 times, H. influenzae \u2014 by 3,9 times. In the course of application of three vaccines, The carrier state of S. pneumoniae reduced by 2,5 times, H. influenzae \u2014 by 4,1 times. Thus, vaccine immunization to treat for flu, pneumococcal experimental electronic paramagnetic resonance (EPR) and electronic absorption data indicate that the Co(II) ion bound to H349A-DapE is analogous to that of WT DapE after the addition of a single Co(II) ion. of Co(II) to H67A DapE provides spectra that are very different from those of the first Co(II) binding site of the WT enzyme, but that are similar to those of the second binding site. The EPR and electronic absorption data, in conjunction with the kinetic data, are consistent with the assignment of H67 and H349 as ligands H. Furthermore, the data suggest that H67 is a ligand in the first metal binding site, while H349 resides in the second metal binding site. A three-dimensional of as template DapE with the dizinc(II) structure of AAP indicates that within 4.0 A of the Zn(II) binding sites of AAP all of serine activities. FAP tumours. enzymatic and tumour cells. FAP are fertile and viable with no gross abnormality, but little data exist on the role of FAP in the immune system. FAP is upregulated in association with microbial stimulation and chronic inflammation, but its function in immune including CD4+ and CD8+ T cells, cells are and maintained normally in FAP knockout mice. intranasal challenge with influenza virus, FAP and of supporting normal anti-influenza T and B cell responses. There was no evidence of compensatory family [Efectividad comunitaria de las vacunas frente a la Parotiditis Infecciosa. Estudio de casos](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57271999000400003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Lim\u00f3n Mora Juan 1999-01-01 Full Text Available FUNDAMENTO: En nuestro pa\u00eds existen dos tipos de vacunas disponibles frente a la parotiditis infecciosa. En los \u00faltimos tiempos se han planteado dudas sobre la eficacia global de estas vacunas y de la eficacia comparada entre ambas (cepa Rubini y cepa Jeryl Lynn. En el distrito sanitario de A.P. \"Sevilla Este\" se registraron 256 casos durante 1997 (90,1 casos por 100.000 habitantes. Con este estudio se pretende aprovechar la aparici\u00f3n de casos de parotiditis para evaluar poblaciones afectadas e incidencia comparada seg\u00fan tipo de vacuna recibida durante la infancia. M\u00c9TODOS: An\u00e1lisis descriptivo de los casos (edad, distribuci\u00f3n territorial, antecedentes vacunales,... y an\u00e1lisis evolutivo (tasas de incidencia anuales en el distrito sanitario y su entorno. Se eval\u00faa la efectividad global de las vacunas frente a la parotiditis. Igualmente se estiman las tasas de incidencia de casos entre los vacunados con cepa Rubini y Jeryl Lynn. RESULTADOS: Se observan las tasas de incidencias m\u00e1s elevadas en ni\u00f1os entre 1 y 4 a\u00f1os. Se han estimado niveles de efectividad global para estas vacunas. Adem\u00e1s se observa una incidencia de casos significativamente m\u00e1s elevada entre los ni\u00f1os vacunados con cepa Rubini que en los que lo hicieron con Jeryl Lynn (riesgo relativo de 6,5 con Intervalo de confianza 95% 3,6-11,8. CONCLUSIONES: La efectividad que se desprende de este estudio no parece ser tan buena como la eficacia te\u00f3rica preconizada para las vacunas frente a la parotiditis. Se plantea la conveniencia de realizar otros estudios de casos seg\u00fan tipos de vacunas utilizadas. Igualmente son de gran inter\u00e9s los datos a suministrar por estudios seroepidemiol\u00f3gicos. [Physical size of ampicillin developed. to after the to occur at all with the third. The frequency transformation All three clinical ampicillin-resistant strains poor recipients, presence of the ampicillin resistant genes in strain BC200 did not reduce en Embarazo, inmunodepresi\u00f3n, transplante](https://www.openaire.eu/search/publication?articleId=od______1404::05502ca26081377cb9ac9b967d7e66d8) Farjas Abad\u00eda, M\u00aa Pilar 2005-01-01 En las recomendaciones de vacunaci\u00f3n de grupos de poblaci\u00f3n que por su situaci\u00f3n de salud requieren medidas espec\u00edficas deben conjugarse: Las limitaciones en la aplicaci\u00f3n de determinadas vacunas por la mayor probabilidad de efectos secundarios en estos pacientes (por ejemplo la aplicaci\u00f3n de vacunas de virus vivos en pacientes inmunodeprimidos). El mayor riesgo de infecci\u00f3n frente a determinados agentes que genera la patolog\u00eda o situaci\u00f3n inmunitaria del paciente, y que determina un mayor in... [PRACTICAS MEDICAS, PRACTICAS POLITICAS. ROSAS Y LA \u00abVACUNA INDIGENA\u00bb](http://www.revistas.usach.cl/ojs/index.php/historiasocial/article/view/319) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) MAR\u00cdA SILVIA DI LISCIA 2011-10-01 Full Text Available BUENOS AIRES, 1830. Se declara una epidemia de viruela entre los indios \u00abpampas\u00bb que est\u00e1n en la ciudad para honrar al Restaurador de las Leyes. Los caciques no disimulan su admiraci\u00f3n ante la valent\u00eda de Rosas, quien los visita sin alarma ante el contagio y los estimula a vacunarse para eliminar el temible mal. Un n\u00famero estimado en m\u00e1s de cien indios acepta, entonces, inmunizarse, coloc\u00e1ndose, seg\u00fan el testimonio de Parish, la \u00abvacuna a ind\u00edgenas \u00bb. Buenos Aires, 1833. Francisco X. Mu\u00f1iz, m\u00e9dico de la campa\u00f1a bonaerense, inicia las investigaciones con las que diez a\u00f1os despu\u00e9s se logra el redescubrimiento del cow pox, es decir, la viruela vacuna, llamada por Sarmiento \u00abla vacuna demonstrate efficacy only trends of protective efficacy against NTHi AOM in were shown. Areas covered: This review aims to consider all evidence to date from pre-clinical and clinical phase III studies with further since PHiD-CV has been introduced into routine clinical worldwide, to better describe the clinical utility of protein D in preventing to reduce the burden of AOM due to NTHi. There remains a develop improved vaccines for underutilized national Haemophilus vaccine, this paper endeavors to explain these delays through analysis and policy-related factors, as well as the Global Alliance for Vaccines and Immunisation (GAVI Alliance). Data for 147 countries from 1990 to 2007 were analyzed in accelerated failure time models to identify factors that are associated with the time to decision to adopt Hib vaccine. In multivariable models that control for Gross National Income, region, and burden of Hib disease, the receipt of GAVI support speeded the time to decision by a factor of 0.37 (95% CI 0.18-0.76), or 63%. The presence of two or more neighboring country adopters accelerated decisions to adopt by a factor of 0.50 (95% CI 0.33-0.75). For each 1% increase in vaccine price, decisions to adopt are delayed by a factor of 1.02 (95% CI 1.00-1.04). Global recommendations and local studies were not associated with time to decision. This study substantiates previous findings related to vaccine price and presents new evidence to suggest that GAVI eligibility is associated with significant, Dr. Rodolfo Villena 2017-01-01 Las vacunas han demostrado ser una excelente estrategia para reducir la morbimortalidad en infecciones respiratorias, con un perfil de seguridad adecuado. Nuestro PNI incorpora varias de ellas con este objetivo, logrando resultados de alto impacto a nivel de salud p\u00fablica. Para que esto prosiga se requiere de nuestro compromiso y conocimiento para estimular, difundir y obtener altas tasas de cobertura, de manera de lograr efectos de protecci\u00f3n indirecta, conocidos como inmunidad comunitaria. ... [Applying Central Composite Design and Response meningitis, otitis media, pneumonia, cellulitis, bacteremia, and septic The Hib capsule contains the major factor, and is the infections. to processes are too expensive. To enhance biomass, in this research we focused on optimizing Hib growth with respect to physical factors conditions for growth and biomass production of H. b. The analysis of experimental data was performed by the RSM-CCD. The model showed that had shaking flasks about 5470 mg/L, which was under an initial pH of 8.5, at 250 rpm and 35\u00b0 C. We found CCD and can lead to 1) an increase in bacterial biomass and PRP productions, 2) lower vaccine prices, 3) vaccination of more susceptible populations, and 4) lower risk of Hib infections. caused by Streptococcus pneumoniae b W rates associated caused by these organisms are high in developing countries, little known about the long-term outcome of survivors. The purpose of the importance of disabilities following pneumococcal and Hib The Gambia. 257 children aged 0-12 years hospitalized between 1990 and 1995 with culture-proven S. pneumoniae (n = 134) or Hib (n = 123) meningitis were included retrospectively in the study. 48% of children with pneumococcal meningitis and 27% of children with Hib meningitis died whilst in hospital. Of the 160 survivors, 89 (55%) were followed up between September 1996 and October 1997. Of the children with pneumococcal meningitis that were traced, 58% had clinical sequelae; half of them had major disabilities preventing normal adaptation to social life. 38% of survivors of Hib meningitis had clinical sequelae, a quarter of had disabilities. were hearing loss, mental retardation, motor abnormalities and despite treatment with effective antibiotics, pneumococcal and Hib meningitis kill severe pulmonary disease airways, and evaluate the effect of selective pressure on Strains in Slipped-strand mispairing, mediated by changes major mechanism for survival in the hostile environment of the human airways. A understanding a critical role in COPD production system that includes a protein (RbsB) with the chinchilla middle similar to our previous results with luxS mutants. Based of Publishing [Vaccination coverage among children aged 13 to 59 months in Buenos Aires, Argentina, 2002 La cobertura de la vacunaci\u00f3n en ni\u00f1os de 13 a 59 meses de edad en Buenos Aires, Argentina, en 2002](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892004000900002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Aires; to compare the results of tracts Aires were surveyed systematically in March and April, 2002. Three children aged 13 to 24 months and 25 to 59 months were surveyed per block in each census tract. Written documentation of vaccination was required. associated multivariate from vaccination to 99% BCG vaccination. Except for measles, coverage estimates found the survey did not differ substantially from those obtained from city health authority logistic regression analysis showed child's age (P OBJETIVOS: Calcular la cobertura con el r\u00e9gimen de vacunaci\u00f3n completo y con vacunas contra ant\u00edgenos particulares en ni\u00f1os de 13 a 59 meses de edad en Buenos Aires; comparar los resultados de una encuesta comunitaria a domicilio con los porcentajes de cobertura indicados en los registros p\u00fablicos; e identificar los factores que ponen a los ni\u00f1os en riesgo de no recibir todas las dosis de vacunas recomendadas bajo el r\u00e9gimen oficial. M\u00c9TODOS: Se encuestaron sistem\u00e1ticamente los corredores censales en Buenos Aires en marzo y abril de 2002. En cada cuadra de cada corredor censal se encuest\u00f3 a tres ni\u00f1os entre las edades de 13 a 24 meses y de 25 a 29 meses. Se solicitaba ver una constancia de vacunaci\u00f3n escrita. Se identificaron factores de riesgo asociados con la falta de vacunaci\u00f3n completa mediante un an\u00e1lisis unifactorial when masks of A Resistance to Penetration by Synthetic Blood tests designed to test the filtration properties of face masks in accordance with the of biocidal masks may significantly reduce the risk of hand or environmental contamination, and thereby subsequent infection, due to [El de la Real Expedici\u00f3n Filantr\u00f3pica de la Vacuna (1803-1810: las juntas de vacuna](http://asclepio.revistas.csic.es/index.php/asclepio/article/view/71/74) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Ram\u00edrez Mart\u00edn, Susana 2004-06-01 Full Text Available The Royal Vaccination Expedition, directed by the physicians Francisco Xavier Balmis and Jos\u00e9 Salvany, was the most important scientific and medical achievement of the Spanish colonial era. It took place at a time of political restlessness, and its achievements were thus conditioned by each of the cultures into which the was introduced. As its legacy, the philantropic expedition left the Vaccination established of medical expertise to sustain the expedition\u00b4s principal objetive: the battle against the smallpox epidemics in pursuit of public health. La Expedici\u00f3n de la Vacuna, dirigida por los m\u00e9dicos Francisco Xavier Balmis y Jos\u00e9 Salvany, es la gesta cient\u00edfica y sanitaria m\u00e1s importante de \u00e9poca colonial. Su desarrollo tuvo lugar en un momento pol\u00edtico convulso y los resultados estuvieron condicionados por las sociedades donde la vacuna se estableci\u00f3. El legado de esta expedici\u00f3n filantr\u00f3pica fue la creaci\u00f3n de las Juntas de Vacuna. Estas instituciones se erigieron como centros creadores de saber m\u00e9dico en Am\u00e9rica y consolidaron el objetivo primario de la expedici\u00f3n: la b\u00fasqueda de la salud p\u00fablica luchando contra las epidemias de viruela. [Computational screen and experimental validation of anti-influenza effects of Chen, Ze; Zhang, Ran 2016-01-01 The Influenza A virus is a great threat for human health, while various subtypes of the virus made it difficult to the computational docking could serve as a virtual screen of potential leading compound. In this study, we performed molecular docking for influenza A H1N1 (A/PR/8/34) with small such quercetin and chlorogenic were derived from traditional Chinese medicine. The showed design and development. in in have validated the anti-influenza effect it that be of Journals 2003-06-01 Text Available trial, For analysis, study groups were subdivided into adult (18-60 years old and elderly (over 60 years subjects. Blood was drawn immediately before and one were seen with the split vaccine Imovax Gripe\u00e2, giving it a better overall immunogenicity.En un ensayo comparativo realizado en dos centros, se asignaron de manera aleatoria 344 adultos para recibir una dosis de vacuna contra la gripe de virus fraccionado inactivado (Imovax Gripe\u00e2 o de vacuna de subunidades (Agrippal S1\u00e2 (formulaciones 1999-2000. Para el an\u00e1lisis, los grupos estudiados fueron subdivididos en adultos (18-60 a\u00f1os y ancianos (m\u00e1s de 60 a\u00f1os. La sangre fue extra\u00edda justo antes y un mes despu\u00e9s de la vacunaci\u00f3n. La inocuidad fue evaluada utilizando un informe sobre reacciones adversas, usando un dise\u00f1o de observador a ciegas. Ambas vacunas fueron muy bien toleradas, con perfiles de reactogenicidad similares y desarrollaron escasas reacciones adversas en los individuos ancianos. La vacunaci\u00f3n con [La vacuna en Cuba durante el gobierno de Someruelos](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::9c7220297c636745e06628ec37f2b47e) V\u00e1zquez Cienfuegos, Sigfrido 2004-01-01 La Real Expedici\u00f3n Filantr\u00f3pica de la Vacuna (1803-1806), dirigida por Francisco Javier de Balmis, se dirigi\u00f3 al Nuevo Mundo para paliar las epidemias de viruelas que hab\u00edan venido asolando Am\u00e9rica desde casi el mismo momento del Descubrimiento. Para entonces en la isla de Cuba ya se hab\u00eda iniciado una labor con el mismo objetivo por el m\u00e9dico cubano Tom\u00e1s Romay, apoyado en el fomento de la introducci\u00f3n y aplicaci\u00f3n de la vacuna por el marqu\u00e9s de Someruelos gobernador y capit\u00e1n general de la ... [Development and Validation of a Multiplex in that they only provide for the detection of a single infectious agent. molecular accomplished by multiplex assays, which can detect, individually that are associated with syndromic illness. As part of a larger program of panel assay chosen as they are the most common bacterial pathogens associated with both the acute and chronic forms of media; percentage sinus infections in both children and adults. In addition, H. S. for each of the three target which were then evaluated for sensitivity and specificity. Utilizing the simplex assays a matrix style assay. The duplex assay was then used as a single component in the development of a triplex assay, wherein the various M. catarrhalis single-step PCR protocol, with species-specific primers for 2010-12-01 Full Text Available Con el objetivo de mostrar el perfil de seguridad de la vacuna antileptospir\u00f3sica cubana, vax-SPIRAL\u00ae, se realiz\u00f3 un estudio observacional descriptivo y transversal, a partir de la base de datos de la red nacional de farmacovigilancia a medicamentos. Se estim\u00f3 la frecuencia de reportes por dosis de vacunas administradas, la valoraci\u00f3n de causalidad, severidad, localizaci\u00f3n y los eventos adversos con mayor asociaci\u00f3n estad\u00edstica, a partir del c\u00e1lculo de disproporcionalidad de las combinaciones de eventos adversos a vacunas de todos los diagn\u00f3sticos en los reportes de eventos del grupo farmacol\u00f3gico de vacunas y el c\u00e1lculo de la Raz\u00f3n de Riesgo Proporcional (PRR y la Raz\u00f3n Diferencial de Riesgo (ROR. Hubo 1,62 reportes por 100 000 dosis administradas y 1,9 diagn\u00f3sticos por reporte en personas entre 18 y 77 a\u00f1os de edad y una media \u00b1DE de 40 \u00b1 13 a\u00f1os, con predominio del sexo femenino (65,54%. No se reportaron casos graves; el 74,17% fueron con severidad leve y el 66,96% fueron manifestaciones adversas sist\u00e9micas. El 94,17% de los reportes estuvieron relacionados con la vacuna. Los eventos adversos m\u00e1s frecuentes fueron: fiebre/hipertermia (18,75%, cefalea (14,73%, dolor local (13,84%, sitio de inyecci\u00f3n (12,05%, malestar general (8,48% y manifestaciones de hipersensibilidad m\u00ednimas, s\u00f3lo a nivel cut\u00e1neo. Entre los que mostraron mayor asociaci\u00f3n: cefalea, malestar general y rubor. Los resultados obtenidos son similares y con mejor perfil de seguridad que los de la vacuna francesa SPIROLEPT, por lo cual se recomienda para la protecci\u00f3n en grupos de riesgo de leptospirosis. [Haemophilus influenzae Type 298 members of 2 Amish communities (A and B) in Pennsylvania and, as a comparison group, 136 non-Amish family members who participated in state immunization clinics. From December 1999 8 cases of invasive Hib disease occurred among children who were 5 years of age or younger in Pennsylvania. Six of the case-patients were from Amish communities. None of the children had been vaccinated. Among children who were 5 years of age or younger, Hib vaccine coverage was low in the 2 Amish communities: A (9 [28%] of 32) and B (3 [7%] of 41) compared with the non-Amish group (19 [95%] Hib carriers than in community A (8 [28%] 3 [9%] of 32). Among Amish parents who did not vaccinate their children, only (13 of 51) identified either religious or philosophical objections reported vaccinating was not a priority compared with other activities of daily life. Seventy-three percent (36 of 49) were offered locally. strains were isolated from non-gonococcal urethritis (NGU). We amplified the resistance-determining region of the gyrA gene and the analogous region of the parC gene from bacterial DNAs by PCR and sequenced the PCR products. Two strains with a LVFX MIC of 0.03 g/ml had an amino acid change of Asp88 to Gly in GyrA. One with a LVFX MIC of 0.06 g/ml had a change of Asp88 to Tyr in GyrA. Two with respective LVFX MICs of 0.12 and 0.25 g/ml had a change of Ser84 to Leu in GyrA. One with a LVFX MIC of 1 g/ml had changes of Ser84 to Leu in GyrA and of Ser84 to Ile in ParC. Multilocus sequence typing showed two strains with a change of Asp88 to Gly in GyrA had the same sequence type, but the others had sequence types different from each other. Single amino acid changes in GyrA alone or single changes in both GyrA and ParC could contribute to decreased susceptibility to fluoroquinolones in H. influenzae still be susceptible to fluoroquinolones commonly prescribed for treatment of NGU. Copyright \u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. [Estudio de inmunogenicidad de la antitifo\u00eddica cubana de vax-TyVi\u00ae en ratones](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Text Available Salmonella enterica serovar Typhi es un microorganismo que provoca m\u00e1s de 16 millones de casos de fiebre tifoidea con aproximadamente 600 000 muertes al a\u00f1o en todo el mundo. Dentro de las vacunas antitifo\u00eddicas la de polisac\u00e1rido capsular Vi ha encontrado, gracias a sus incuestionables ventajas, una gran aceptaci\u00f3n entre productores y consumidores. El presente trabajo aborda el estudio de inmunogenicidad de la vacuna antitifo\u00eddica cubana de polisac\u00e1rido Vi vax-TyVi\u00e2 en ratones. El estudio estuvo conformado por un grupo control no inoculado y un segundo grupo que recibi\u00f3 0,05 mL de la vacuna por v\u00eda intramuscular. Se tomaron muestras de sangre a los -3, 7, 14, 21, 28, 42, 56 y 84 d\u00edas. La actividad de anticuerpos IgG antipolisac\u00e1rido Vi de los sueros individuales fue determinada por ELISA. Los datos fueron analizados por grupo y por sexo y se calcul\u00f3 el porcentaje de seroconversi\u00f3n, consider\u00e1ndose respondedor aquel animal que al menos aumentara en cuatro veces su t\u00edtulo inicial. La respuesta de anticuerpos inducida por la vacuna mostr\u00f3 un aumento notable de los t\u00edtulos de IgG antipolisac\u00e1rido Vi en el grupo vacunado (100% de seroconversi\u00f3n, mientras que el grupo control no increment\u00f3 sus niveles m\u00ednimos iniciales (0% de respondedores. Aunque m\u00e1s dispersa, la respuesta de anticuerpos antiVi fue significativamente mayor en las hembras que en los machos. [A new class of synthetic anti-lipopolysaccharide are a continuous threat to human health as illustrated by the 2009 pandemic. Since Here, we have evaluated virus replication in vitro and in vivo. We found that particularly SALP PEP 19-2.5 shows high binding affinities for the influenza virus receptor molecule, N-Acetylneuraminic acid, leading to impaired viral attachment and cellular otherwise 100% lethal H7N7 influenza virus infection. These findings show SALPs exhibit antiviral activity against influenza viruses by blocking virus attachment and entry into host cells. Thus, SALPs present a new class of broad-spectrum antiviral peptides for further development for influenza virus \u00a9 2014 Elsevier B.V. All rights reserved. [Aceptabilidad de la vacuna contra el virus papiloma humano en padres de adolescentes, en colombia](https://www.openaire.eu/search/publication?articleId=od______1326::8ba7ba7cedd44552d4d60ca52f50c9aa) Wiesner, Carolina; Pi\u00f1eros, Marion; Cort\u00e9s, Claudia; Jaime Ardila, Jaime Ardila 2012-01-01 Objetivo La vacuna contra el VPH es una nueva tecnolog\u00eda disponible para el control del c\u00e1ncer de cuello uterino. Se espera, que en el menor tiempo posible esta vacuna pueda tener cobertura universal. Este art\u00edculo presenta la aceptabilidad que tiene los padres de adolescentes en Colombia hacia la vacuna contra el VPH y hace una aproximaci\u00f3n a sus determinantes. M\u00e9todos Estudio cualitativo en cuatro regiones en Colombia. Se realizaron 17 grupos focales con padres de ni\u00f1as y ni\u00f1os entre 11 a 1... [Basic Characterization of porcine industry. In this study, natural competence was investigated in H. parasuis. We found competence genes in H. parasuis homologous to ones in Haemophilus influenzae and a high phase from to 1.625). As a whole, bacteria cultured in liquid media were observed to have lower competence grown media revealed that natural transformation in this species is stable after 200 passages and largely homologs of competence-genes in H. influenzae. Taken together, this study is the first to investigate natural transformation in influenzae type b (Hib vaccination as a national vaccine immunization program in Thailand. A decision tree combined with Markov model health care payer perspectives. This analysis considered children aged under 5 + 0 and three-dose series plus a booster does (3 + 1 compared with no vaccination. cases cost-effectiveness (ICERs in 2014 baht 59 disability cases, and 97 deaths can be prevented by national Hib vaccination program. The for QALY to pneumonia incidence among aged under 5 years old and direct care cost per episode of Hib pneumonia. Hib vaccination very impact analysis showed that Thai government needed to invest budget [No Robert Haemophilus influenzae (Hi type a disease have been reported from North American native children from circumpolar regions, raising the question of serotype replacement being driven by against Hi type b (Hib. Indigenous Australians had high rates of invasive Hib disease in the past, comparable Indigenous populations. Objective. Evaluate incidence in Indigenous Australian children over time. Design. Descriptive study of Hi incidence rates by serotype, in the Northern Territory (NT and South Australia (SA from 2001 to 2011. Comparison of NT data with a study that was conducted in the NT in 1985-1988, before Hib vaccine was introduced. Results. The average annual rate of invasive Hi type a (Hia disease of in 2001-2003 was lower than during 2004-2011, this may be due to changes in surveillance. No other trend over time in individual serotypes or total invasive Hi disease, in groupings, by 98% for Hib, 75% for Hia, 79% for other serotypes and 67% for non-typeable Hi. Conclusions. There is no evidence of increases in invasive disease due to Hia, other specific non-b types, or non-typeable Hi in Australian Indigenous children. These data suggest that the increase in Hia some time after the introduction of Hib vaccine, as seen in the North American Arctic Region, is not common to all populations with high pre-vaccine rates of invasive Hib disease. However, small case numbers and the lack subtyping and PCR confirmation of influenzae type b after institution of the conjugated vaccine on the expanded programm on immunization in Chile].](https://www.ncbi.nlm.nih.gov/pubmed/16462964) Cruces R, Pablo; Donoso F, Alejandro; Camacho A, Jorge; Llorente H, Marcela 2006-03-01 After almost a decade since introduction of Haemophilus influenzae type children whom developed Hib invasive disease in children since 2000 to 2004. Medical records of children with Hib were reviewed in order to describe the epidemiology, main clinical and laboratory findings, management and complications. Twenty three patients (17 male), between and 71 months (median 30 were pneumonia empyema (2), meningitis (1), fulminans miositis (1) and remains as sporadic disease in Chile and thus for physicians should still keep it in mind. Case analysis and active surveillance are necessary to monitor the current immunization regimen. Patarroyo, Manuel Elkin 2017-01-01 La malaria es una enfermedad parasitaria producida por la picadura de un mosquito; una afecci\u00f3n que en el a\u00f1o 2015 registr\u00f3 212 millones de casos y 429.000 muertes. Cada dos minutos, la malaria provoc\u00f3 la muerte de un ni\u00f1o menor de cinco a\u00f1os en todo el mundo. Diferentes cient\u00edficos a lo largo de todo el mundo han hecho m\u00faltiples intentos para combatir esta enfermedad con una vacuna efectiva que pueda erradicarla de ra\u00edz. when masks of A from the copper oxide containing masks 4.67+/-1.35 log(10TCID(50 Resistance to Penetration by Synthetic Blood tests designed to test the filtration properties of face masks in accordance with contra cepas de Ochoa-Azze 2016-08-01 Full Text Available La efectividad de las vacunas de ves\u00edculas de membrana externa de Neisseria meningitidis serogrupo B ha sido cuestionada por algunos investigadores, limit\u00e1ndola a la cepa vacunal. VA-MENGOC-BC\u00ae es una vacuna antimeningoc\u00f3cica basada en dicha tecnolog\u00eda. Presentamos un metaan\u00e1lisis de estudios realizados en diferentes contextos epidemiol\u00f3gicos, evaluando su efectividad contra cepas heter\u00f3logas de meningococo B en varios grupos de edades. Se demuestra que la vacuna es efectiva contra cepas hom\u00f3logas, heter\u00f3logas y de ftsI gene encoding the transpeptidase domain of penicillin-binding amino amino acid substitutions at the Lys-Thr-Gly (KTG) motif, the two most common being Asn526 to Lys (83.9%) and Arg517 to His (9.3%). Amino acid substitutions at and 389, which conferred cefotaxime and cefixime MICs 10 to 60 times higher than those of susceptible strains, were found for the first time in Europe. In 72 isolates for which the repressor acrR gene of pump 0.25 2 g/ml that the early termination Pulsed-field resistance cefotaxime and horizontal spread and to adapt rapidly to the increased selective pressures oral penicillins and cephalosporins. PMID:17470649 [Inmunogenicidad y tolerancia de una vacuna contra influenza, en una poblaci\u00f3n mexicana mayor de 55 a\u00f1os de edad Immunogenicity and safety of the influenza vaccine, in a population older than 55-years Text Available OBJETIVO: Verificar la inmunogenicidad y tolerancia de una vacuna purificada, inactivada y fraccionada contra influenza, en adultos mexicanos derechohabientes de Petr\u00f3leos Mexicanos (Pemex. MATERIAL Y M\u00c9TODOS: Se incluyeron 90 adultos mayores de 55 a\u00f1os de edad, derechohabientes de los servicios m\u00e9dicos del Hospital Central Sur Pemex, durante los meses de noviembre y diciembre de 2000. Los criterios evaluados en relaci\u00f3n con la inmunogenicidad incluyeron el porcentaje de sujetos protegidos, cuantificados por medio de anticuerpos antihemaglutininas superior o igual a 1:40, as\u00ed como por el porcentaje de seroconversi\u00f3n determinado por el t\u00edtulo inicial de anticuerpos multiplicado por un factor 4X. Los criterios secundarios fueron la frecuencia de reacciones adversas tanto locales como sist\u00e9micas. Se realizaron estudios de afinidad ant\u00edgeno-anticuerpo para determinar la respuesta policlonal de anticuerpos y de anticuerpos de alta afinidad prevacunaci\u00f3n y posvacunaci\u00f3n. Se calcularon frecuencias y porcentajes. RESULTADOS: Se identific\u00f3 una seroprotecci\u00f3n en 95.6% de los sujetos a la cepa H1N1, de 98.9% a la cepa H3N2 y de 100% a la cepa B/ Yamanashi. En cuanto a los porcentajes de seroconversi\u00f3n, se identific\u00f3 un incremento 4X de 74.4 para la cepa H1N1, de 88.9 para la cepa H3N2, y de 82.2 para la cepa B / Yamanashi. Un total de 18 individuos (20% presentaron reacciones locales, mientras que 17 (18.8% presentaron reacciones sist\u00e9micas a los cinco d\u00edas posvacunaci\u00f3n y nueve sujetos (10% a los 28 d\u00edas. Las reacciones locales a los cinco d\u00edas consistieron en dolor, en 10 individuos (11.1%; enrojecimiento, en ocho (8.8%, e induraci\u00f3n, en seis (6.6%. Malestar general, cefalea y fiebre se presentaron a los cinco d\u00edas en 10, 8.8, y 0% de individuos, respectivamente, y en 4.4, 6.6, y 0%, respectivamente, a los 28 d\u00edas. CONCLUSIONES: Esta vacuna contra influenza demostr\u00f3 ser altamente inmunog\u00e9nica en adultos mexicanos mayores de 55 a [Patterns of binding of aluminum-containing adjuvants to to weak binding of to Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) C. Giannina Izquierdo, Dra. 2014-05-01 Las principales estrategias para la prevenci\u00f3n de la enfermedad son el uso de vacunas (prevenci\u00f3n primaria y el uso de quimioprofilaxis a los contactos de un caso \u00edndice (prevenci\u00f3n secundaria. A la fecha existen numerosas vacunas contra Nmen, todas ellas con adecuados perfiles de seguridad e inmunogenicidad, por lo que la elecci\u00f3n de la vacuna a utilizar depender\u00e1 del serogrupo prevalente en cada pa\u00eds; de las caracter\u00edsticas de la poblaci\u00f3n m\u00e1s afectada y de la factibilidad de disponer de ella e insertarla dentro de los programas nacionales o campa\u00f1as respectivas of COPD, specimens of human lung tissue were used in our experiments. Intracellular infection the new key enzyme in well vaccine (Infanrix hexa, GSK; control group) at 2, 4 months age. Infants were planned to receive a booster Primary study; however, associated investigational formulations in the Primary study, the Booster study protocol was amended and all infants yet to receive a booster dose (N = 385) received the in and all of which impose substantial treatment costs. In this study increased biomass. ratio of protein per response. were subsequent antibiotic challenges, and act as a reservoir of viable bacteria once antibiotic exposure has ended. PMID:25007395 [El estado actual de las contra las [Directory of Open Access Journals Full Text Available Introducci\u00f3n: por lo com\u00fan, la adicci\u00f3n a las drogas se trata con psicoterapia y farmacolog\u00eda que evita la uni\u00f3n de las sustancias psicoactivas a receptores espec\u00edficos en el cerebro. El resultado de estos tratamientos no ha sido del todo satisfactorio, por lo que el desarrollo de terapias m\u00e1s eficaces representa un reto constante para tratar las adicciones. Una alternativa a la farmacolog\u00eda antiadictiva es la vacunaci\u00f3n activa dirigida contra las sustancias de abuso. Objetivo: esta revisi\u00f3n re\u00fane la informaci\u00f3n disponible sobre los fundamentos y avances cient\u00edficos en la generaci\u00f3n de una terapia inmunol\u00f3gica, que coadyuve al tratamiento de la adicci\u00f3n a sustancias como la hero\u00edna-morfina, la coca\u00edna, la nicotina y la anfetamina. M\u00e9todo: se consideraron los reportes cient\u00edficos disponibles en PubMed -de 2005 a abril de 2017-, sobre los fundamentos, la metodolog\u00eda empleada, los estudios precl\u00ednicos y cl\u00ednicos, y los resultados obtenidos en dichas investigaciones para generar vacunas contra las drogas. Resultados: las vacunas lograron mitigar los efectos producidos por las sustancias en los estudios precl\u00ednicos en modelos de estudio en animales; sin embargo, con pacientes humanos los resultados no han sido del todo satisfactorios. Discusi\u00f3n y conclusiones: a pesar de los esfuerzos realizados por diferentes grupos de investigaci\u00f3n y compa\u00f1\u00edas farmac\u00e9uticas para generar vacunas terap\u00e9uticas contra el uso de diferentes drogas, ninguna ha alcanzado la fase III de estudios cl\u00ednicos. En la actualidad, se contin\u00faa con los esfuerzos para lograr que las vacunas contra las adicciones alcancen su m\u00e1xima eficiencia y eficacia, y contribuyan al tratamiento de la adicci\u00f3n a las drogas. [Combination Chemotherapy for Influenza](http://www.mdpi.com/1999-4915/2/8/1510/) [Directory of Open Access Journals Text of pandemic H1N1 influenza H5N1 viruses underscore the for human influenza infection. drugs the neuraminidase chemotherapy the logical therapeutic Here data on combination chemotherapy with currently available agents podcast, los ni\u00c3\u00b1os de Kidtastics hablan sobre la importancia de las vacunas y c\u00c3\u00b3mo funcionan. Created: 4/23/2013 by Centers dermal infection was used to investigate the roles of H. ducreyi bacteria and HdCDT in the development, clinical of the H. ducreyi-induced and absence of HdCDT, showed dense infiltrates of the same type of a toxin. Signs chronic involvement cells, were observed after H. ducreyi with causes a pronounced, chronic inflammation macrophages, and in combination with HdCDT production of ulcers in the rabbit model. These pathogenic protect Among them, there is the false information that Italy is the only one country with mandatory vaccination policy. Aim of our study is confronting vaccination children under 18 to de C](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57271997000200003) [Directory of Open Gonz\u00e1lez Enr\u00edquez Jes\u00fas 1997-01-01 Full Text Available FUNDAMENTO: Este trabajo consiste esencialmente en una revisi\u00f3n sistem\u00e1tica de la literatura cient\u00edfica sobre los efectos, intensidad y duraci\u00f3n de la respuesta serol\u00f3gica, as\u00ed como sobre la eficacia, efectividad y seguridad de la vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del grupo C. M\u00c9TODOS: B\u00fasqueda en repertorio MEDLINE en el periodo 1970-1996. B\u00fasqueda espec\u00edfica de ensayos cl\u00ednicos aleatorizados y estudios de intervenci\u00f3n prospectivos en humanos con vacunas de polisac\u00e1ridos capsulares de meningococo en el mismo repertorio y periodo. An\u00e1lisis cr\u00edtico de literatura cient\u00edfica y s\u00edntesis de evidencia. RESULTADOS: La vacuna de polisac\u00e1rido capsular del serogrupo C es considerada segura y ha mostrado una eficacia superior al 85% en adultos y ni\u00f1os mayores, 70% (IC95%: 5-91% en ni\u00f1os menores de 5 a\u00f1os y 55% (IC90%: 14-76% en ni\u00f1os de 2-3 a\u00f1os. La vacuna no se ha mostrado eficaz en ni\u00f1os menores de 2 a\u00f1os. La duraci\u00f3n de niveles de anticuerpos protectores disminuye con la edad. La proporci\u00f3n de ni\u00f1os menores de 6 a\u00f1os efectivamente protegidos al a\u00f1o de la vacunaci\u00f3n es baja. La vacunaci\u00f3n no limita la respuesta serol\u00f3gica de vacunaciones ulteriores. CONCLUSIONES: La vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del serogrupo C est\u00e1 indicada en adultos y ni\u00f1os mayores de 2 a\u00f1os como protecci\u00f3n contra la enfermedad meningoc\u00f3cica causada por este serogrupo en situaciones de alto riesgo de enfermedad. La escasa protecci\u00f3n que ofrece la vacuna en los menores de 2 a\u00f1os, la limitada eficacia en menores de 5 a\u00f1os y la corta duraci\u00f3n de la inmunidad que confiere a estas edades, hace que la vacunaci\u00f3n rutinaria no est\u00e9 recomendada y que la vacuna se use fundamentalmente en el control de brotes epid\u00e9micos causados por serogrupo C. [Properties of polysaccharides Fucus one green alga ( Ulva lactuca) by sequential extraction with cold water, hot water, and alkali solutions. These polysaccharides were analyzed for monosaccharide composition and other general chemical properties, and they were evaluated for anti-influenza virus activities. Total sugar contents in ranged U. lactuca) to 91.4% (in F. lumbricalis); sulfation level was as high as 17.6% in a polysaccharide from U. lactuca, whereas it could not be detected in an alikali-extract from P. palmaria. For polysaccharides from red seaweeds, the main sugar units were sulfated galactans (agar or carrageenan) for P. lanosa, lumbricalis, antiviral marine polysaccharides with potential antiviral properties. [Estrategia y resultados de la farmacovigilancia de vacunas desde el Instituto Finlay, 2009](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2010000200006&lng=es&nrm=iso) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Iv\u00e1n E. Cuevas-Valdespino 2010-08-01 Full Text Available El objetivo de este trabajo fue mostrar la estrategia y los resultados de la farmacovigilancia desde el Instituto Finlay, como titular de registros sanitarios. Se concret\u00f3 la biograf\u00eda de los productos en la etapa de poscomercializaci\u00f3n y se examin\u00f3 el balance riesgo/beneficio. Esto fue posible gracias a convenios con instituciones que permitieron el acceso a bases de datos digitales y auditables, donde se encontr\u00f3 la notificaci\u00f3n espont\u00e1nea de eventos adversos y el cumplimiento de las buenas pr\u00e1cticas, reglamentos y regulaciones de la autoridad reguladora. La miner\u00eda de datos para la b\u00fasqueda de la agrupaci\u00f3n de eventos raros e inesperados para un mismo lote o de accidentes, la confecci\u00f3n de los informes peri\u00f3dicos de seguridad y la pr\u00e1ctica sistem\u00e1tica para completar la informaci\u00f3n de seguridad solicitada en subpoblaciones y grupos especiales permiti\u00f3 actualizar el perfil de seguridad de las vacunas. Se confirm\u00f3 que la vacuna antileptospir\u00f3sica trivalente, la antitifo\u00eddica Vi y el toxoide tet\u00e1nico, presentaron una frecuencia de eventos adversos menor de 0,1 reporte por cada 100.000 dosis administradas, mientras las dem\u00e1s vacunas tuvieron valores entre 1 y 10 por cada 10.000 vacunados. Entre el 80% y 95% de las notificaciones fueron relacionadas causalmente con la vacuna, y solo el 0,89% fueron de severidad grave, casi todas en ni\u00f1os menores de un a\u00f1o. Las manifestaciones generales fueron las que predominaron. Los resultados presentados muestran la importancia que tiene la farmacovigilancia desde la industria para obtener una valiosa informaci\u00f3n de la seguridad en la aplicaci\u00f3n de las vacunas. [Antibiotic Resistance in isolated in 2007 (study group) isolated (control group). area, children by 15.6% 33 17.4%, = 0.01), but amoxicillin resistance without -lactamase production by TEM-1, but five different promoter regions were identified, with Pdel being the most prevalent in both years, and Prpt being associated with the highest amoxicillin resistance. A new promoter consisting of bp was detected. Community consumption of most decreased, amoxicillin-clavulanic acid and azithromycin by ca. For amoxicillin-clavulanic acid, a 14.2% increase in the population with an MIC of 2 to 4 g/ml (P = 0.02) was observed; for azithromycin, a 21.2% increase in the population with an MIC of 2 to 8 g/ml (P = 0.0005) was observed. In both periods, the most common gBLNAR (i.e., H. influenzae isolates with mutations in the ftsI gene as previously were IIc and 54%, = 0.04). Antibiotic resistance in H. influenzae decreased in Spain from 1997 to 2007, but surveillance should be maintained since influenzae en menores de 5 a\u00f1os: distribuci\u00f3n de los serotipos y de la sensibilidad antimicrobiana, SIREVA II, Colombia 2002-2013](http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0123-93922015000200004&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Mabel Karina Rodr\u00edguez Full Text Available Objetivo: Analizar del 2002 al 2013 los datos de la vigilancia de los serotipos y sensibilidad antimicrobiana de los aislamientos invasivos de Haemophilus influenzae ( H. influenzae en ni\u00f1os menores de 60 meses. Materiales y m\u00e9todos: Se analizaron los datos demogr\u00e1ficos, fuente y enfermedad asociada de los aislamientos invasivos de H. influenzae recibidos entre 2002 y 2013. Todos los aislamientos hab\u00edan sido confirmados bacteriol\u00f3gicamente, ten\u00edan el dato del serotipo, el cual fue determinado por el m\u00e9todo de aglutinaci\u00f3n en l\u00e1mina y PCR y los patrones de sensibilidad antimicrobiana por concentraci\u00f3n inhibitoria m\u00ednima a ampicilina, SXT, cloranfenicol, cefuroxima y ceftriaxona. El an\u00e1lisis se realiz\u00f3 por periodos de 3 a\u00f1os. Resultados: Por enfermedad invasiva el 50,5% eran de pacientes con 23,5% de neumon\u00edas, 19,5% de sepsis y bacteriemia, 2,0% de otros y 4,5% sin dato. Por procedencia se recibieron de Bogot\u00e1 y Antioquia 55 aislamientos de cada uno, de Risaralda 24, de Valle 15, de Santander 11 y 40 de 14 departamentos. El serotipo predominante fue el Hib (40,5%, seguido de HiNT (38,0%, Hia (17,5%, Hid (2,0%, Hif (1,5% y Hie (0,5%. Del total de los aislamientos, 12,0% eran resistentes a ampicilina; 16,5% a SXT; cloranfenicol y 0,5% a ceftriaxona. Todos los aislamientos fueron sensibles a cefuroxima y a rifampicina. Conclusiones: La vigilancia por el laboratorio es una vigilancia pasiva voluntaria pero, no obstante el n\u00famero reducido de aislamientos, permite determinar que Hib contin\u00faa circulando en esta poblaci\u00f3n y que hay otros serotipos de H. influenzae que causan enfermedad invasiva. Por tanto es necesario mantener y fortalecer la vigilancia de este pat\u00f3geno. [Perspectivas para nuevas vacunas antituberculosas en la era posgen\u00f3mica.](http://www.revistabiomedica.org/index.php/biomedica/article/view/1320) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Luis F. Garc\u00eda 2004-06-01 Full Text Available A pesar de que la vacunaci\u00f3n con Mycobacterium bovis BCG es el procedimiento m\u00e1s utilizado a nivel mundial para prevenir la tuberculosis, su eficicacia es muy cuestionable, lo cual ha motivado la b\u00fasqueda de nuevas opciones inmunoprofil\u00e1cticas. El conocimiento generado con el secuenciamiento completo de una cepa de Mycobacterium tuberculosis H37Rv y la aplicaci\u00f3n de nuevas tecnolog\u00edas inmunol\u00f3gicas, bioqu\u00edmicas y gen\u00e9ticas han permitido realizar una disecci\u00f3n fina del transcriptoma y el proteoma de M. tuberculosis, lo cual ha generado una gran cantidad de conocimiento sobre la biolog\u00eda de este microorganismo. Dado que alrededor de una tercera parte de la poblaci\u00f3n mundial puede estar infectada con M. tuberculosis y que \u00e9ste s\u00f3lo se detecta cuando se inicia la enfermedad, la mayor parte de los esfuerzos se han dedicado al dise\u00f1o de vacunas posinfecci\u00f3n que induzcan un aumento selectivo de la inmunidad celular espec\u00edfica del hospedero a largo plazo, no generen reacciones adversas y sean de bajo costo. Dentro de las nuevas estrategias que est\u00e1n siendo utilizadas para el desarrollo de vacunas, se destaca la utilizaci\u00f3n de mezclas de prote\u00ednas con una alta inmunogenicidad, cepas de M. bovis BCG recombinantes y de M. tuberculosis gen\u00e9ticamente atenuadas o modificadas para inducir una mayor respuesta inmune, y las vacunas de ADN desnudo. Los candidatos con m\u00e1s potencial incluyen las vacunas de subunidades micobacterianas, las cuales expresan mol\u00e9culas ampliamente reconocidas por el sistema inmune y cuyo reconocimiento resulta en el incremento de la respuesta Th1 y aqu\u00e9llas que utilizan vectores virales dise\u00f1ados para expresar mol\u00e9culas micobacterianas antig\u00e9nicas. Aunque los modelos animales son de valor limitado, puesto que la patolog\u00eda observada en ellos s\u00f3lo reproduce parcialmente la observada en humanos, los resultados obtenidos con estas vacunas son muy prometedores y algunas est\u00e1n siendo actualmente evaluadas en [Asymtomatic carriage of morbidity and mortality among children in many parts of the world. Main reservoir of carriage and site of meningococcal dissemination appears to be the upper respiratory and lactamica and factors this years. and N. subjects, respectively. Number (%) of serogroups for meningococci was 1 (6), 5 (29), 0 (0), 1 (6), 1 (6), and 9 (53) for A, B, C, D, W135, and Y, respectively. Having more than 24-month was was a reverse carriage rate between N. meningitidis and N. may suggest a to weak binding of to All rights reserved. [Vaccines against dengue: a review of current candidate vaccines at advanced development stages Vacunas contra el dengue: una revisi\u00f3n de las vacunas candidatas en etapas avanzadas de desarrollo](https://www.openaire.eu/search/publication?articleId=doajarticles::d1c5d56abb3c55f6f0d140a1ec694442) Joachim Hombach 2007-01-01 Los esfuerzos sistem\u00e1ticos para desarrollar una vacuna contra el dengue comenzaron durante la Segunda Guerra Mundial, inspirados en el desarrollo exitoso de una vacuna contra la fiebre amarilla. Sin embargo, la falta de modelos adecuados de la enfermedad, la informaci\u00f3n incompleta acerca de los mecanismos patog\u00e9nicos y los insuficientes incentivos econ\u00f3micos han dificultado los avances. Debido al impacto actual del dengue en todo el mundo y su explosiva diseminaci\u00f3n, ha aumentado el inter\u00e9s e... [Vacuna contra la fiebre hemorr\u00e1gica argentina Candid#1 producida en la Inmunogenicidad y A. Enria 2010-06-01 Full Text Available Se realiz\u00f3 un estudio cl\u00ednico en 946 voluntarios humanos sanos, donde se compar\u00f3 la vacuna Candid#1 producida en Argentina con la elaborada en EE.UU., que hab\u00eda sido utilizada en estudios previos. Como objetivo primario se evalu\u00f3 la equivalencia en la eficacia utilizando como marcador subrogante a la inmunogenicidad medida por detecci\u00f3n de anticuerpos neutralizantes. Como objetivo secundario se evalu\u00f3 la equivalencia en inocuidad comparando las tasas de reacciones adversas. Ambas vacunas mostraron una tasa equivalente de inmunogenicidad ligeramente superior al 95.5%, que es la eficacia estimada para Candid #1 en estudios previos. No se observaron eventos adversos graves relacionados con la vacuna. Los eventos adversos generales considerados relacionados fueron de escasa significaci\u00f3n cl\u00ednica y de resoluci\u00f3n espont\u00e1nea o con tratamiento sintom\u00e1tico; se presentaron en los receptores de ambas vacunas en tasas equivalentes (29.9% para la vacuna fabricada en la Argentina y 35.0% para la fabricada en EE.UU., e incluyeron: cefalea, decaimiento, mialgias, plaquetopenia leve (< 150 000 plaquetas/mm\u00b3, n\u00e1useas y/o v\u00f3mitos, leucopenia leve (< 4 000 blancos/mm\u00b3, fiebre, dolor retroocular, mareos, microhematuria, lumbalgia y exantema. Estos resultados indican que la vacuna Candid #1 elaborada en la Argentina es equivalente a la elaborada en los EE.UU. Este estudio permiti\u00f3 el registro del biol\u00f3gico producido en la Argentina ante la autoridad regulatoria del in and all of which impose substantial treatment costs. In this study increased biomass. ratio of protein per response. were subsequent antibiotic challenges, and act as a reservoir of viable bacteria once antibiotic exposure has ended. [Provada amb \u00e8xit en cabres una nova vacuna contra la tuberculosi](https://www.openaire.eu/search/publication?articleId=od______1404::4dfcdb9afa501d98d59e07e37c0dec1f) P\u00e9rez del Val, Bernat 2014-01-01 Investigadors del CReSA proven per primer cop i amb \u00e8xit una nova vacuna contra la tuberculosi que millora la protecci\u00f3 de i la resposta immunol\u00f2gica a la infecci\u00f3 tuberculosa activa en humans i que, pel fet de ser hostes Salvador, Brasil, sobre la vacuna antisarampionosa](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891997001200001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Moreira Luiza A. Cabus 1997-01-01 Full Text Available El \u00e9xito de las iniciativas internacionales para la erradicaci\u00f3n del sarampi\u00f3n depende en gran medida del grado de conocimiento sobre la vacunaci\u00f3n. En 1992 se evaluaron mediante un estudio transversal los conocimientos sobre la vacuna antisarampionosa de los pediatras de la ciudad brasile\u00f1a de Salvador, Bahia. Del total de 506 pediatras residentes en la ciudad, 299 (59% pudieron ser localizados y respondieron a un cuestionario de 15 preguntas en las que se planteaban situaciones hipot\u00e9ticas sobre indicaciones y contraindicaciones de esta vacuna. El promedio de aciertos fue de 9,3 preguntas de las 15, lo que muestra el poco conocimiento de los pediatras sobre la vacunaci\u00f3n antisarampiososa. Situaciones comunes en la pr\u00e1ctica pedi\u00e1trica brasile\u00f1a -desnutrici\u00f3n, infecci\u00f3n de v\u00edas respiratorias altas, diarrea y estado prematuro- fueron a menudo err\u00f3neamente consideradas como contraindicaciones para la inmunizaci\u00f3n. M\u00e1s de la mitad (62% de los pediatras no conoc\u00edan la v\u00eda correcta de administraci\u00f3n de la vacuna. Los conocimientos sobre la vacuna no variaron en funci\u00f3n del tiempo transcurrido desde la formaci\u00f3n universitaria del pediatra o de su trabajo en centros sanitarios de la Secretar\u00eda Estatal de Salud. Los profesores universitarios, los pediatras con maestr\u00eda y los que cursaban estudios de posgrado tuvieron una media de aciertos ligeramente superior a la del resto. Estos resultados indican la necesidad de reforzar la ense\u00f1anza sobre la vacunaci\u00f3n antisarampionosa en las facultades de medicina y en los programas de formaci\u00f3n continuada para pediatras. [Conocimientos de los pediatras de Salvador, Brasil, sobre la vacuna antisarampionosa](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891997001200001&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Luiza A. Cabus Moreira 1997-12-01 Full Text Available El \u00e9xito de las iniciativas internacionales para la erradicaci\u00f3n del sarampi\u00f3n depende en gran medida del grado de conocimiento sobre la vacunaci\u00f3n. En 1992 se evaluaron mediante un estudio transversal los conocimientos sobre la vacuna antisarampionosa de los pediatras de la ciudad brasile\u00f1a de Salvador, Bahia. Del total de 506 pediatras residentes en la ciudad, 299 (59% pudieron ser localizados y respondieron a un cuestionario de 15 preguntas en las que se planteaban situaciones hipot\u00e9ticas sobre indicaciones y contraindicaciones de esta vacuna. El promedio de aciertos fue de 9,3 preguntas de las 15, lo que muestra el poco conocimiento de los pediatras sobre la vacunaci\u00f3n antisarampiososa. Situaciones comunes en la pr\u00e1ctica pedi\u00e1trica brasile\u00f1a -desnutrici\u00f3n, infecci\u00f3n de v\u00edas respiratorias altas, diarrea y estado prematuro- fueron a menudo err\u00f3neamente consideradas como contraindicaciones para la inmunizaci\u00f3n. M\u00e1s de la mitad (62% de los pediatras no conoc\u00edan la v\u00eda correcta de administraci\u00f3n de la vacuna. Los conocimientos sobre la vacuna no variaron en funci\u00f3n del tiempo transcurrido desde la formaci\u00f3n universitaria del pediatra o de su trabajo en centros sanitarios de la Secretar\u00eda Estatal de Salud. Los profesores universitarios, los pediatras con maestr\u00eda y los que cursaban estudios de posgrado tuvieron una media de aciertos ligeramente superior a la del resto. Estos resultados indican la necesidad de reforzar la ense\u00f1anza sobre la vacunaci\u00f3n antisarampionosa en las facultades de medicina y en los programas de formaci\u00f3n continuada para pediatras. [Identidad de la vacuna contra Streptococcus pneumoniae \"Quimi-Vio\" mediante la t\u00e9cnica Dot Blot empleando los anticuerpos monoclonales contra los polisac\u00e1ridos capsulares 1,5, 6B, 14 y 19F de la bacteria](http://revistabionatura.com/2017.02.01.7.html) of Open Access Journals Full Text Available Streptococcus pneumoniae (neumococo constituye una de las principales causas de enfermedades infecciosas bacterianas, particularmente en ni\u00f1os menores de 2 a\u00f1os de edad. Basadas en el polisac\u00e1rido capsular (PsC, su principal factor de virulencia, existen dos tipos de vacunas aprobadas para uso en humanos: las vacunas polisacar\u00eddicas planas y las vacunas polisacar\u00eddicas conjugadas. Quimi-Vio, la vacuna antineumoc\u00f3cica cubana, pertenece al segundo grupo y est\u00e1 compuesta por los PsC de los siete serotipos de mayor incidencia y circulaci\u00f3n en Cuba (1, 5, 6B, 14, 18C, 19F y 23F. El objetivo de este trabajo fue realizar el ensayo de identidad de la vacuna cubana Quimi-Vio empleando los AcM contra los PsC 1, 5, 6B, 14, y 19F de Sp obtenidos recientemente en el Instituto Finlay de Vacunas, teniendo en cuenta que los Ensayos de identidad de las vacunas son requisito indispensable para la liberaci\u00f3n final de los lotes. La t\u00e9cnica empleada para la realizaci\u00f3n del ensayo de identidad de Quimi-Vio fue el Dot Blot, donde empleando membrana de Nitrocelulosa se realiz\u00f3 la captura de tres lotes de vacuna Quimi-Vio y como control positivo de la t\u00e9cnica los respectivos PsC de los serotipos 1, 5, 6B, 14, y 19F sin conjugar y una vacuna comercial Prevenar-13. Para la identidad de los PsC de neumococo se emplearon los respectivos AcM a una concentraci\u00f3n de 10\u00b5g/mL y como segundo anticuerpo anti IgG de rat\u00f3n conjugado a peroxidasa teniendo en cuenta que los AcMs empleados son murinos. Cada AcM fue capaz de identificar de forma altamente especifica al PsC homologo (mismo serotipo, tanto en su forma no conjugada y monovalente como en el contexto de las vacunas Quimi-Vio y Prevenar 13V, donde adem\u00e1s de estar conjugado al TT se encuentra mezclado con otros PsC de forma multivalente. La t\u00e9cnica Dot Blot empleando los AcMs contra los PsC serotipos 1, 5,6B, 14 y 19F permite identificar de forma espec\u00edfica cada PsC en la formulaci\u00f3n multivalente, por lo [VARIABILIDAD EN LA NOTIFICACI\u00d3N DE REACCIONES ADVERSAS A LAS VACUNAS DE LA GRIPE PAND\u00c9MICA Y ESTACIONAL. TEMPORADAS 2009-2010 Y 2010-2011, COMUNITAT VALENCIANA](http://www.redalyc.org/articulo.oa?id=17023106004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Ana Mar\u00eda Alguacil Ramos 2012-01-01 Full Text Available Fundamentos: La p\u00e9rdida de confianza en la seguridad de las vacunas derivada de situaciones de alarma, como en el caso de la gripe pand\u00e9mica, puede afectar tanto a las coberturas vacunales como a la sensibilidad frente a la notificaci\u00f3n de las sospechas de reacciones adversas asociadas a vacunas (SRAAV. El objetivo del trabajo es describir los efectos adversos a la vacuna frente a la gripe pand\u00e9mica notificados en la temporada 2009-2010 y comparar si existen diferencias con los descritos con la vacuna de la gripe estacional en las temporadas 2009-2010 y 2010-2011 en la Comunitat Valenciana (CV. M\u00e9todos: Se realiz\u00f3 un estudio descriptivo de los individuos vacunados frente a la gripe que presentaron alguna SRAAV a la vacuna antigripal y que fue notificada a trav\u00e9s del Sistema de Informaci\u00f3n Vacunal, durante las temporadas 2009-2010 (incluyendo la vacunaci\u00f3n pand\u00e9mica y 2010-2011 en CV. se calcularon las tasas de notificaci\u00f3n de sospechas de reacciones adversas asociadas a vacunas por cada mil dosis de vacunas administradas y sus intervalos de confianza al 95%. Resultados: Durante el periodo 2009-2010 la tasa de notificaci\u00f3n de SRAAV para la vacuna de la gripe estacional fue de 0,02 por mil dosis administradas, para la vacuna pand\u00e9mica de 0,95. En el periodo 2010-2011 la tasa para la vacuna de la gripe estacional fue de 0,04 por mil. Conclusiones: Durante las temporadas analizadas se increment\u00f3 el n\u00famero de notificaciones de SRAAV para las vacunas pand\u00e9micas en comparaci\u00f3n con el resto de vacunas antigripales. La mayor tasa de notificaci\u00f3n de SRAAV correspondi\u00f3 al grupo de profesionales sociosanitarios, tanto para las vacunas frente a la gripe estacional como pand\u00e9- mica. [Evaluaci\u00f3n de la eficiencia de la vacunaci\u00f3n antigripal en la poblaci\u00f3n laboral espa\u00f1ola Efficiency of influenza vaccination in the working population in Spain](http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-91112006000200004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Jos\u00e9 Ram\u00f3n de Juanes 2006-03-01 Full Text Available Introducci\u00f3n: La gripe es la mayor causa de morbimortalidad en el mundo. Actualmente, las vacunas contra la gripe son efectivas y seguras. Las intervenciones que reduzcan la carga de la enfermedad deben analizarse desde el punto de vista cl\u00ednico y econ\u00f3mico. Objetivos: Evaluar la eficiencia de un programa de vacunaci\u00f3n contra la gripe en la poblaci\u00f3n laboral espa\u00f1ola. M\u00e9todos: Modelo te\u00f3rico de an\u00e1lisis de costes y beneficios en t\u00e9rminos de ahorro para una cohorte de 1.000 trabajadores entre 16 y 65 a\u00f1os de edad vacunada, y otra no vacunada, a 1 a\u00f1o desde la perspectiva social. Intervenciones: vacunaci\u00f3n contra la gripe respecto a no vacunaci\u00f3n. Mediciones principales: datos epidemiol\u00f3gicos y cl\u00ednicos de incidencia de gripe y efectividad de la vacuna. Datos de uso de recursos directos (de atenci\u00f3n primaria y especializada e indirectos obtenidos por consenso de 5 expertos en medicina preventiva, microbiolog\u00eda, medicina del trabajo y econom\u00eda de la salud. Datos de costes unitarios (euros de 2003. Se realiz\u00f3 un an\u00e1lisis de sensibilidad con la incidencia de gripe, la efectividad de la vacuna y los d\u00edas de ausencia del trabajo por gripe. Resultados: En el escenario base, la vacuna permite ahorrar 35 euros netos por trabajador (el 88% corresponde al ahorro en p\u00e9rdidas de productividad evitadas. El an\u00e1lisis de sensibilidad indica que los valores umbral de incidencia de gripe y de ausencia del trabajo son del 6% y de 1,5 d\u00edas, respectivamente, a partir de los cuales la vacunaci\u00f3n se asocia con el ahorro neto. Conclusiones: Vacunar contra la gripe a la poblaci\u00f3n laboral espa\u00f1ola puede comportar un ahorro neto a la sociedad.Introduction: Influenza is a major cause of morbidity and mortality worldwide. Currently, perspective. To assess the costs and benefits of an econ\u00f3mico de las vacunas 10-valente y 13-valente contra 2014-01-01 Introducci\u00f3n: Las vacunas cl\u00e1sicamente han representado un m\u00e9todo econ\u00f3mico y eficaz para el control y prevenci\u00f3n de m\u00faltiples enfermedades infecciosas. En los \u00faltimos a\u00f1os se han introducido nuevas vacunas contra neumococo a precios elevados, y los diferentes an\u00e1lisis econ\u00f3micos a nivel mundial de estas vacunas no muestran tendencias. El objetivo de este trabajo era resumir la evidencia existente a trav\u00e9s de los diferentes estudios econ\u00f3micos evaluando las dos vacunas de segunda generaci\u00f3n c... [Peroxiredoxin-glutaredoxin and of the human airways. For example, NTHI is a leading cause of otitis media and is the most common cause of airway associated are with oxidative stress responses. The goal of this study was to define the roles of catalase (encoded by hktE) and chinchilla infection model for otitis media, as well as in a murine model for COPD. Additional work extracellular traps (NETs), which we have shown to be an integral part of NTHI biofilms in vivo. Based on these data, we conclude 2015, American Society for Microbiology. All Rights Reserved. [Generation and testing anti-influenza human in numerous fatalities around expresses a found to be suitable for influenza virus infection, as it can clear a sub-lethal infection and sustain a lethal infection influenza high among seven influenza type viruses. A single the lung damage. The results demonstrated that DRAGA mouse is a suitable heterotype mouse model for influenza infection, and (iii) assess the efficacy of anti-influenza antibody-based human in low- and middle-income countries has been limited by cost and availability of Hib conjugate vaccines for a long time. It by the Institute for Translational Vaccinology (Intravacc, originating from the former Vaccinology Unit of the National Institute of Public Health [RIVM] and the Netherlands Vaccine Institute [NVI]) that local production of a Hib conjugate vaccine would increase the affordability and sustainability of vaccine and thereby help to speed up Hib introduction in these countries. A new affordable and a was developed, relevant quality control tests, and the technology was transferred to a number of vaccine manufacturers in India, Indonesia, and China. As part of the Hib technology transfer project managed by Intravacc, a preclinical toxicity study was conducted in the Netherlands to test the safety and immunogenicity of this new Hib conjugate vaccine. The data generated by this study were used by the technology transfer partners to accelerate the clinical development of the new Hib conjugate vaccine. repeated toxicity the immunogenicity new compared to a licensed vaccine. The the vaccine was well tolerated and immunogenic in rats, no major differences in both safety and immunogenicity in rats were found between the vaccine produced according to the production process developed by Intravacc one. new Hib vaccine, including this proof of concept (safety and immunogenicity study in rats), made it possible for technology transfer partners, having implemented the original process no changes [A cells in Q 2016-08-01 T Follicular focused on order to enhance vaccine efficacy. We experiment, anti-HA responses only seen in of Our reserved. [Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae of Andrew safety and immunogenicity of a hepatitis A virus (HAV) vaccine when coadministered vaccines 15 months of age. This was multicenter study with healthy subjects enrolled and randomized (1:1:1) 3 treatment groups. A total of 394 subjects received the first study vaccinations at 15 months of age. Group HAV (N = 135) received 2 doses of HAV vaccine 6 to 9 months apart. Group HAV+DTaP+Hib (N Hib vaccines and dose HAV vaccine, 6 to 9 months later. Group (N = 132) received the vaccines at 15 months of age, followed by HAV vaccine 30 days later and the second dose of HAV vaccine 7 to months after the DTaP+Hib vaccines. Immune responses were evaluated before the first 30 days after each vaccine dose. Solicited, unsolicited, and serious adverse events were collected. After 2 doses of the HAV vaccine, all subjects in the 3 groups was well tolerated and immunogenic when administered to children starting at 15 months of age. Immune responses to the DTaP or Hib vaccines were similar whether they were administered or Australia, PRP-OMP from 1993 until they were replaced by PRP-T between late 2005 and 2009. Analytic descriptive study of 20 years of enhanced surveillance data (1993-2013) for invasive Hib disease in Australian children PRP-OMP period (1993-1996) to 6.2 (95% CI: 4.0, 9.2) and 4.7 (95% CI: 1.7, 10.3) CI: 16, 145) and 58 (95% CI: 7, 2660) incidence among indigenous Australian children living in high-incidence regions in the first 4 years following a change to PRP-T-containing combination vaccines. This may be relevance indigenous populations characterized by suboptimal be recommended, such as Alaska Natives. [Prescripci\u00f3n de vacunas no incluidas en el calendario vacunal en la Comunitat Valenciana durante el per\u00edodo 2004-2009](http://www.redalyc.org/articulo.oa?id=17020115007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Ana Ruiz Palacio 2011-01-01 Full Text Available Fundamentos, En el marco de las pol\u00edticas de uso racional del medicamento, y al objeto de conseguir una gesti\u00f3n eficiente de los programas de vacunaciones, el objetivo de este trabajo es conocer el n\u00famero de envases de las vacunas prescritas no incluidas en los programas de vacunaci\u00f3n en la Comunitat Valenciana y en sus departamentos de salud, as\u00ed como el gasto que produjeron en 2009, y analizar la evoluci\u00f3n desde 2004, centrando el an\u00e1lisis en la vacuna heptavalente conjugada frente al Streptococcus pneumoniae en menores de dos a\u00f1os. M\u00e9todo, Estudio descriptivo retrospectivo de las vacunas prescritas mediante receta en la Comunitat Valenciana durante el a\u00f1o 2009 y su evoluci\u00f3n desde 2004. Variables, n\u00famero de envases, tipo de beneficiario (activo/pensionista, departamento y gasto generado. Fuentes, Gestor de Prestaci\u00f3n Farmac\u00e9utica (GAIA y Sistema Informaci\u00f3n Poblacional (SIP. Resultados: En 2009 la prescripci\u00f3n mediante receta de vacunas no incluidas en los programas de vacunaci\u00f3n gener\u00f3 un gasto de 683.445,71 ] correspondiente a 17.353 envases, lo que supuso el 87! del total del gasto en vacunas recetadas. La vacuna frente al S. pneumoniae gener\u00f3 el 72! del gasto total de las vacunas no incluidas en el calendario. La evoluci\u00f3n 2004-2009 muestra un aumento del gasto de 735.334 ] (24,66! en 2005 a partir del cual se produjo un descenso acusado y paulatino que alcanz\u00f3 los 1.562.650,67 ] (-228.64!. El gasto por departamentos para la vacuna del neumococo conjugada heptavalente por mil ni\u00f1os/as menores de dos a\u00f1os oscil\u00f3 entre 17.377 y 324 ]. Conclusiones: La tendencia descendente del gasto en recetas prescritas se mantuvo durante 2009, fundamentalmente de vacunas conjugadas frente a neumococo. No obstante, se observ\u00f3 gran variabilidad interdepartamental en las tasas de prescripci\u00f3n que debe ser corregida. [Australian Aboriginal Children with with increased chronicity and severity, compared to experienced counterparts. Data immune responses however, protein from in PD, and P6 in Aboriginal and non-Aboriginal who were undergoing and compared the levels with those in healthy non-Aboriginal children (controls). We found that Aboriginal cases had IgG titers to each of these 3 proteins were equivalent to or higher than those in healthy serum antibody levels controls, in titers were observed with age in non-Aboriginal cases, and a trend toward decreasing titers with age observed of chronic and severe OM in Australian Aboriginal children and other indigenous populations. These data understanding the of its bioactive natural products. After infection by influenza virus strain A/FM/1/47-MA in vivo, antiviral activity of the extracts The target fraction was applied the not only among older people but its placebo-controlled trial using the new vaccine was carried out over the winter of 1997-98 on 274 healthy patients aged 12-60 from three Israeli general practices, 182 in the vaccine group and 92 in the placebo group. Following vaccination the changes in the antigen levels and episodes of respiratory illness groups measured. Protective antibody levels Between January and March 1998, when influenza activity was at a peak in Israel, the average number of respiratory illness events in the the average number of respiratory illness days in the vaccine group over the same [69 days/100 subjects per month] month]. The new vaccine possessed significant associated with a significant among vaccines are are activated chinchilla (OM). are activated in the oropharynx. We wish to report the first published case of endocarditis caused by H. segnis. The patient, 2 courses of ampicillin given for a total of 57 days. In the second course of treatm......Haemophilus segnis is a rarely recognised commensal in the oropharynx. We wish to report the first published case of endocarditis caused by H. segnis. The patient, 2 courses of ampicillin given for a total of 57 days. In the second course... [Influenza virus neutralizing antibodies and IgG isotype profiles the development of influenza virus neutralizing antibodies and distribution of anti-influenza virus IgG isotypes after immunization of mice with influenza A (H3N2) subunit was connection with several viral vaccines in animal models and in humans. We investigated a that bound exclusively to the HA2 domain but not to the HA1 globular head. No hemagglutination inhibition titers acids 32 to 77 of pH1N1-HA2 domain, close to fusion peptide. fusion activity correlated lung substance, para-aminobenzoic acid (PABA. The aim of this work is to study antiviral activity of para-aminobenzoic acid, -aminocaproic acid, and their mixture against influenza virus, to evaluate their cytotoxic effect and to calculate their selectivity in MDCK of was between 3.0 and 9.0 lgID50. Results. As a result of our studies, that PABA in the concentration range studied from 10 to 1,000 did not cytopahtic effect in MDCK culture cells. We equal SI=128205, this fact confirm high level of therapeutic safety of this substance. The result of our experiments demonstrate that anti-influenza PABA that of \"ACA\", furthermore in in vitro experiment the mixture of -aminocaproic our in vitro studies, we have determined a high-level antiviral activity of para-aminobenzoic acid against influenza virus, and in combination with -aminocaproic acid it demonstrated a synergetic effect. and demonstrates high level of therapeutic safety. Alejandro Roque Vald\u00e9s 2004-01-01 El presente trabajo es un art\u00edculo de revisi\u00f3n que pretende abordar un tema tan controvertido como actual: la posible asociaci\u00f3n causal que se ha querido establecer entre el autismo y las vacunas infantiles. A partir de la \u00faltima d\u00e9cada del siglo XX se producen una serie de cambios en la clasificaci\u00f3n, nomenclatura y criterios diagn\u00f3sticos del autismo. Los hallazgos de estudios epidemiol\u00f3gicos llevados a cabo bajo estos nuevos ponderados han revelado que las tasas de prevalencia del autismo s... [Dot Blot para determinar la identidad antig\u00e9nica en vacunas conjugadas Text Available Las autoridades regulatorias recomiendan el uso de t\u00e9cnicas de Resonancia Magn\u00e9tica Nuclear o t\u00e9cnicas serol\u00f3gicas para la determinaci\u00f3n de la identidad de los ant\u00edgenos presentes en las vacunas conjugadas. Con la aparici\u00f3n de las vacunas conjugadas multivalentes, se ha hecho necesario recurrir a t\u00e9cnicas inmunoqu\u00edmicas con la utilizaci\u00f3n de anticuerpos monoclonales para aumentar la sensibilidad en la determinaci\u00f3n de la identidad de los ant\u00edgenos en dichas vacunas conjugadas. El objetivo del presente trabajo fue establecer las condiciones \u00f3ptimas de trabajo que permitieran utilizar la t\u00e9cnica del Dot Blot para determinar la identidad de los ant\u00edgenos en vacunas conjugadas de Streptococcus pneumoniae serotipo 19F. Para ello se estudiaron los tiempos de incubaci\u00f3n, la influencia del reactivo en la soluci\u00f3n de bloqueo; tambi\u00e9n las concentraciones \u00f3ptimas del anticuerpo monoclonal y de los ingredientes farmac\u00e9uticos activos, as\u00ed como los vol\u00famenes de aplicaci\u00f3n \u00f3ptimos para estos y vacunas. Se utiliz\u00f3 un anticuerpo monoclonal contra el polisac\u00e1rido capsular del serotipo 19F de neumococo. Las muestras empleadas en este trabajo fueron lotes de ingredientes farmac\u00e9uticos activos de conjugados de polisac\u00e1rido capsular 19F y lotes de un candidato vacunal cubano conjugado heptavalente contra neumococos. Los resultados mostraron que para la determinaci\u00f3n de la identidad antig\u00e9nica fueron suficientes 10 \u00b5L de muestras de los principios activos a una concentraci\u00f3n de 125 \u00b5g/mL e igual volumen para las vacunas heptavalentes. Qued\u00f3 demostrado que una concentraci\u00f3n de 1 \u00b5g/mL para el anticuerpo monoclonal y tiempos de incubaci\u00f3n de 30 min a 37 \u00b0C fueron suficientes para la determinaci\u00f3n. Estos resultados permiten concluir que quedaron establecidas las condiciones \u00f3ptimas de trabajo para determinar la identidad antig\u00e9nica por Dot Blot del polisac\u00e1rido capsular de S. pneumoniae las vacunas [Characterization of the Activity of the Chinese Herbal Access root of Paeonia lactiflora Pall., common herb treat viral infection as an mechanism and components for its antiviral function to be elucidated. In this study, an ethanolic (EAex for EAex exhibited an IC50 of 0.016 an viral RNA and protein was profoundly inhibited when the cells the virus replication cycle. We addressed its activity that inhibits viral hemagglutination and viral binding to and penetration into host cells. In vivo animal testing showed that 200 mg/kg/d of EAex offered possesses antiviral activity and has potential 175 H. influenzae strains were collected between 1994 and 2009 from all aged patient groups. The strains were methods. Serotyping was done by coagglutination test and by molecular PCR capsular genotyping. Beta-lactamase production was determined by the chromogenic as substrate. Most of the isolated H. influenzae strains were from children under 5 years of age (57.7%. Overall, 61 strains belonged to serotype b means of PCR capsular typing, 1 strain type non-typeable (non-encapsulated H. influenzae. Among or other invasive infections, aged 2 month to 5 years, all strains, were serotype b. In respiratory tract common - 96.5% were non-typeable strains in both groups children and adults. Overall, the prevalence of beta-lactamase production was 19.4%. But, it was much higher for invasive strains from CSF isolates - 37.7%, URT samples - 2.3%. The rate of beta-lactamase production in CSF isolates has changed for the last 10 years.PCR capsular method strains. The implementation of Hib vaccine in our country be accompanied by a reduction in invasive diseases caused by H. influenzae type b in children, but it is not useful preventing Un grup d'investigadors de la Unitat de Tuberculosi Experimental de la Fundaci\u00f3 Institut Germans Trias i Pujol ha creat una vacuna que permet reduir la durada del tractament de la infecci\u00f3 la tuberculosi de nou mesos a nom\u00e9s un. [Vacunas para la prevenci\u00f3n de la gripe en personas de edad avanzada](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::9f9342f04c4ecfc6206eb357ddd593ea) Antecedentes: Durante las \u00faltimas cuatro d\u00e9cadas, las vacunas han sido la principal arma global para disminuir la repercusi\u00f3n de la gripe en las personas de edad avanzada, y a nivel mundial se recomiendan para los individuos de 65 a\u00f1os o m\u00e1s de edad. El objetivo principal de la vacunaci\u00f3n contra la gripe en las personas de edad avanzada es reducir el riesgo de complicaciones en quienes son m\u00e1s vulnerables. Objetivos: Evaluar la efectividad de las vacunas sobre la prevenci\u00f3n de la gripe, la... [Chancroid and Haemophilus ducreyi.](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=358107) Morse, S genital ulcerative is the major cause of genital ulcer disease in Africa and Southeast Asia and is of increasing concern in the United States. Definitive diagnosis isolation this is difficult and all Fluorescent antibody and serologic tests are of limited value. In general, our knowledge of this organism is rather limited, and indeed, recent studies Antimicrobial resistance in H. ducreyi is of special gram-negative developed by the unprecedented construction of two rings and five new bonds in one-pot. It was proved that water was an important promoter of the reaction and PEG2000 was found of yield. 32 Derivatives were newly synthesized and most of them prepared scope 2 O was successfully recycled and reused at least 5 times without any decrease The anti-influenza activities into drug discovery chemists. [Eficacia de la vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del grupo C](https://www.openaire.eu/search/publication?articleId=doajarticles::665616b0e79abcde2883f393f494e02c) Gonz\u00e1lez Enr\u00edquez Jes\u00fas; Garc\u00eda Comas Luis; Alcaide Jim\u00e9nez Juan Francisco; S\u00e1enz Calvo Antonio; Conde Olasagasti Jos\u00e9 1997-01-01 FUNDAMENTO: Este trabajo consiste esencialmente en una revisi\u00f3n sistem\u00e1tica de la literatura cient\u00edfica sobre los efectos, intensidad y duraci\u00f3n de la respuesta serol\u00f3gica, as\u00ed como sobre la eficacia, efectividad y seguridad de la vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del grupo C. M\u00c9TODOS: B\u00fasqueda en repertorio MEDLINE en el periodo 1970-1996. B\u00fasqueda espec\u00edfica de ensayos cl\u00ednicos aleatorizados y estudios de intervenci\u00f3n prospectivos en humanos con in the OMVs were purified from three HMW1/HMW2-expressing killing The three OMV-specific antisera mediated killing of 18 of 65, 24 of 65, and 30 of 65 unrelated HMW1/HMW2-expressing NTHi strains. Overall, they mediated killing strains. The two Hia-expressing OMV-specific antisera mediated killing of 25 and of 25 unrelated Hia-expressing NTHi strains. Overall, they mediated NTHi of middle ear was monitored following intrabullar control animals developed culture-positive otitis media, as did two of three HMW1/HMW2-immunized animals. All OMV-immunized animals, with or without supplemental HMW1/HMW2 immunization, were completely protected against otitis media. NTHi OMVs are the first immunogens examined complete protection with immunity after and irritability were the common solicited AEs in both groups. Incidences of unsolicited AEs were comparable between groups. Serious AEs were reported for 47 children (28 in PHiD-CV in a 3-dose priming booster regimen to Japanese children. [Seguridad, reactogenicidad e inmunogenicidad de una nueva vacuna de polisac\u00e1ridos meningoc\u00f3cicos en adultos cubanos](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000100003&lng=es&nrm=iso&tlng=es) [Directory Rossana Estruch-de la 2017-04-01 Full Text Available Se realiz\u00f3 un estudio aleatorizado, controlado y a doble ciegas, en 352 adultos j\u00f3venes cubanos entre 18 y 35 a\u00f1os de edad, con el objetivo de evaluar la seguridad, reactogenicidad y la inmunogenicidad de una nueva vacuna de polisac\u00e1ridos de Neisseria meningitidis serogrupos A, C y W135, producida por el Instituto Finlay de Vacunas (La Habana, Cuba, con respecto a su similar comercial Mencevax\u00ae ACW de Glaxo Smith Kline. Se tomaron muestras de suero antes y 28 d\u00edas despu\u00e9s de la vacunaci\u00f3n. La reactogenicidad de ambas vacunas fue similar. Los s\u00edntomas y signos, tanto locales como generales fueron leves y aparecieron principalmente durante las primeras 48 h despu\u00e9s de la vacunaci\u00f3n. Ning\u00fan sujeto present\u00f3 eventos adversos graves durante los 28 d\u00edas del per\u00edodo de vigilancia. La vacuna en estudio mostr\u00f3 ser segura y poco reactog\u00e9nica; sus porcentajes de seroconversi\u00f3n a los 28 d\u00edas posteriores a la vacunaci\u00f3n fueron de: 92,19 % para el serogrupo A, 88,89 % para C y 90,06 % para W135. No se detectaron diferencias con respecto a la seroconversi\u00f3n. La seroprotecci\u00f3n alcanzada con la vacuna en estudio fue de 98,44 %, 91,81 % y 95,32 % para los serogrupos A, C y W135 respectivamente y no fue inferior con respecto a la vacuna control para los tres serogrupos estudiados. [Inmunizaci\u00f3n para influenza y neumococo en prevenci\u00f3n cardiovascular](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802014000300017&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Mar\u00eda In\u00e9s Sosa Liprandi 2014-06-01 Full Text Available La relaci\u00f3n entre las infecciones respiratorias producidas por el virus de la influenza y el neumococo y los eventos cardiovasculares motivaron la reuni\u00f3n de un grupo interdisciplinario (cardi\u00f3logos, cl\u00ednicos e infect\u00f3logos, con el objeto de analizar la evidencia entre la asociaci\u00f3n de estos fen\u00f3menos y el rol de las estrategias de inmunizaci\u00f3n en la prevenci\u00f3n de la enfermedad cardiovascular. El presente documento sintetiza las conclusiones del grupo de trabajo. El an\u00e1lisis de revisiones sistem\u00e1ticas sugiere una evidencia consistente entre la infecci\u00f3n por influenza y neumococo como desencadenantes de infarto agudo de miocardio y muerte cardiovascular. Los estudios publicados en los \u00faltimos 15 a\u00f1os sugieren que la vacunaci\u00f3n para influenza y neumococo reducen el riesgo de s\u00edndromes coronarios agudos. Con la evidencia existente y teniendo en cuenta los an\u00e1lisis de costo-efectividad, ahorro de costos y perfil de seguridad de las vacunas, las sociedades cient\u00edficas y agencias gubernamentales de salud, tanto nacionales como internacionales, recomiendan fuertemente la incorporaci\u00f3n de la inmunizaci\u00f3n en el grupo de pacientes con enfermedad cardiovascular cr\u00f3nica. [Influence of Media The information distribution on influenza epidemics were evaluated. Four indices for epidemics of epidemic curves) indices and anti-flu drug prescription dose, vaccine coverage, the volume of media and search trend on influenza through internet were analyzed. Epidemiological data on seasonal influenza collected of Infectious Diseases of Japan. The duration and its ratio positively with volume of media information. Pre-epidemic search trend and media volume on influenza correlated with the vaccine coverage in the season. no strong epidemic the curve of seasonal influenza. Copyright \u00a9 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved. [Immunogenicity, safety coadministered. We immunogenicity, viruses are one of 4 postinfection that correlated with the dose of virus used to inoculate the animal but not the amount of virus recovered from the lung. In addition, pathology demonstrated a requirement for exposure to, and infection by, large amounts of live virus for induction of tachypnea. A variety with the pathologic observations, that early disruption of the lower respiratory tract epithelium is a major component of the pathophysiology of influenza infection. Therapeutic approaches need to be restore an intact epithelium [Estudios de inmunogenicidad, seguridad y eficacia de la Vacuna Q frente a la leishmaniosis canina](https://www.openaire.eu/search/publication?articleId=od_______296::4dfda7f2f3e4339756541268672e7022) Fern\u00e1ndez Cotrina, Javier 2016-01-01 Se analizaron la seguridad, inmunogenicidad y eficacia protectiva de cuatro dosis de la vacuna Q de Leishmania infantum (VQ). Para ello, cincuenta perros beagle (10 por grupo) fueron vacunados con una dosis \u00fanica de 200, 100, 50 y 25 \u00b5g de VQ. A los perros del grupo control se les inyect\u00f3 el diluyente de la vacuna. Los datos muestran que la vacunaci\u00f3n con VQ indujo una respuesta humoral temprana y espec\u00edfica dependiente de la dosis. Adem\u00e1s, durante el per\u00edodo post-vacunaci\u00f3n no se detect\u00f3 rea... [Desarrollo de una vacuna profil\u00e1ctica de segunda generaci\u00f3n contra el papilomavirus humano](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802011000500015&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Full Text Available Los papilomavirus humanos (HPV son el agente etiol\u00f3gico del c\u00e1ncer cervical (CC, la segunda causa de muerte por c\u00e1ncer en mujeres. Se estima que medio mill\u00f3n de nuevos c\u00e1nceres se diagnostica cada a\u00f1o, ocurriendo la mayor\u00eda de ellos en pa\u00edses en v\u00edas de desarrollo debido a la ausencia o ineficiencia de los programas masivos de detecci\u00f3n temprana. Recientemente se han introducido en el mercado dos vacunas profil\u00e1cticas contra las principales cepas oncog\u00e9nicas de HPV, la cepa 16 y 18, responsables por el 80% de todos los CC. Estas vacunas se obtienen en forma recombinante y han demostrado ser extremadamente seguras y eficaces. Sin embargo, su impacto inmediato en la incidencia de la infecci\u00f3n por HPV en pa\u00edses en v\u00edas de desarrollo ser\u00e1 m\u00ednimo, debido principalmente al alto costo de las mismas. Existe la necesidad de contar con vacunas de segunda generaci\u00f3n, de bajo costo y de aplicaci\u00f3n masiva que permitan disminuir sensiblemente el n\u00famero de CC en la poblaci\u00f3n. Con este objetivo hemos desarrollado una plataforma de expresi\u00f3n recombinante que permite obtener part\u00edculas tipo virus (VLPs con las cuales es posible formular vacunas efectivas y accesibles contra la infecci\u00f3n por HPV. Barik, Sailen 2012-09-13 Influenza has a long history of mortality in the human population and pandemics. The high mutation rate of the RNA genome of the influenza virus, assortment of and become resistant to antiviral drugs. There new anti-influenza therapy using novel and Full Text Available Abstract Background Staphylococcus aureus is associated with a spectrum of symbiotic relationships with its human host from carriage to sepsis is frequently associated clustering yielded 3,155 orthologous clusters, of which 2,266 were core, 755 were distributed, and 134 were unique. revealed a mean difference of 296 genes and a maximum difference of 476 genes. We developed a revised version of our finite supragenome model the of the S. supragenome (3,221 genes, with 2,245 core genes, and with those of Haemophilus of supragenome model provide an our orthologous gene clustering algorithm. [Evaluaci\u00f3n de la toxicidad por dosis \u00fanica y tolerancia local de la vacuna vax-SPIRAL\u00ae en ratas Sprague Dawley](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2004000200002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Juan F. Infante 2004-04-01 Full Text Available Las pruebas precl\u00ednicas de toxicidad en dosis \u00fanica y en dosis repetidas brindan una valiosa informaci\u00f3n sobre la seguridad del producto, al incluir el estudio macrosc\u00f3pico e histopatol\u00f3gico de \u00f3rganos importantes, as\u00ed como evaluaciones de las v\u00edas de administraci\u00f3n y el r\u00e9gimen de dosificaci\u00f3n. Cuba desarroll\u00f3 una vacuna polivalente de c\u00e9lulas inactivadas qu\u00edmicamente adyuvadas con hidr\u00f3xido de aluminio, vax-SPIRAL\u00ae. Esta vacuna presenta ventajas en relaci\u00f3n con otras vacunas como la procedente de la antigua URSS. El esquema de vacunaci\u00f3n para humanos consiste en dos dosis de 0,5 mL, separadas por un intervalo \u00f3ptimo de seis semanas. El objetivo de este estudio de toxicidad en ratas Sprague Dawley fue determinar la toxicidad potencial, letalidad, \u00f3rganos y sistemas susceptibles y otros eventos adversos, as\u00ed como la toxicidad en el sitio de inoculaci\u00f3n despu\u00e9s de la administraci\u00f3n de una dosis de la vacuna en estudio. Los resultados indicaron que, bajo las condiciones en estudio y seg\u00fan los criterios establecidos para evaluar los datos obtenidos, la vacuna antileptospir\u00f3sica trivalente no produce efectos t\u00f3xicos en el modelo animal usado. Las \u00fanicas alteraciones encontradas fueron formaciones granulomatosas a nivel del sitio de inoculaci\u00f3n. Estas formaciones han sido reportadas como pertenecientes al adyuvante de dep\u00f3sito (hidr\u00f3xido de aluminio, tambi\u00e9n usado en otras vacunas de aplicaci\u00f3n parenteral. [Prophage induction in Haemophilus influenzae and its relationship to mutation by chemical are not mutagenic EMS and MNNG All of these however, are known to be both mutagenic and able to induce prophage in E. coli. We report here that all the agents except HZ induce prophage in H. influenzae, and EMS induces in the recl mutant, which is non-inducible by UV, MMC, MNNG and MMS. MMS did not cause single-strand breaks or gaps in DNA synthesized after treatment of H. influenzae, but EMS and MNNG produced them. EMS caused more breaks in DNA synthesized before treatment than in that synthesized after treatment. On the other hand we did observe such breaks or gaps induced in E. coli in DNA synthesized posttreatment by EMS as well as by MMS and MNNG, at comparable survival levels. (orig.) [Prophage induction in Haemophilus influenzae and to mutation by chemical Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp) Balganesh, M.; Setlow, J.K. National Lab., Upton, 1984-01-01 It is known that UV, X-rays, MMC and MMS are not mutagenic EMS and MNNG All of these however, are known to be both mutagenic and able to induce prophage in E. coli. We report here that all the agents except HZ induce prophage in H. influenzae, and EMS induces in the recl mutant, which is non-inducible by UV, MMC, MNNG and MMS. MMS did not cause single-strand breaks or gaps in DNA synthesized after treatment of H. influenzae, but EMS and MNNG produced them. EMS caused more breaks in DNA synthesized before treatment than in that synthesized after treatment. On the other hand we did observe such breaks or gaps induced in E. coli in DNA synthesized posttreatment by EMS as well as by MMS and MNNG, at comparable survival levels. [Avalia\u00e7\u00e3o do impacto do programa de vacina\u00e7\u00e3o contra o Haemophilus influenzae tipo b (Hib) no Estado de S\u00e3o Paulo e munic\u00edpio de S\u00e3o Paulo, ap\u00f3s dez de contra o Haemophilus influenzae tipo b (Hib), no estado de S\u00e3o Paulo (ESP) e no munic\u00edpio de S\u00e3o Paulo (MSP), na popula\u00e7\u00e3o de 0 - 59 meses, comparando os per\u00edodos pr\u00e9-vacinal (1996 - 1998) e p\u00f3s-vacinal (2001 - 2009). M\u00e9todos: estudo com componente descritivo cunho anal\u00edtico, retrospectivo. A popula\u00e7\u00e3o de estudo incluiu os menores de cinco anos residentes no ESP e no MSP. Adotou-se com... [La Real Expedici\u00f3n Filantr\u00f3pica de la vacuna (1803 - 1810](http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0465-546X2007000400010) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Jorge Veiga de Cabo 2007-12-01 Full Text Available La Expedici\u00f3n Filantr\u00f3pica de la vacuna supuso una de las empresas sanitarias realizadas en el Siglo XVIII de mayor envergadura, por su complejidad, dificultad y sobre todo, por constituir una de las misiones de Salud P\u00fablica m\u00e1s importantes realizadas en la Historia. Supone el resultado de un proceso en el que una serie de acontecimientos hist\u00f3ricos, sanitarios y sociales confluyen para generar uno de los primeros programas de intervenci\u00f3n en salud p\u00fablica a escala internacional y de expansi\u00f3n de la vacuna de la viruela. Se crean Centros de producci\u00f3n, almacenamiento y distribuci\u00f3n de la vacuna, y programas de capacitaci\u00f3n t\u00e9cnica enfocados a mantener campa\u00f1as de vacunaci\u00f3n poblacional.One of the most important medical achievements made in the eighteenth century was the Philanthropic Expedition of the Vaccine. Due to its complexity and difficulty it was one of the most important Public Health undertakings in history. It was the outcome of a series of historical, social and health advances that converged in creating one of the earliest international programs for the expansion of the smallpox vaccine, creating centres for the production, storage and distribution of the vaccine together with technical training of N-succinyl-L,L-diaminopimelic acid by the dapE-encoded desuccinylase for the bacterial synthesis of meso-diaminopimelic acid. have verified the enzyme is metal-dependent, with a Km for N-succinyl-L,L-diaminopimelic acid of 1.3 mM and a turnover number of 200 s-1 in the presence of zinc. The maximal velocity was independent of pH above 7 but decreased slope was pKs of 8.3. Both L,L- and D,L-diaminopimelic acid were competitive inhibitors of by tightly bound metal ion, while sequence homologies suggest the presence of two metal binding sites. On the basis of these observations, we propose a chemical mechanism for this metalloenzyme, was identified and considered a strong candidate for a novel influenza pandemic. As part of an ongoing anti-influenza screening programme on natural products, eight active double-blinded study evaluating the of a combined diphtheria-tetanus-pertussis-Haemophilus influenzae type b vaccine entirely produced and Instituto Butantan (DTP/Hib-BM was undertaken. The reference vaccine had the Hib was produced is registered and has supplied the Brazilian National Immunization Program for over more than five years. One thousand infants were recruited for the study and received vaccinations at two, four and six months of age. With respect to immunogenicity, the vaccination protocol was followed in 95.6% and infants DTP/Hib-GSK groups, respectively. For the Hib component of the study, there was 100% seroprotection (>0.15 \u00b5g/mL with all mean 10.3 \u00b5g/mL and 10.3 \u00b5g/mL for lots 1, 2 and 3 of DTP/Hib-BM, respectively, and the GMT was 11.3 g/mL across lots and vaccines. Adverse were DTP/Hib vaccine demonstrated an immunogenicity and reactogenicity profile similar to that of the reference vaccine. [Estudio de toxicidad por dosis \u00fanica y tolerancia local de una vacuna antimeningoc\u00f3cica tipo B en ratas Sprague Dawley](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200004&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Juan F. N\u00fa\u00f1ez 2006-08-01 Full Text Available La vacuna antimeningoc\u00f3cica tipo B, objetivo de este estudio, contiene ves\u00edculas purificadas de la membrana externa del meningococo del serogrupo B de la cepa (Cu- 385 - 83 B:4:P1.19,15. El esquema de vacunaci\u00f3n propuesto en humanos consiste en tres dosis de 0,5 mL, separadas por un intervalo \u00f3ptimo de ocho semanas. El objetivo de este estudio de toxicidad en ratas Sprague Dawley (SD fue determinar la toxicidad potencial, letalidad, \u00f3rganos, sistemas susceptibles y otros eventos adversos, as\u00ed como la toxicidad en el sitio de inoculaci\u00f3n despu\u00e9s de la administraci\u00f3n de una dosis de la vacuna en estudio. Los resultados indicaron que, bajo las condiciones del estudio y seg\u00fan los criterios establecidos para evaluar los resultados, la vacuna antimeningoc\u00f3cica tipo B, no produce efectos t\u00f3xicos en el modelo animal usado. Todo lo que se observ\u00f3 fueron formaciones granulomatosas a nivel del punto de inoculaci\u00f3n. Estas formaciones han sido reportadas como pertenecientes a los adyuvantes de dep\u00f3sito, como el hidr\u00f3xido de aluminio, usado en otras vacunas parenterales. Se concluye que la vacuna antimeningoc\u00f3cica tipo B result\u00f3 satisfactoria en las pruebas de toxicidad por dosis\u00fanica y tolerancia local realizadas en la especie rata. [Drug Discovery of Host CLK1 Inhibitors for Influenza Mian Zu 2015-11-01 Full Text Available The of influenza virus makes antiviral drugs less effective, which is considered to be a major bottleneck in antiviral therapy. The key proteins in the host cells, which are related with the replication cycle of influenza virus, are potential drug targets due to their and drug resistance. Cdc2-like kinase 1 (CLK1 in the host cells is responsible for alternative splicing of the M2 gene of influenza virus during influenza infection and replication. In this study, we screening for new drug design and development in influenza treatment, and CLK1 may be a potent drug target for anti-influenza drug information cause by these... [Influenza infection and heart failure-vaccination may pathogenesis of acute heart failure (AHF) and the worsening of heart failure (CHF) is complex. The effects influenza infection on AHF/CHF can be attenuated by specific immunization. Our review aimed to summarize the effectiveness, safety, and dosage of anti-influenza vaccination in HF. In this literature review, we searched and EMBASE from January 1st 1966 to used sensitivity of the search. HF was a prerequisite for our search. The search fields included \"heart \"vaccination,\" restrictions on the type of study design were applied. The most common clinical Full Text Available Abstract a long history of causing morbidity and mortality in the human population and pandemics. The high mutation rate of the RNA genome of the influenza virus, assortment of and become resistant to antiviral drugs. There new anti-influenza therapy using novel and discoveries. [Evaluaci\u00f3n de la informaci\u00f3n sanitaria disponible en internet sobre la vacuna antigripal](https://www.openaire.eu/search/publication?articleId=doajarticles::10bf287ae0007ca1c04dfbe102687a3b) I. Hern\u00e1ndez-Garc\u00eda; R. Gonz\u00e1lez Celador 2014-01-01 Fundamento: La calidad de la informaci\u00f3n sanitaria en internet preocupa a gobiernos y usuarios. Nuestro objetivo fue determinar en qu\u00e9 medida la informaci\u00f3n sobre la vacuna antigripal se adhiere al gold est\u00e1ndar representado por lo establecido por el Ministerio de Sanidad espa\u00f1ol. Material y m\u00e9todos: Entre junio-julio 2014 se evalu\u00f3 la adhesi\u00f3n al gold est\u00e1ndar de la informaci\u00f3n sobre indicaciones, efectos adversos y contraindicaciones de la vacuna. Dicha informaci\u00f3n se obtuvo a trav\u00e9s de Goo... [LA VACUNACI\u00d3N ANTI-NEUMOC\u00d3CICA CON LA VACUNA CONJUGADA 13-VALENTE EN POBLACI\u00d3N INMUNOCOMPETENTE DE 65 A\u00d1OS: ANALISIS DEL IMPACTO PRESUPUESTARIO EN ESPA\u00d1A APLICANDO UN MODELO DE TRANSMISI\u00d3N DIN\u00c1MICA](http://www.redalyc.org/articulo.oa?id=17043728001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Reyes Lorente Anto\u00f1anzas 2016-01-01 Full Text Available Fundamentos: Las infecciones causadas por el Streptococcus pneumoniae en el adulto tienen repercusiones importantes en la salud. El objetivo fue analizar el impacto econ\u00f3mico y sanitario en 5 a\u00f1os de la vacunaci\u00f3n de la cohorte espa\u00f1ola de 65 a\u00f1os inmunocompetente con la vacuna antineumoc\u00f3cica conjugada 13-valente.M\u00e9todos: Mediante un modelo de transmisi\u00f3n din\u00e1mica basado en ecuaciones diferenciales se analiz\u00f3 la carga de la enfermedad neumoc\u00f3cica (EN en sujetos de 65 a\u00f1os en 5 a\u00f1os, siendo vacunada anualmente el 36,5% de la cohorte. Se aplic\u00f3 la eficacia de la vacuna del 52,5% observada en el estudio CAPITA en pacientes de 65 a\u00f1os inmunocompetentes, cobertura de serotipos vacunales del 63,4% (estudio CAPA, incidencia de infecci\u00f3n neumoc\u00f3cica de 162,2/100.000 casos a\u00f1o (CMBD 2010-2013 y proporci\u00f3n de vacunados previamente al arranque del modelo del 0,99%. La perspectiva fue la del Sistema Nacional de Salud (SNS. Costes de casos de EN seg\u00fan CMBD y precio de venta de laboratorio de la vacuna conjugada.Resultados: En 5 a\u00f1os la vacunaci\u00f3n con vacuna conjugada 13-valente espera evitar 10.360 casos de EN (7.411 hospitalizaciones por neumon\u00edas y 699 muertes (14.736 a\u00f1os de vida ganados -AVG-, en una cohorte de 65 a 69 a\u00f1os de edad. El coste de vacunaci\u00f3n esperado de 36,5 millones de euros se compensar\u00eda completamente por la reducci\u00f3n de 41,5 millones de costes m\u00e9dicos evitados, con un ahorro neto acumulado de 3,8 millones de euros a precios constantes (4,9 a precios corrientes.Conclusi\u00f3n: La vacunaci\u00f3n con vacuna conjugada 13-valente en adultos de 65 a\u00f1os inmunocompetentes resulta eficiente para el Sistema Nacional de Salud, reduciendo la carga de enfermedad y evitando un n\u00famero importante de muertes. [Dengue, zika, chikungunya y el desarrollo tres arbovirosis transmitidas por mosquitos Aedes, se han propagado en las \u00faltimas d\u00e9cadas en zonas tropicales y subtropicales h\u00famedas. El dengue es epid\u00e9mico en \u00e1reas subtropicales de la Argentina. Despu\u00e9s de la infecci\u00f3n por DENV hay inmunidad duradera contra el serotipo infectante, pero aumenta el riesgo de enfermedad grave por los otros tres. La vacuna recombinante tetravalente, Dengvaxia\u00ae previene el dengue grave y la hospitalizaci\u00f3n en s... [Multi-Omics Studies towards Novel Modulators of (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Available and two viral 48 of them has been reported previously, whereas the antiviral efficacy of the 665 remains Studying anti-influenza efficacy and immuno/neuro-modulating properties combinations as well as potential viral and host resistance to them may lead to the discovery of novel modulators of IAV-host resistant variants of the influenza virus has led to a need to identify novel and effective antiviral agents. As an alternative to synthetic drugs, the consolidation of empirical knowledge with ethnopharmacological evidence of medicinal plants offers a novel platform for the development of antiviral drugs. The aim of this study was to identify plant extracts with proven activity against the influenza virus. of fifty medicinal plants, originating from the tropical assays along with performed on MDCK cells. Most plant extracts were found to be minimally cytotoxic, indicating that linked pathway. samples (NI penetration, thereby indicating potent action the involving Receptor Destroying responsible for hemagglutination inhibition. The manifestation of both modes of viral inhibition in a single extract suggests that there may be a synergistic effect one active component. Overall, our substantive support the use Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Ivan Lozada-Requena Full Text Available La presente es una revisi\u00f3n narrativa que muestra la informaci\u00f3n accesible a la comunidad cient\u00edfica sobre melanoma e inmunoterapia. Las c\u00e9lulas dendr\u00edticas tienen la capacidad de participar en la inmunidad innata y adaptativa, pero no son ajenas a la evasi\u00f3n inmune de los tumores. Conocer su biolog\u00eda y rol ha llevado a generar in vitro varios prospectos de vacunas celulares aut\u00f3logas contra diversos tipos de c\u00e1ncer en humanos y modelos animales; sin embargo, en vista de la poca eficiencia que han mostrado, se deben implementar estrategias para potenciar su capacidad natural ya sea a trav\u00e9s de la coexpresi\u00f3n de mol\u00e9culas clave para activar o reactivar al sistema inmune, en combinaci\u00f3n con biosimilares o drogas quimioterape\u00faticas y no se debe descartar la acci\u00f3n de productos naturales como alternativa inmunoestimulante o adyuvante. Todos los tipos de inmunoterap\u00eda deber\u00edan medir el impacto de las c\u00e9lulas supresoras de origen mieloide, las que pueden atacar al sistema inmune y ayudar a la progresi\u00f3n tumoral, respectivamente. Esto puede reducir la actividad de las vacunas celulares y/o sus combinaciones pudiendo ser la diferencia entre el \u00e9xito o no de la inmunoterapia. Aunque en melanoma existen biosimilares aprobados por la Food and Drug Administration (FDA no todos tienen el \u00e9xito esperado por lo que es necesario evaluar otras estrategias que incluyan vacunas celulares cargadas con p\u00e9ptidos antig\u00e9nicos tumorales expresados exclusivamente o ant\u00edgenos provenientes y sus respectivos adyuvantes. Agualimpia Janning, Andr\u00e9s; Fundaci\u00f3n Valle una vacuna?/\u00bfC\u00f3mo funciona una vacuna?/\u00bfLa vacunaci\u00f3n Available This current technologies generating antibodies for passive immunization/immunotherapy. Contemporary DNA of engineered therapeutic monoclonal antibodies in a strategies particularly for at high risk for severe morbidity. In a setting where vaccines are not available, that virus portion no ADE effect in recipients are available. These neumon\u00eda en ni\u00f1os guatemaltecos: importancia influenzae tipo b de Streptococcus pneumoniae](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892003001100002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Edwin J. 2003-12-01 Full Text Available OBJECTIVE: determine the important issue since Hib vaccine has not been incorporated into the routine immunization program in Guatemala and information from hospital records in 1995 indicated a low incidence of Hib and S. pneumoniae as causes of meningitis and invasive infections. METHODS: Children who were hospitalized in Guatemala City with clinical signs compatible with bacterial infections were evaluated for evidence Hib 1-59 months of age hospitalized over a 28-month period, 725 of them (60.3% had a primary diagnosis of pneumonia, 357 (29.7% of 60 (5.0% and (5.1% sepsis and other conditions. Hib was identified in 20.0% of children with meningitis and S. pneumoniae in 12.9%. The average annual incidence of Hib meningitis was 13.8 cases per 100 000 children under 5 years of age, and 32.4% of meningitides caused by Hib and 14.1%, culture-negative and antigen-negative meningitis. Prior antibiotic therapy was and was associated with significant reductions in CSF-culture-positive results for children with other evidence of Hib or pneumoniae meningitis. CONCLUSIONS: Improvements Guatemalan children. Using a of > 10 white blood cells per cubic millimeter in CSF would improve otitis with effusion bacteria do not clear by To were divided into control (C), HI group, Laser (L), PS, PDT A, and PDT B groups. The C group received no treatment. HI group was injected with 20l (108CFU/ml) of H. influenzae into the formation of biofilms in the bullae was obtained by 5 days. For L group, 120 J/cm2 (100 mw \u00d7 20 min) of 632 nm LD laser was irradiated by a fiber inserted into the bullae 5 days after the H. influenzaeinjection. For PS group, photofrin 40l (1mg/ml) were injected into bullae 5 influenzae J/cm2 that were administered into bullae 5 days after the H. influenzae PDT received photofrin 2 mg/ml and Results: The C group showed normal mucosa of bullae. The HI, L, and PS groups have shown well formed biofilm. Twenty five percent of the PDT A group and 50 % of the PDT B group have shown completely or in implication: may be media with biofilm formation. durante las vacunas existentes](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832008000100006&lng=en&tlng=en) of Open Jos\u00e9 Mar\u00eda Guevara-Duncan 2008-03-01 Full Text Available Objetivos: Identificar los serotipos de S. pneumoniae aislados, correlacion\u00e1ndolos con los incluidos en las vacunas existentes y su resistencia antimicrobiana. Dise\u00f1o: Estudio descriptivo, observacional y longitudinal. Lugar: Instituto de Medicina Tropical Daniel A. Carri\u00f3n, Facultad de Medicina, UNMSM. Material biol\u00f3gico: Cepas Intervenciones: Cuarenta Streptococcus pneumoniae de nuestro cepario, aislados entre el 2002 y 2006, fueron serotipificados en el Instituto de Salud Carlos III en Madrid -Espa\u00f1a; 15 fueron invasivos, 11 aislados de infecciones localizadas, 6 de portadores y 8 eran multiresistentes. Principales medidas de resultados: Protecci\u00f3n de las vacunas existentes en nuestro medio a las infecciones causadas por Streptococcus pneumoniae. Resultados: Hubo 14 serotipos diferentes y los serogrupos m\u00e1s identificados fueron 23, 19 y 6. El 28,6% estaba contenido en la vacuna 7-valente, 42,9% en la 9-valente, 50% en la 11-valente y el 71,4% en la 23-valente; 57,5% fue resistente a la penicilina y 30% a eritromicina. El grupo de Streptococcus invasivo result\u00f3 m\u00e1s sensible a los antibi\u00f3ticos que los otros grupos. Los serotipos asociados a multirresistencia fueron 19F y 23F. Conclusiones: Ninguna de las vacunas protege a todas las infecciones causadas por Streptococcus pneumoniae, en nuestro medio. [Desarrollo de una vacuna probi\u00f3tica para el tratamiento del c\u00e1ncer c\u00e9rvico-uterino](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::1ea3de1bdf059dfdef615fb2bb624b84) Cort\u00e9s P\u00e9rez, Naima Gisela; Berm\u00fadez Humar\u00e1n, Phillipe; Luna Leal, Roberto Montes de Oca 2003-01-01 Dado que el virus del papiloma humano tipo 16 (HPV- 16) es la principal causa del c\u00e1ncer c\u00e9rvicouterino, hay una gran necesidad de desarrollar una vacuna profil\u00e1ctica y/o terap\u00e9utica. La oncoprote\u00edna E7 es constitutivamente producida por neoplasias cervicales y, por tanto, considerada como un blanco potencial para dirigir el desarrollo de una vacuna terap\u00e9utica contra el c\u00e1ncer c\u00e9rvico-uterino. En este trabajo desarrollamos un sistema inducible para expresar la prote\u00edn... [Now and future influenza vaccines.](https://www.ncbi.nlm.nih.gov/pubmed/2407775) Ruben, F L 1990-03-01 Influenza is a modern day plague. In the young, the clinical picture is classical, but in the elderly, the go unsuspected until and these viruses mutate with great regularity. Antibodies to the HA and NA surface antigens of influenza viruses, both naturally and The earliest the correct virus strains to be incorporated into each new vaccine. Those who have been experiencing the worst effects of influenza have been identified. These individuals need to be immunized each year. In the future, live influenza virus vaccines may offer the enhancement. For the present, greater efforts must be made to use existing influenza vaccines. Ca\u00f1as Giraldo, Camilo Augusto; Fundaci\u00f3n otitis media. known about the media, it has been suggested antibody may be impaired in these children. IgG PD) proteins in a cross-sectional study of 172 children under 3 years of age with a history of recurrent levels against pneumococcal protein antigens. In both children with a history of acute otitis media, antibody levels increased with age colonised with S. pneumoniae or NTHi compared with children that were not colonised. Proteins from S. pneumoniae and NTHi induce serum IgG in children with a history of acute otitis media. The mechanisms acute otitis [Directory of otitis media. known about the media, it has been suggested antibody be impaired in these children. PD proteins in a cross-sectional study of 172 children under 3 years of age with a history of recurrent levels against pneumococcal protein antigens. In both children with a history of acute otitis media, antibody levels increased with age colonised with S. pneumoniae or with children that not Proteins from S. pneumoniae and NTHi induce serum IgG in children with a history of acute otitis media. The mechanisms be reconsidered. [Avances en el desarrollo de vacunas contra la neosporosis bovina Advances in the development of vaccines Full Text Available La neosporosis es una enfermedad que ocasiona abortos en bovinos y est\u00e1 causada por un protozoo intracelular obligado denominado Neospora caninum. Las graves p\u00e9rdidas econ\u00f3micas que provoca en los sistemas de producci\u00f3n de bovinos justifica la necesidad de avanzar en el desarrollo de vacunas. La resistencia a par\u00e1sitos Apicomplexa est\u00e1 asociada a una respuesta inmune T helper 1 mediada por linfocitos T CD4 citot\u00f3xicos y a la producci\u00f3n de interfer\u00f3n-gamma, interleuquina-12, factor de necrosis tumoral e inmunoglobulina G2. La disminuci\u00f3n de la transmisi\u00f3n vertical en las sucesivas pre\u00f1eces y el bajo nivel de repetici\u00f3n de abortos en animales infectados sugieren la existencia de mecanismos inmunitarios de protecci\u00f3n. Hasta el momento se conoce que la inoculaci\u00f3n pre-servicio con taquizo\u00edtos vivos protege contra la infecci\u00f3n y el aborto. Los antecedentes de desarrollo de vacunas vivas contra otros protozoos estimulan a los investigadores a continuar en la b\u00fasqueda de una vacuna de este tipo contra N. caninum de buena eficacia. Por otra parte, una vacuna inactivada, aun con una baja eficacia, es \u00fatil en la prevenci\u00f3n del aborto en aquellos establecimientos donde la enfermedad es epizo\u00f3tica. Una vacuna contra la neosporosis deber\u00eda evitar el aborto, la transmisi\u00f3n transplacental y la persistencia de la infecci\u00f3n. Este trabajo menciona los diversos tipos de vacunas que han sido evaluados hasta el momento, incluyendo inmun\u00f3genos inactivos, taquizo\u00edtos vivos, ant\u00edgenos recombinantes y interferon-gamma, interleukin-12, tumor necrosis [VARIABILIDAD EN LA NOTIFICACI\u00d3N DE REACCIONES ADVERSAS A LAS VACUNAS DE LA GRIPE PAND\u00c9MICA Y ESTACIONAL. TEMPORADAS 2009-2010 Y 2010-2011, COMUNITAT VALENCIANA](https://www.openaire.eu/search/publication?articleId=doajarticles::6f322a77ce0bd5fd88c95f861a1a0782) Ana Mar\u00eda Alguacil Ramos; Jos\u00e9 Antonio Lluch Rodrigo; Antonio Portero Alonso; Rosa Mart\u00edn Ivorra; Eliseo Pastor Villalba 2012-01-01 Fundamentos: La p\u00e9rdida de confianza en la seguridad de las vacunas derivada de situaciones de alarma, como en el caso de la gripe pand\u00e9mica, puede afectar tanto a las coberturas vacunales como a la sensibilidad frente a la notificaci\u00f3n de las sospechas de reacciones adversas asociadas a vacunas (SRAAV). El objetivo del trabajo es describir los efectos adversos a la vacuna frente a la gripe pand\u00e9mica notificados en la temporada 2009-2010 y comparar si existen diferencias con los descritos con... [Process development of a New Haemophilus influenzae type b conjugate vaccine and the is one the most successful public health interventions being a cost-effective tool in development tools, for example mathematical modeling, as well as new regulatory initiatives requiring better understanding of both the product and being applied to well-characterized biopharmaceuticals (for example recombinant proteins). The vaccine industry is still running behind in comparison to these industries. A production process for a new influenzae a number of emerging vaccine manufacturers. supply of conjugate vaccines, as illustrated the market launch of the first Hib vaccine based on this technology in 2007 and concomitant price reduction of Hib vaccines. This for Hib conjugate well as mathematical modeling tool recently in order was a targeted and integrated approach based on prior knowledge and experience similar expertise. Mathematical modeling (the model) well proposing lead to further reduction in price. 2016 American Institute of Chemical Engineers Biotechnol. Prog., 32:568-580, 2016. \u00a9 2016 American Institute of Chemical Engineers. [Perspectivas para el desarrollo de vacunas e inmunoterapia contra c\u00e1ncer [Directory of Text Available El c\u00e1ncer cervicouterino representa un grave problema de salud p\u00fablica, debido a la asociaci\u00f3n de la neoplasia con el virus del papiloma humano; actualmente se realizan estudios usando estrategias dirigidas a combatir este pat\u00f3geno, mediante vacunas, que podr\u00edan ser de gran utilidad para el control de la progresi\u00f3n de la enfermedad. El estudio tanto de la inmunolog\u00eda humoral como celular ha servido para el desarrollo de vacunas. As\u00ed, la utilizaci\u00f3n de part\u00edculas virales sint\u00e9ticas para el estudio de anticuerpos neutralizantes y el uso de prote\u00ednas tempranas virales, entre otras, para la inducci\u00f3n de inmunidad mediada por c\u00e9lulas, han sido la pauta para realizar estudios que dirijan la respuesta inmune para prevenir la infecci\u00f3n celular tanto hacia c\u00e9lulas infectadas no transformadas como hacia c\u00e9lulas transformadas viralmente con resultados favorables. [Comparison of two recombinant hepatitis B vaccines and their interchangeability in Argentine infants Comparaci\u00f3n de dos vacunas recombinantes contra la hepatitis B y su intercambiabilidad en lactantes argentinos](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892004000100006) [Directory of Open Access dos vacunas pedi\u00e1tricas recombinantes contra la hepatitis B -Euvax-B y la vacuna de referencia Engerix-B- en cuanto a su inmunogenicidad y reactogenicidad, e investigar su intercambiabilidad, es decir, si el esquema de vacunaci\u00f3n contra la hepatitis B de tres dosis comenzado con una primera dosis de Engerix-B puede completarse con dos dosis de Euvax-B. M\u00c9TODOS: Este estudio se llev\u00f3 a cabo en la ciudad de C\u00f3rdoba, Argentina, entre marzo de 1999 y febrero de 2000. Se vacun\u00f3 contra la hepatitis B a tres grupos de 100 lactantes argentinos a los 0, 1 y 6 meses de edad. El grupo A recibi\u00f3 tres dosis de Euvax-B; el grupo B, tres dosis de Engerix-B; y el grupo C, una dosis de Engerix-B seguida de dos dosis de Euvax-B. Para evaluar la reactogenicidad se utiliz\u00f3 la informaci\u00f3n brindada por los padres acerca de determinados fen\u00f3menos locales o sist\u00e9micos solicitados por los investigadores que hubieran ocurrido durante los siete d\u00edas posteriores a la vacunaci\u00f3n. Para establecer si eran id\u00e9nticas cl\u00ednicamente las vacunas Euvax-B y Engerix-B se utilizaron las tasas de seroprotecci\u00f3n -es decir, t\u00edtulos de anticuerpos contra el ant\u00edgeno de superficie de hepatitis B (anti-HBsAg > 10 miliunidades internacionales por mililitro (mUI/mL- alcanzados dos meses despu\u00e9s de la tercera dosis. RESULTADOS: La reactogenicidad fue baja en los tres grupos de estudio. A los 5 meses de la segunda dosis (es decir, inmediatamente antes de la tercera dosis, las tasas de seroprotecci\u00f3n fueron 95,9%, 94,7% y 90,2% en los grupos A, B y C, respectivamente. Dos meses despu\u00e9s de la tercera dosis, todos los lactantes se encontraban protegidos, con concentraciones medias geom\u00e9tricas de anti-HBsAg de 2 468,1 mUI/mL en el grupo A, de 1 714,8 mUI/mL en el grupo B y de 2 075,3 mUI/mL en el grupo C. CONCLUSIONES: Las dos vacunas recombinantes contra la hepatitis B estudiadas fueron bien toleradas y altamente inmunog\u00e9nicas. La vacuna Euvax-B fue cl\u00ednicamente id\u00e9ntica (no inferior a la [La evidencia acerca de la controversia de las vacunas que contienen timerosal y su asociaci\u00f3n con el autismo](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342013000200018&lng=en&tlng=en) [Directory of Text Available La vacunaci\u00f3n es una de las medidas de mayor impacto en la salud p\u00fablica para la reducci\u00f3n de la morbimortalidad infantil. El timerosal es un compuesto org\u00e1nico del mercurio utilizado como preservante de los frascos multidosis. Eventualmente, en el Per\u00fa, surgen olas de controversia acerca de la seguridad de estas vacunas, asoci\u00e1ndolas especialmente con el autismo. Como resultado de estas controversias, se han propuesto, incluso, leyes que proh\u00edben este tipo de vacunas, lo que tendr\u00eda un importante impacto en los costos y en los aspectos log\u00edsticos de la estrategia nacional de vacunaci\u00f3n. En este art\u00edculo se revisa la literatura sobre las principales controversias acerca de las vacunas que contienen timerosal y su supuesta asociaci\u00f3n con el autismo. Se realiza una aproximaci\u00f3n hist\u00f3rica sobre estas controversias, se hace una actualizaci\u00f3n de la evidencia cient\u00edfica disponible al momento, y se revisa la posici\u00f3n de los organismos internacionales m\u00e1s importantes con respecto a este tema. Se concluye que la evidencia cient\u00edfica no apoya la noci\u00f3n que exista una asociaci\u00f3n entre el uso del timerosal en las vacunas con los trastornos del espectro autista en ni\u00f1os. [[THE NATIONAL NUTRIENT MEDIUM were for isolating and cultivating of main agents of purulent bacterial meningitis--haemophilus agar, chocolate agar, PBM-agar. The and characteristics developed growth mediums match analogues. Under application of growth agents of meningitis with inhibition of growth of microbes-associates. [Caracter\u00edsticas de los v\u00eddeos en espa\u00f1ol publicados en YouTube sobre la vacuna contra el virus del papiloma humano](http://www.redalyc.org/articulo.oa?id=17033372012) [Directory of Open Full Text Available Fundamentos: Internet constituye un recurso de b\u00fasqueda de informaci\u00f3n relacionada con la salud. El objetivo de este trabajo fue conocer las caracter\u00edsticas de los v\u00eddeos en idioma espa\u00f1ol de YouTube relacionados con la vacuna contra el virus del papiloma humano (VPH. M\u00e9todos: Se realiz\u00f3 un estudio observacional a partir de una b\u00fasqueda en YouTube el 26 de julio de 2013, con las palabras establecieron categor\u00edas por tipo, fuente de publicaci\u00f3n y predisposici\u00f3n favorable o no hacia la vacuna. Se registr\u00f3 el n\u00famero de visitas, tiempo de duraci\u00f3n de los videos y origen de los 20 v\u00eddeos m\u00e1s visitados. Resultados. Se encontraron 1.080 videos registrados, 170 fueron seleccionados y clasificados como: noticias locales (n=39; 37 favorables, 2 internacionales (n=3; 3/0; 0:11:33; 1667 visitas. De los 20 videos m\u00e1s reproducidos predominan los favorables a la vacunaci\u00f3n (n=12; 0:43:43; 161.789 visitas frente a los desfavorables (n=8; 2:44:14; 86.583 visitas. Conclusiones. Predominan los videos que tiene una opini\u00f3n favorable hacia la vacuna contra el VPH, aunque los videos de contenido negativo son los m\u00e1s extensos y reproducidos- [The impact of residency and urbanicity on Cohort Study.](http://europepmc.org/articles/PMC4020859?pdf=render) [Directory of Open Text Available type b residency and urbanicity on Hib vaccine and PCV coverage for children aged 2 to 7 years living in Shanghai, China, in August 2012. METHODS: In this exploratory cohort study, a sample of children aged 2 to 7 years, all of whom were eligible to have received the complete series of Hib vaccine and PCV, was obtained from the Shanghai Immunization Program Information System. Three measures of vaccination coverage for Hib vaccine and PCV were for PCV the abstracted records. locals and the floating population was greater in suburban areas than urban areas. Of all children who received dose 1, 79.7% completed the Hib Timely 1 coverage Hib vaccine and the Expanded Program on Immunization would increase uptake and administration completion is targeted for Sailen Barik 2010-07-01 Full Text Available Influenza of the most prevalent and ancient infections in humans. About a fifth of world's population is infected by influenza virus annually, leading morbidity and mortality, particularly in infants, the elderly and the In alone, influenza outbreaks lead to deaths each year. Current vaccines and anti-influenza drugs are of limited use due to high mutation rate of the virus and side effects. In recent RNA interference, triggered by synthetic RNA been design, modest cost, and fast turnaround. Although specificity and tissue delivery remain major bottlenecks in the clinical applications of RNAi intranasal application of siRNA against respiratory viruses including, but not limited to influenza virus, has experienced significant success and optimism, which is reviewed here. Barik, Sailen 2010-07-01 Influenza virus is one of the most prevalent and ancient infections in humans. About a fifth of world's population is infected by influenza virus annually, leading morbidity and mortality, particularly in infants, the elderly and the In alone, influenza outbreaks lead to deaths each year. Current vaccines and anti-influenza drugs are of limited use due to high mutation rate of the virus and side effects. In recent RNA interference, triggered by synthetic RNA been design, modest cost, and fast turnaround. Although specificity and tissue delivery remain major bottlenecks in the clinical applications of RNAi intranasal application of siRNA against respiratory viruses including, but not limited to influenza virus, has experienced significant success and optimism, which is reviewed here. [Vacunas de ADN: inducci\u00f3n de la respuesta inmunitaria DNA Vaccines: Induction of the immune (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Javier Mota-S\u00e1nchez 2009-01-01 Full Text Available La efectividad de las vacunas y la inmunizaci\u00f3n en la prevenci\u00f3n de las enfermedades infecciosas es uno de los grandes avances de la medicina. En la actualidad, el acceso a la tecnolog\u00eda de punta en el \u00e1rea de la gen\u00f3mica y la prote\u00f3mica ha hecho posible acelerar el desarrollo de nuevos modelos de vacunas con caracter\u00edsticas mejoradas en aspectos fundamentales, como la inmunogenicidad y la seguridad. A casi dos d\u00e9cadas del primer informe, en el cual se demostr\u00f3 que un gen puede expresarse mediante la inyecci\u00f3n directa de ADN desnudo, las vacunas de ADN han probado ser eficientes para inducir una respuesta inmunitaria protectora contra par\u00e1sitos, virus y bacterias en diversos modelos animales. Esta revisi\u00f3n tiene por objetivo presentar un panorama general de las vacunas de ADN y los mecanismos mediante los cuales la inmunizaci\u00f3n con ant\u00edgenos insertados en vectores de ADN (pl\u00e1smidos inducen una respuesta inmunitaria.The effectiveness of vaccines and immunization in the prevention of infectious diseases is one of the greatest successes in medicine. In recent years, with access to cutting edge genomic and proteomic technology, it is possible to accelerate the development of new and improved vaccines with better immunogenicity and safety characteristics. Since the first report almost two decades ago, where it was demonstrated that gene expression is possible by directed injection of naked DNA, proven induce protective immune virus in diverse disease models. This review aims to present an overview about DNA vaccines and the mechanisms by which to approximately Zn(II)-loaded The order of substrate, L,L-SDAP, by the absence of the amine group on the amino acid side chain. These data imply that the carboxylate the succinyl moiety and the form site of DapE. of DapE for one versus two vs K(d2) = 300 plot was constructed from k(cat) values measured between 16 and 35 degrees and was linear over this temperature range. The activation energy for [ZnZn(DapE)] was found 31 kJ/mol with the remaining thermodynamic parameters calculated that the first Co(II) binding site is five-coordinate, while the second site is octahedral. In addition, any spin-spin interaction between the binding drugs and for refining the influenza surveillance case definition in practice. This study describes the implementation of laboratory-supported influenza an influenza-like illness proven to have sentinel general practices contributed clinical to of influenza. Two laboratories at major teaching hospitals in Melbourne provided additional data on influenza virus identification. General practice sentinel surveillance and laboratory identification of influenza provided similar data on the pattern of influenza in the community between May and September. The clinical suspicion of influenza was confirmed in 49 to 54 per cent of cases seen in general practice. [Crystal structures of active acid to the cytoplasmic precursor of the bacterial cell wall peptidoglycan. The crystal structures of Haemophilus influenzae MurC complex with its substrate UDP-N-acetylmuramic acid (UNAM) and Mg(2+) and of a fully assembled MurC complex with its product UDP-N-acetylmuramoyl-L-alanine (UMA), the nonhydrolyzable analogue AMPPNP, binding sites for UNAM and ATP formed at the domain interfaces: the N-terminal domain binds the UDP portion of UNAM, and the central and C-terminal domains form the ATP-binding site, while active enzyme structure is thus assembled at the common domain interfaces when all three substrates are bound. The MurC active site clearly shows that the gamma-phosphate of AMPPNP is positioned between two bound metal ions, one of which also binds the reactive UNAM carboxylate, and that oriented by interactions with positively charged substrate by MurC and the subsequent ligases the bacterial cell wall biosynthesis pathway in [Evaluaci\u00f3n del impacto de la vacuna contra rotavirus en Colombia usando m\u00e9todos r\u00e1pidos de evaluaci\u00f3n](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892013001000002&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Karol Cotes 2013-10-01 Full Text Available OBJETIVO: Estimar la efectividad de la vacuna monovalente antirrotav\u00edrica para prevenir la hospitalizaci\u00f3n por enfermedad diarreica aguda en ni\u00f1os menores de 2 a\u00f1os en cinco ciudades de Colombia. M\u00c9TODOS: Se realiz\u00f3 una encuesta poblacional sobre una muestra probabil\u00edstica de ni\u00f1os mayores de 2 meses y menores de 24 meses de edad en cinco ciudades de Colombia (Barranquilla, Bogot\u00e1, Cali, Cartagena y Riohacha en el per\u00edodo de agosto a octubre de 2010. La vacuna fue introducida en el Programa Ampliado de Inmunizaciones en enero de 2009. Se estimaron las coberturas de vacunaci\u00f3n contra rotavirus por grupos de edad y la incidencia acumulada de hospitalizaci\u00f3n por diarrea severa, y se evalu\u00f3 la magnitud de la asociaci\u00f3n entre la vacunaci\u00f3n con una o dos dosis de vacuna antirrotav\u00edrica y la hospitalizaci\u00f3n por diarrea, utilizando la raz\u00f3n de probabilidades (RP ajustada por edad y otros factores de importancia epidemiol\u00f3gica. La efectividad de la vacunaci\u00f3n se estim\u00f3 usando la expresi\u00f3n 1 - RP. RESULTADOS: La cobertura de vacunaci\u00f3n con una dosis de vacuna fue de 87,3%. En los 12 meses previos a la encuesta 43,2% (1 453 ni\u00f1os de menores de 24 meses presentaron diarrea, y de ellos, 5,2% (174 ni\u00f1os fueron hospitalizados por esta causa. La efectividad de dos dosis de vacuna antirrotav\u00edrica para prevenir la hospitalizaci\u00f3n por diarrea severa fue de 68% (intervalo de confianza de 95%: 55%-77%. CONCLUSIONES: La vacunaci\u00f3n contra rotavirus en Colombia protege contra la hospitalizaci\u00f3n por diarrea por cualquier causa. El uso de encuestas transversales se mostr\u00f3 adecuado para evaluar r\u00e1pidamente la efectividad de un programa de vacunaci\u00f3n con una nueva vacuna. [La evidencia acerca de la controversia de las vacunas que contienen timerosal y su asociaci\u00f3n con el autismo](https://www.openaire.eu/search/publication?articleId=doajarticles::9f083d9cb2b9e06dbceeb1cf2c0fabe3) Lisset Garc\u00eda-Fern\u00e1ndez; Adri\u00e1n Hern\u00e1ndez; V\u00edctor Su\u00e1rez Moreno; Fabi\u00e1n Fiestas 2013-01-01 La vacunaci\u00f3n es una de las medidas de mayor impacto en la salud p\u00fablica para la reducci\u00f3n de la morbimortalidad infantil. El timerosal es un compuesto org\u00e1nico del mercurio utilizado como preservante de los frascos multidosis. Eventualmente, en el Per\u00fa, surgen olas de controversia acerca de la seguridad de estas vacunas, asoci\u00e1ndolas especialmente con el autismo. Como resultado de estas controversias, se han propuesto, incluso, leyes que proh\u00edben este tipo de vacunas, lo que tendr\u00eda un impor... [Chalcones as novel influenza of highly pathogenic A virus strains, as the new H1N1 swine influenza (novel influenza), represents a serious threat to global human health. During our course of an anti-influenza screening program on natural products, one new licochalcone G and seven known (2-8) ... [IgA and neutralizing antibodies to influenza milk: a serum antibodies and reduces the rates of influenza illness in mothers and their infants. We report the effect of antenatal immunization on the levels of trimester. at birth, 6 weeks, 6 months, and 12 months, and serum at 10 weeks and 12 months. Milk and serum specimens from 57 subjects were (ELISA) and total IgA using ELISA. Influenza-specific IgA breast vaccinees, versus 2.3 to 13.7 ELISA units/mL in controls. Virus neutralization titers in milk were 1.2 to 3 fold greater in vaccinees, and correlated with influenza-specific IgA levels (r = 0.86). Greater exclusivity of breastfeeding in the 6 infants influenza-vaccinated mothers (p = 0.0042) but not in infants of pneumococcal-vaccinated mothers (p The of produced respiratory may local for for at least 6 months. that shows Available virus interacts with other pathogens colonising the Taking into interactions with other pathogens may be critical to determining the real influenza burden and the full impact of public health policies targeting influenza. This is particularly true for mathematical modelling studies, which have become critical in public health decision-making. Yet models usually focus on influenza virus acquisition and alone, thereby making broad oversimplifications of Herein, we report evidence of influenza virus interactions with bacteria and viruses and systematically review the modelling very few mathematical models have integrated other pathogens alongside influenza. The notable exception is which several recent modelling biological hypotheses interactions on public health surveillance using simple transmission models. We demonstrate that the development of multipathogen models is essential to assessing the true public health burden of influenza and that it is needed to help improve planning and evaluation of control measures. modelling, and biological challenges and ELISA tipo inhibici\u00f3n para cuantificar polisac\u00e1rido Vi en la vacuna antitifo\u00eddica cubana vax-TyVi](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Esther Mar\u00eda Fajardo 2006-08-01 Full Text Available Se describe la validaci\u00f3n de un ELISA tipo inhibici\u00f3n, reportado por primera vez en la literatura cient\u00edfica para cuantificar un ant\u00edgeno vacunal: el polisac\u00e1rido Vi de Salmonella Typhi, para ser empleado en el control de la calidad de la vacuna antitifo\u00eddica cubana vax- TyVi\u00e2. El ensayo consta de seis pasos: 1 Recubrimiento de placa de reacci\u00f3n con poli-L-lisina y posteriormente polisac\u00e1rido Vi; 2 Bloqueo con leche descremada; 3 Inhibici\u00f3n o neutralizaci\u00f3n en tubos de suero anti-Vi de conejo, respectivamente, con polisac\u00e1rido Vi de Curva de Calibraci\u00f3n (concentraciones desde 1-32 g/mL, control positivo y muestras de vacuna (3 diluciones; 4 Neutralizaci\u00f3n de anticuerpos anti-Vi libres, presentes en las mezclas anteriores, por el Polisac\u00e1rido de Recubrimiento; 5 Reconocimiento de anticuerpos anti-Vi unidos a la placa (conjugado anti-IgG de conejo-fosfatasa alcalina y 6 Revelado por reacci\u00f3n enzima-sustrato. Los par\u00e1metros de validaci\u00f3n estudiados y sus resultados fueron: 1 Precisi\u00f3n, expresada como coeficiente de variaci\u00f3n a tres niveles de concentraci\u00f3n de polisac\u00e1rido, comprendidos en el rango de su especificaci\u00f3n (35, 50 y 70 g/mL y evaluada en t\u00e9rminos de repetibilidad; precisi\u00f3n intraensayos (cuatro analistas y L\u00edmite de detecci\u00f3n: 0,5 g/mL; 4 Exactitud (recuperaci\u00f3n para las tres diluciones de la muestra: entre 100 y 118%, y 5 Robustez: no influye 1,5 h de bloqueo (p = 0,52 ni \u00b1 5 min para leer placa (p = 0,56; influye grandemente la calidad del agua (p = 0,026, a favor del agua para inyecci\u00f3n. El ensayo es adecuado para los fines propuestos y es una medida de la inmunogenicidad in vitro del at Geneva University Hospitals between 2009 and 2014. Alterations in PBPs were investigated by gene sequencing. in CCCP-treated cells at concentrations ranging between 0.5 and 8 g/mL. The present study provides robust evidence indicating slowed influx enhanced efflux due to the loss of regulation led to the development of imipenem heteroresistance NTHi. was to pose conclude risk to algal growth was found during seasonal exposure risk. de la vacuna vax-TyVi\u00ae en ratas Sprague Dawley](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2005000100003&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Eligio Full Text Available La antitifo\u00eddica vax-TyVi\u00ae consiste en una preparaci\u00f3n de polisac\u00e1rido capsular Vi de Salmonella typhi, el cual es diluido en una soluci\u00f3n buffer isot\u00f3nica soluci\u00f3n amortiguador, a la que se le a\u00f1ade fenol como preservo. Cada dosis de 0,5 mL contiene 25 g de polisac\u00e1rido como sustancia activa. En nuestro pa\u00eds el esquema de vacunaci\u00f3n contra la fiebre tifoidea con vax- TyVi\u00ae se aplica a los alumnos de 9-10 a\u00f1os (5to grado, una 2da dosis a la edad de 12-13 a\u00f1os (8vo grado y una 3ra dosis a la edad de 16-17 a\u00f1os (11no grado. Adem\u00e1s, es vacunado el personal de riesgo de Salud P\u00fablica y el personal que manipula alimentos. En el presente trabajo se describe el ensayo de tolerancia local llevado a cabo con la vacuna vax-TyVi\u00ae durante su fase de estudios precl\u00ednicos, actualmente utilizada en la vacunaci\u00f3n contra la fiebre tifoidea en Cuba. Se emple\u00f3 un total de 170 ratas que fueron tratadas con la vacuna, su placebo (todos los componentes, excepto la materia prima activa, o que no recibieron tratamiento alguno (controles. Se realizaron observaciones cl\u00ednicas diarias durante todo el ensayo, se determin\u00f3 el consumo de agua y alimentos y se realizaron investigaciones anatomopatol\u00f3gicas a animales sacrificados 3, 7, 14, 21, 28, 35 y 42 d\u00edas despu\u00e9s de la inoculaci\u00f3n. No se observaron muertes ni s\u00edntomas de toxicidad; no se encontraron diferencias estad\u00edsticamente significativas entre los pesos vivos, el consumo de agua ni el de alimentos entre los grupos del ensayo. Tampoco se observaron lesiones anatomopatol\u00f3gicas que indicaran toxicidad por parte del producto inoculado. Los resultados permitieron concluir que la potencialidad de la vacuna vax-TyVi\u00ae para producir efectos adversos locales es baja. [Immunogenicity and safety of a fully liquid aluminum phosphate adjuvanted influenzae vaccine has been widely used since conjugated to diphtheria PRP-T vaccine administered subcutaneously to healthy Japanese children in a phase III study. Additionally, we evaluated the the PRP-T group. The intergroup LA VACUNA](https://revistas.unal.edu.co/index.php/actabiol/article/view/11338) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) V\u00cdCTOR ANDR\u00c9S VANEGAS 2008-09-01 Full Text Available La prote\u00edna L1 del Virus del Papiloma Humano (VPH constituye el 80% de la c\u00e1pside viral. Las vacunas profil\u00e1cticas contra el VPH son sintetizadas a partir de la prote\u00edna L1 ensamblada en Part\u00edculas similares al Virus (del ingl\u00e9s VLP, las cuales son altamente inmunog\u00e9nicas generando anticuerpos espec\u00edficos de tipo y en algunos casos pueden presentar reacci\u00f3n cruzada entre tipos de VPH filogen\u00e9ticamente pr\u00f3ximos. La estructura de la prote\u00edna L1 del VPH es importante porque confiere estabilidad a la c\u00e1pside mediante el establecimiento de interacciones intra e intercapsom\u00e9ricas lo que asegura la integridad viral y antig\u00e9nicamente porque contiene los ep\u00edtopes que inducen la respuesta inmune protectora. En estudios en los que se evalu\u00f3 la antigenicidad de la prote\u00edna L1 se determin\u00f3 que los ep\u00edtopes inmunodominantes de la c\u00e1pside viral se encuentran en los bucles B-C, D-E, F-G, H-I y en el extremo C-terminal. Estos bucles son poco conservados entre los diferentes genotipos y se encuentran en segmentos de la prote\u00edna expuestos en la superficie de la c\u00e1pside. Los amino\u00e1cidos situados en los bucles B-C, F-G y H-I son primordiales para el reconocimiento por los anticuerpos neutralizantes. Los diferentes subtipos y variantes presentan cambios en estos amino\u00e1cidos o en residuos que conforman otros ep\u00edtopes. En esta revisi\u00f3n se presentar\u00e1 un estado del arte de la prote\u00edna L1 del VPH genotipo 16, la estructura y su importancia en el desarrollo de vacunas contra la infecci\u00f3n producida por este virus. [Structure-based drug discovery for combating influenza virus health concerns throughout the world. The development of compounds with novel mechanisms of action is urgently required due to the emergence viruses Nagasaki a half inhibitory of 0.47 M. Because our rapid and efficient, it may help effective drug discovery against the influenza virus and other emerging viruses. [Vacuna atenuada de Salmonella como vector de ant\u00edgenos heter\u00f3logos](http://www.revistabiomedica.org/index.php/biomedica/article/view/1056) of Open Access serotipo Typhi, es el agente etiol\u00f3gico de la fiebre tifoidea de los habitantes de las regiones m\u00e1s pobres del mundo y es, adem\u00e1s. el centro de atenci\u00f3n de muchos investigadores dados sus fascinantes mecanismos de invasi\u00f3n, multiplicaci\u00f3n intracelular y diseminaci\u00f3n intercelular que expresa in vivo e in vitro. Aunque estos mecanismos se asocian directamente con la patogenicidad y la severidad de la enfermedad, las mutaciones definidas en el cromosoma de Salmonella han permitido que estos mecanismos de virulencia se puedan utilizar en beneficio del hospedero. Las mutantes atenuadas de Salmonella son capaces de invadir las c\u00e9lulas M de la mucosa intestinal y de migrar a las c\u00e9lulas linfoides del sistema reticuloendotelial donde, en lugar de causar enfermedad, activan eficazmente las respuestas inmunes humoral y celular no s\u00f3lo contra el microorganismo mismo sino tambi\u00e9n contra aquellos antigenos heter\u00f3logos recombinantes que la bacteria pueda expresar y transportar. En la presente revisi\u00f3n, se discutir\u00e1n los avances m\u00e1s recientes en el campo de las vacunas vivas atenuadas de Salmonella, su evaluaci\u00f3n preclinica y clinica y, tambi\u00e9n, su aplicaci\u00f3n como vector de antigenos. Se dar\u00e1n a conocer las t\u00e9cnicas biomoleculares de clonaci\u00f3n y expresi\u00f3n procari\u00f3tica de las toxinas dift\u00e9rica, tet\u00e1nica y de pertusis. as\u00ed como de los ant\u00edgenos de Helicobacterpylori y de Plasmodium falciparum. Finalmente, se propone el uso de Salmonella atenuada como vector de vacunas de ADN para expresi\u00f3n eucari\u00f3tica de los ant\u00edgenos recombinantes. Los continuos esfuerzos cientificos y tecnol\u00f3gicos en el campo de la vacunaci\u00f3n con vectores vivos atenuados sugieren que Salmonella es una herramienta potencialmente \u00fatil para enfrentar el constante reto de la fiebre tifoidea. Igualmente, los estudios precl\u00ednicos y cl\u00ednicos de fase I demuestran la eficacia de la vacuna de Salmonella viva atenuada como vector de ant\u00edgenos applications proteins carbohydrates that nonetheless have an extensive array of epitopes. The study of human monoclonal antibodies to different pathogens shows that there are mechanisms used to generate a lambda light-chain family II In for the immune to a their high affinity and neutralizing abilities), 26% of light chains and 13% of heavy chains showed a very low level of somatic mutation, equivalent to IgM Although of the monoclonal antibodies specific for viruses or bacteria have a level of somatic hypermutation similar to that of the adult IgM repertoire. A number of studies have shown that there are similarities in antibody responses to and to protease variants (A1, A2, B1, and B2) that play varies from initial and immediately Upon acquisition, 89 (88%) expressed IgA protease. A total of 16 of 101 open reading frame of igaB2 We conclude that changes in iga gene sequences \u00a9 2018 Available Receptor 2 (FPR2 is a novel promising target for the treatment of influenza. During viral infection, FPR2 is activated by annexinA1, which is in envelope of influenza viruses; activation virus. We found that, upon infection and cell treatment with independent on strain and trafficking of influenza viruses and provides, for the first time, the proof of that use of anti-FPR2 antibodies against influenza hold great promise for the future. of interleukin nontypeable Haemophilus 2 of Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) of beta-defensin (DEFB4 according to new nomenclature of the Human Genome Organization in human middle ear epithelial cells via a Raf-MEK1/2-ERK signaling pathway. Based observations, we human middle ear epithelial cells could release IL-1 alpha upon exposure to a lysate of NTHi and if this cytokine could have a synergistic effect on beta-defensin otitis media (OM. to Real time quantitative PCR was done to compare the induction of IL-1 alpha or beta-defensin 2 to induction. Middle We IL-1 ear epithelial cells upon exposure to NTHi components and that it can synergistically act with certain of these molecules to los programas de vacunaci\u00f3n mediante estudios serol\u00f3gicos y vacunas distribuidas Full Text Available Antecedentes: El objetivo del estudio fue comparar las coberturas vacunales en escolares para la vacuna triple v\u00edrica (sarampi\u00f3n-rub\u00e9ola-parotiditis, DTP (difteria-t\u00e9tanos-tos ferina y poliomielitis, obtenidas a partir de las vacunas distribuidas a los centros de vacunaci\u00f3n, las vacunaciones declaradas y el an\u00e1lisis serol\u00f3gico de anticuerpos. M\u00e9todos: La cobertura vacunal se obtuvo a partir de los antecedentes de vacunaci\u00f3n recogidos en un cuestionario y mediante el an\u00e1lisis serol\u00f3gico de anticuerpos frente al sarampi\u00f3n para la vacuna triple v\u00edrica, y el t\u00e9tanos para la vacuna DTP en una muestra representativa de escolares en 2001. La cobertura vacunal por registros se obtuvo dividiendo el n\u00famero de individuos que pod\u00edan haber completado la vacunaci\u00f3n por la poblaci\u00f3n objetivo. Se evalu\u00f3 la concordancia entre los antecedentes de vacunaci\u00f3n y los resultados serol\u00f3gicos mediante el \u00edndice kappa. Resultados: En los escolares de 6-8 y 9-11 a\u00f1os de edad se obtuvo una cobertura vacunal por cuestionario del 85,5 y el 87,6% para la vacuna DTP, del 89,9 y el 89,6% para la vacuna triple v\u00edrica, y del 90,4 y el 89,4% para la vacuna poliomiel\u00edtica, respectivamente, mientras la cobertura vacunal por an\u00e1lisis serol\u00f3gico fue del 100 y el 99,6% para la vacuna DTP, y del 85,5 y el 93,3% para la vacuna triple v\u00edrica, respectivamente. La cobertura vacunal por registros fue significativamente mayor que la obtenida mediante estos 2 m\u00e9todos: un 93,5 y un 100% para la vacuna DTP, un 96,3 y un 98,8% para la vacuna triple v\u00edrica, y un 100% para la vacuna poliomiel\u00edtica. La concordancia obtenida entre los antecedentes de vacunaci\u00f3n y los resultados serol\u00f3gicos fue muy baja ( Background: The objective of this study was vaccines distributed to vaccination [Desarrollo de vacunas contra el virus de la inmunodeficiencia humana tipo 1: Relevancia de la inmunidad celular contra subtipos](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000600014&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Ana Mar\u00eda Rodr\u00edguez 2010-12-01 Full Text Available Han pasado casi 30 a\u00f1os de la detecci\u00f3n de los primeros casos de infecci\u00f3n con HIV-1 y a\u00fan no se ha conseguido desarrollar una vacuna efectiva y segura. A pesar del impacto positivo sobre la pandemia que se ha conseguido gracias a los avances en la terapia antirretroviral (TARV, el HIV/sida sigue constituyendo un grave problema para la salud p\u00fablica, especialmente en los pa\u00edses en desarrollo, donde es dif\u00edcil el acceso al tratamiento. En el mundo, 33 millones de personas viven con el virus del sida, mientras que en la Argentina se calcula que habr\u00eda unos 120 000 infectados. Uno de los desaf\u00edos para lograr una vacuna contra el HIV es la variabilidad viral. El grupo M, responsable de la pandemia, se encuentra dividido en 10 subtipos y varios sub-subtipos, adem\u00e1s de las 48 formas recombinantes circulantes y m\u00e1s de cien formas recombinantes \u00fanicas. La epidemia de HIV en nuestro pa\u00eds es tan compleja como en el resto del mundo, con la co-circulaci\u00f3n principalmente de virus pertenecientes al subtipo B y recombinantes BF (CRF12_BF y derivadas. A pesar de la cantidad de trabajos dedicados a la caracterizaci\u00f3n de la respuesta inmune y al desarrollo de vacunas, no queda claro cu\u00e1l es el impacto de la variabilidad en la elecci\u00f3n del ant\u00edgeno. Trabajos realizados en nuestro laboratorio demuestran el papel que juega la inmunidad celular con respecto a las variantes recombinantes BF, tanto en humanos como en modelos animales. Estos resultados son de importancia en el desarrollo de futuras vacunas para nuestra regi\u00f3n. [Evaluaci\u00f3n de la toxicidad por dosis \u00fanica de la vacuna antitet\u00e1nica vax-TET en ratas Sprague Dawley](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2007000300004&lng=es&nrm=iso&tlng=es) [Directory of Yulie\u00e9 L\u00f3pez. 2007-12-01 Full Text Available La vacuna vax-TET\u00ae est\u00e1 indicada en la prevenci\u00f3n del t\u00e9tanos y es efectiva si se logra un completo y apropiado esquema de inmunizaci\u00f3n. Para investigar el potencial t\u00f3xico de este producto se realiz\u00f3 una prueba toxicol\u00f3gica con una dosis \u00fanica, por v\u00eda intramuscular, en un volumen de 0,2 mL en ratas Sprague Dawley. La composici\u00f3n de la vacuna de ensayo probada fue la misma de la vacuna comercial. Los animales fueron observados diariamente en busca de s\u00edntomas locales y sist\u00e9micos de toxicidad. Se realizaron mediciones del consumo de agua y alimento, as\u00ed como del peso corporal. Dos semanas despu\u00e9s de la inoculaci\u00f3n las ratas fueron sacrificadas por m\u00e9todos de eutanasia sin dolor y sometidas a necropsia. No se observaron muertes ni s\u00edntomas de toxicidad en los animales estudiados. Tampoco se encontraron diferencias de inter\u00e9s toxicol\u00f3gico entre los grupos experimentales en cuanto a las variables medidas. El estudio anatomopatol\u00f3gico revel\u00f3 la presencia de formaciones granulomatosas de tipo macrof\u00e1gico asociadas, fundamentalmente, al hidr\u00f3xido de aluminio. Estos resultados permitieron concluir que, bajo las condiciones del estudio y seg\u00fan los criterios establecidos, esta vacuna no produce efectos adversos en el modelo animal usado, por lo que se considera potencialmente no t\u00f3xica para humanos. [Pneumonia Prevention during Susan T 2015-08-01 cause of death among five leading causes of bacterial pneumonia. Vaccines of these available to prevent pneumonia. Problem This study describes an economic from a publicly funded health care system perspective performed on a birth cohort in Somalia, a country that has experienced a protracted humanitarian emergency. An impact and cost-effectiveness Hib vaccine only, pneumococcal conjugate vaccine 10 (PCV10) only, and both together supplemental immunization activities (SIAs). The main no vaccine, the DALYs averted by two SIAs for two doses of Hib vaccine was US $202.93 (lower and upper limits: $121.80-$623.52), two doses of PCV10 was US $161.51 ($107.24-$227.21), and two doses of both vaccines was US ($101.20-$214.42). Variables that influenced defines a cost-effective intervention as costing one to three times the per capita gross domestic product (GDP; in 2011, for Somalia=US $112). Based on presented model, Hib or Hib PCV10 given together are cost-effective Experts decision-making factors for vaccine to have all been met: the disease burden is large, the vaccine-related risk is low, prevention in this setting is more feasible than treatment, Omer, Saad B 2012-05-21 According to the World Health Organization in 2008, pneumonia accounted for 20% of deaths and diarrheal diseases accounted for 13% of deaths among Vaccines programs and cost. Pediatricians who are members of the Indian Academy of Pediatrics (IAP) are important stakeholders for vaccine delivery and maintaining public confidence in vaccines. A random sample of 785 pediatricians belonging to IAP was selected for the survey conducted from June 2009 to June 2010. Descriptive analyses using sampling weights more likely to report Hib vaccine (OR 2.42, who had high perceived Hib vaccine efficacy 4.74 times more likely to administer Hib vaccine routinely of disease susceptibility and severity or of vaccine safety and efficacy were not associated with routine administration of PCV or rotavirus vaccine. Understanding predictors of routine use of a new vaccine could help focus interventions to improve the routine use of other vaccines. Hib, and rotavirus perceived efficacy and safety of the vaccines by pediatricians presents an opportunity to [Xanthones disaster- or drug-resistant viruses by additional reassortments in novel influenza A virus. In the course of an anti-influenza screening program for natural products, 10 xanthone derivatives (1-10) were ... [Desarrollo de un m\u00e9todo de CLAR-IR para la determinaci\u00f3n de etanol residual en vacuna Development of a HPLC-IR method for determination of residual ethanol in (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Matilde Cuevas Valdespino 2009-08-01 Full Text Available Los ingredientes farmac\u00e9uticos activos de la vacuna antimeningoc\u00f3cica cubana VA-MENGOC-BC TM (ves\u00edculas de membrana externa serogrupo C son conservados en etanol, de ah\u00ed que dicha vacuna posea un contenido de etanol residual, cuya concentraci\u00f3n real no se conoc\u00eda hasta el momento. Las regulaciones internacionales plantean que los productos biofarmac\u00e9uticos y sus ingredientes farmac\u00e9uticos activos deben tener bien caracterizadas todas sus impurezas, por lo que el objetivo de este trabajo fue el desarrollo de un m\u00e9todo de determinaci\u00f3n de etanol mediante cromatograf\u00eda l\u00edquida de alta resoluci\u00f3n-\u00edndice de refracci\u00f3n para estos fines y su comparaci\u00f3n con un m\u00e9todo utilizado frecuentemente para cuantificar este solvente, como es la cromatograf\u00eda gaseosa. El m\u00e9todo evaluado result\u00f3 ser \u00fatil y con una buena robustez para la determinaci\u00f3n de este solvente org\u00e1nico en esta vacuna antimenigoc\u00f3cica. No se detectaron diferencias estad\u00edsticamente significativas entre los resultados obtenidos al evaluar las mismas muestras de vacuna mediante ambos m\u00e9todos cromatogr\u00e1ficos (cromatograf\u00eda l\u00edquida de alta resoluci\u00f3n y cromatograf\u00eda gaseosa, lo que indica la posibilidad del uso de la cromatograf\u00eda l\u00edquida de alta resoluci\u00f3n en sustituci\u00f3n de la cromatograf\u00eda gaseosa para esta determinaci\u00f3n.Active pharmaceutical ingredients of has residual ethanol content, of which real concentration is not known just now. International regulations propose that the biopharmaceutical products and its active pharmaceutical ingredients must to have well defined all impurities, thus [Investigation an increasing number of within the At Pasteurellaceae genomes are publicly available through internet databases, and another 40 genomes are being sequenced. This investigation will describe...... the core genome for both the family Pasteurellaceae and for the against other, a set core gene families was determined as described... [Anti-phase synchronization influenza A/H1N1 and A/H3N2 and countries in the North Temperate synchronization in influenza A subtypes in Hong Kong and the NTZ. These findings should inform public health preparedness for Full Text Available Abstract Background its direct connection to the nasopharynx which harbors otitis media pathogens as part of its normal flora, the middle ear cavity is kept free of these bacteria by as yet unknown mechanisms. Respiratory mucosal epithelia, these innate immune molecules in the defense and maintenance of sterility of respiratory mucosa such as that of the middle ear, we for testing the antimicrobial activity of the molecules. This was done in order to minimize the possibility that the observed effects were immune molecules on OM For the data, Student's t-test performed. was active against all four OM pathogens tested, while treatment with defensin-1 appeared seems to have a more pronounced impact the growth of the Gram-positive S. pneumoniae as compared to that of Gram-negative pathogens. Lactoferrin on the other hand, enhanced the growth of the bacteria tested. The results of the in Spain](http://asclepio.revistas.csic.es/index.php/asclepio/article/view/266/263) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Porras Gallo, Mar\u00eda Isabel 2008-12-01 Full Text Available Against the background of the renewed interest aroused in recent years by the influenza pandemic of 1918-1919, and the leading role now played by research analysing the process of innovation medicine, role played by serums and vaccines \u2014the new resources of the medical science of the time\u2014 in the fight against the influenza outbreak of 1918-1919. The paper highlights the dependence on combined scientific, social, economic and professional factors, and also shows the main consequences arising from the fine-tuning and implementation of these therapeutic and prophylactic resources. En el marco de la renovada actualidad alcanzada por la pandemia de gripe de 1918-1919 en los \u00faltimos a\u00f1os y del protagonismo logrado por los estudios que analizan el proceso de innovaci\u00f3n en Medicina, el presente trabajo analiza el papel representado por sueros y vacunas \u2014los nuevos recursos de la ciencia m\u00e9dica del momento\u2014 en la lucha contra la gripe de 1918-1919. El estudio pone de relieve su dependencia de los factores cient\u00edficos, sociales, econ\u00f3micos y profesionales que concurrieron, y muestra tambi\u00e9n las principales consecuencias derivadas de la puesta a punto y uso de los citados recursos terap\u00e9uticos y profil\u00e1cticos. [Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the the impact of the development of a new intervention on the public health and health care costs so that they can plan for economic and financial objectives. The aim of this study was to determine the budget impact of adding Haemophilus influenzae type b (Hib) as a part of a Pentavalent vaccine (Hib-HBV-DTP) to the national childhood immunization schedule of Iran. An excel-based model was developed to determine the costs of including the Pentavalent vaccine in the national immunization program (NIP), comparing the present schedule with the previous one (including separate DTP and hepatitis B vaccines). The total annual costs included the cost of vaccination (the vaccine and syringe) and the cost of Hib treatment. The health outcome was the estimated annual cases of the diseases. The net budget impact was the difference in the total annual cost between the two schedules. Uncertainty about the vaccine effectiveness, vaccination coverage, cost of the vaccine, and cost of the diseases were handled through scenario analysis. The total cost of vaccination during 5 years was $18,060,463 in the previous program and $67,774,786 in the present program. Inclusion of the Pentavalent vaccine would increase the $49 $6 in the healthcare costs due reduction of disease cases and treatment costs. The introduction of the Pentavalent vaccine resulted The results of this study showed that the inclusion of the Pentavalent vaccine in the NIP of Iran had a significant impact on the health care budget and increased on the government. Budget of including Pentavalent vaccine in the national schedule of Iran. [Memory B cells and CD8 lymphocytes do not control seasonal influenza A virus replication after homologous re-challenge of rhesus macaques.](http://europepmc.org/articles/PMC3126839?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Timothy D Carroll Full Text Available This study sought to define the role of memory lymphocytes in the protection from homologous monoclonal antibodies (mAb were administered to the animals prior to their second experimental inoculation with a human seasonal influenza A virus strain. Treatment with either mAbs prior non-human primates with pre-existing anti-influenza A antibodies, memory B cells and CD8 T cells do not contribute to the control of virus replication after re-challenge with a homologous strain of Number Differentiates Influenza A (H1N1pdm09 from Seasonal Influenza in Fatal Cases](http://dx.doi.org/10.1155/2014/921054) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Heidi G. Rodriguez-Ramirez 2014-01-01 Full Text Available In 2009, a new influenza A (H1N1 virus affected many persons around the world. There is an urgent need for finding biomarkers to distinguish between influenza A and seasonal influenza virus. We investigated these possible biomarkers in the lung of fatal cases of confirmed (H1N1pdm09. tissue from both influenza A (H1N1pdm09 and seasonal influenza virus. High levels of IL-17, IFN-, and TNF- positive cells were identical in lung tissue from the influenza A (H1N1pdm09 and seasonal cases when compared with healthy cells, and and CD14+ cells were also found in high levels in both influenza A (H1N1pdm09 and seasonal influenza virus alternatively activated marker lung found in influenza A (H1N1pdm09 when compared with seasonal influenza virus (P<0.05, and the ratio of CD206/CD14+ cells was 2.5-fold higher in seasonal and cells differentiate between influenza A (H1N1pdm09 and seasonal influenza virus in lung tissue of fatal nontypeable Haemophilus influenzae otorrhea were stratified using the chinchilla model of Each clinical assessments carried out daily for 8 days by blinded observers. There was no statistical difference in the time it took for any of the 10 NTHi strains to induce otologic (local disease with respect to any or all of the other strains, however the differences in time to maximal local disease and the severity of local disease of indicated that the strains were of the disease, GG, PittII, and Pitt FF produced the most rapid and most severe local and systemic disease. A post hoc determination of the clinical origins of the 10 NTHi strains revealed that these three strains were of otorrheic whereas the other 7 were from patients of Medicine, Abdulaziz (Saudi Arabia); Department of Biochemistry, Microbiology and Immunology, University Ottawa, ON (Canada); Van Domselaar, Gary [National Microbiology Laboratory, Public Health Agency Canada, Winnipeg, MB (Canada); Li, Changgui; Wang, Junzhi [National Institute for the Control Pharmaceutical and Biological Products, Beijing (China); She, Yi-Min; AIDS, Dana-Farber Institute, Department of Medicine, Harvard Medical School, 44 Binney Street, Boston, MA 02115 (United States); He, Runtao [National Microbiology Laboratory, Public Health of and AIDS, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, 44 Binney Street, Boston, MA 02115 (United and Immunology, of Ottawa, ON (Canada) 2010-12-10 Research highlights: The fusion peptide is HA subtypes. {yields} The universal antibodies different influenza universal antibodies inhibit the fusion process between the viruses and the target cells. -- Abstract: The fusion peptide of influenza viral hemagglutinin plays a critical role in virus entry by facilitating membrane fusion between the virus and target cells. As the fusion peptide is the only universally conserved epitope in all influenza A and B viruses, it could be an attractive target N-terminus of the fusion peptide could to virtually fusion of viral this viral exposed attacked by is universal antibodies that influenza HA subtypes. The universal antibodies cross-neutralize different influenza A subtypes. The universal antibodies inhibit the fusion process between the viruses and the target cells. -- Abstract: The fusion peptide of influenza viral hemagglutinin plays a critical role in virus entry by facilitating membrane fusion between the virus and target cells. As the fusion peptide is the only universally conserved epitope in all influenza A and B viruses, it could be an attractive target N-terminus of the fusion peptide could to virtually fusion of viral this viral exposed attacked by influenza viruses. [INTRODUCCI\u00d3N DE NUEVAS VACUNAS: PROCESOS POL\u00cdTICOS, ADMINISTRATIVOS Y FINANCIEROS EN LA TOMA DE DECISIONES DEL PAI-BRASIL](http://revistamedicina.net/ojsanm/index.php/Revistamedicina/article/view/92) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Carla Magda A.S. Domingues 2012-07-01 Full Text Available Se presentan los antecedentes del PAI en el Brasil remont\u00e1ndose al a\u00f1o de 1804 en que se inicia el programa de vacunaci\u00f3n en Brasil aplicando la vacuna contra la viruela hasta llegar a 1973 cuando se crea el Programa Nacional de Inmunizaciones en Brasil, y a partir de ah\u00ed se mantiene un esquema b\u00e1sico de vacunaci\u00f3n hasta llegar al 2012 cuando se introducen las vacunas VIP y pentavalentes. Muestra las alteraciones sufridas en el Calendario de Vacunaci\u00f3n del 2012, para llegar a la reformulaci\u00f3n de un Nuevo Calendario de Vacunaci\u00f3n a partir del 2012. Se\u00f1ala las estrategias nacionales de vacunaci\u00f3n enmarcadas en acciones de rutina, campa\u00f1as y control de brotes. Hace referencia a los criterios de inclusi\u00f3n de nuevas vacunas referidos a aspectos: epidemiol\u00f3gicos, inmunol\u00f3gicos, tecnol\u00f3gicos, log\u00edstica, socio-econ\u00f3micos, aprobaci\u00f3n por los Comit\u00e9s y presupuesto. Registra las novedades ocurridas en el Sistema de Informaciones del Programa Nacional de Inmunizaciones, relacionadas con la situaci\u00f3n actual, propuesta y Resoluci\u00f3n Ministerial. Por \u00faltimo se\u00f1ala los desaf\u00edos que debe enfrentar el Sistema enmarcados principalmente en la capacidad para mantener altas coberturas de vacunaci\u00f3n. [Evolution of the paralogous hap and but no evidence of intrastrain recombination between the two genes. A conserved hap pseudogene was present in all pseudogenes from the ancestral sequence by zero to two positions within a 1.5 kb stretch suggests that the silencing event happened approximately 2000-11,000 Effect and Possible Mechanism of Patchouli Alcohol [Directory of Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Xue Wang Full Text Available In the study, the anti-influenza A (H2N2 virus activity of patchouli alcohol was studied in vitro, in vivo and in silico. The CC50 of patchouli alcohol was above 20 \u00b5M. Patchouli alcohol could inhibit influenza virus with IC50 of \u00b1 after penetration of the virus into the cell. In the influenza mouse model, patchouli alcohol showed obvious protection against the viral infection at a dose 5 mg/kg/day. Flexible docking and molecular dynamic simulations indicated that patchouli alcohol was bound to the neuraminidase protein of influenza virus, with an interaction a potency and therapeutic potential of [Directory of Access Journals improve efficacy by a novel chimeric flu vaccine expressing the small immunodominant cell epitope A42. people with pre-existing memory Th cells specific to influenza this dual vaccine will simultaneously boost anti-influenza beneficial treatment of AD patients as well as for prevention of development individuals osteocondritis costal t\u00edfica tratado con vacunas y antivirus](https://www.openaire.eu/search/publication?articleId=od______1326::8fd162326a4cf806bef07884700a3945) Lleras Acosta, F.; Rueda H., Alfonso 2011-01-01 Por considerala de importancia pr\u00e1ctica, presentamos la historiacl\u00ednica de una enferma afectada de osteocondritis costal de origen Eberthiano, tratada con \u00e9xito completo por las autovacunas y antivirus, Debemos esta interesante observaci\u00f3n al Dr. Juan N. Carpas y al interno de su servicio de mujeres, Sr. Azuero, quienes galantemente nos suministraron los datos cl\u00ednicos y las observaciones relativas a los efectos producidos por las vacunas. [Trends in global warming and evolution of matrix protein 2 family from influenza A virus.](https://www.ncbi.nlm.nih.gov/pubmed/20640805) Yan, Shao-Min; Wu, Guang 2009-12-01 The global warming is an important factor affecting the biological evolution, and the influenza that threatens humans with possible attempted to analyze the trends in global warming and evolution of matrix protein 2 family from influenza A virus, because this protein is a target of anti-flu drug, to anti-flu drugs. The evolution of matrix protein 2 of influenza A virus from 1959 to 2008 was defined using the unpredictable portion of amino-acid pair predictability. Then the trend in this evolution was compared with the trend in the global temperature, the temperature in north and south hemispheres, and the temperature in influenza A virus sampling site, and species carrying influenza A virus. The results showed the similar trends in global warming and in evolution of M2 proteins although we could not correlate them at this stage of study. The study suggested the potential impact of global warming on the evolution of proteins from influenza A virus. [VIGILANCIA DE LA GRIPE PAND\u00c9MICA EN LA COMUNIDAD VALENCIANA Y VACUNA ANTIGRIPAL ESTACIONAL](http://www.redalyc.org/articulo.oa?id=17015304012) [Directory Open Access 2010-01-01 Full Text Available Fundamento: En la Comunidad Valenciana se ha llevado a cabo la vigilancia de la Gripe pand\u00e9mica. Algunos estudios sobre efectividad de la vacuna estacional para Gripe AnH1N1 han presentado resultados no consistentes. El objetivo del trabajo es describir los resultados de la vigilancia epidemiol\u00f3gica y la efectividad de la vacuna estacional para Gripe pand\u00e9mica en las semanas 28 a 51 de 2009. M\u00e9todos: Se estudiaron los casos en atenci\u00f3n primaria, hospitalizados confirmados, aislamientos virales y prote\u00edna C reactiva (PCR y coberturas vacunales. Se calcul\u00f3 la efectividad vacunal por el m\u00e9todo de screening de Farrington, en tres grupos de edad y dos periodos: vacunados de las temporadas 2008-9 y 2009-10. Resultados: En el primer periodo (semanas 28 a 40 los casos se concentraron en el grupo de 15 a 64 a\u00f1os (7.207 casos, seguido de los menores de 15 a\u00f1os (1.596 casos. En el segundo periodo (semanas 45 a 47 afect\u00f3 m\u00e1s a menores de 15 a\u00f1os (28.218 casos. En ambos periodos las tasas de incidencia en mayores de 65 a\u00f1os fue de 56,3 y 125,1 respectivamente. En el periodo estudiado (semanas 28 a 51 se confirmaron 5.481 casos de los que 1.746 (31,8% fueron hospitalizados. La curva de personas hospitalizadas presentaba un perfil similar al de atenci\u00f3n primaria, y tambi\u00e9n el seguimiento microbiol\u00f3gico del virus. La efectividad vacunal en el segundo periodo fue del 25% en adultos entre 15 y 64 a\u00f1os y del 51% en mayores de 64 a\u00f1os. Conclusiones: Se observ\u00f3 una protecci\u00f3n edad dependiente con efectividad vacunal positiva en los mayores de 64 a\u00f1os, aunque puede estar confundida por exposici\u00f3n natural al virus, vacunas previas y o respuesta inmunitaria. [Obtenci\u00f3n y evaluaci\u00f3n preliminar de un virus canarypox recombinante como candidato a vacuna antirr\u00e1bica Development and preliminary assessment of a recombinant Calamante 2012-01-01 En la Argentina, la rabia est\u00e1 circunscripta a algunas provincias del norte. La disponibilidad de nuevas vacunas que eliminen la manipulaci\u00f3n del virus r\u00e1bico y que permitan el control de la enfermedad es de importancia estrat\u00e9gica nacional y regional. Las vacunas basadas en poxvirus recombinantes se han utilizado con \u00e9xito como vacunas antirr\u00e1bicas a nivel mundial. SI bien estos sistemas no est\u00e1n disponibles comercialmente, la plataforma de obtenci\u00f3n de virus canarypox (CNPV) recombinantes y... [Molecular influenza virus pathogenesis immunology because their low cost, the wide availability of mouse-specific reagents, and the the signs of influenza infection of humans: transmission of influenza between mice is the acquire mutations that enhance their ability to attach to cells, replicate within the cells, and suppress immunity, among other functions. Many such covering all 8 genomic segments of the virus. Identification and analysis of these mutations have provided insight into the molecular determinants of influenza virulence and pathogenesis, not only in mice but also in humans and other species. In mouse-adaptive mutations of influenza viruses vaccines and anti-viral therapies. Mice can be a useful animal model for studying influenza biology as long as differences between infections taken in Salvador, Northeast Brazil, before and after routine use of Haemophilus influenzae type b vaccine Etiologia da meningite bacteriana em crian\u00e7as com idade entre 2 e 59 meses em Salvador, Nordeste do Brasil, antes e depois do uso rotineiro da vacina para describe the frequency (BM in a sample of Salvador, Northeast Brazil, with emphasis on the frequency of BM of unknown etiology (BMUE, just before, during and after aged 2-59 months, whose CSF exam was performed CSF Lab - Jos\u00e9 Silveira Foundation, between January 1989 and December 2001. Every CSF the agent was only on Gram stained smear, the diagnosis was descriptive. BMUE was defined as: glucose 100 mg / dl, white blood cell count > 20 cells / mm\u00b3, percentage of neutrophils > 80%. RESULTS: Of 1519 patients, 894 (58.9% had normal exams and respectively, decreasing and 2001. that implementation of the conjugate Hib vaccine during the 1990's has been decreasing not occurrence Hib meningitis but also BMUE.OBJETIVO: Descrever a dos etiol\u00f3gicos bacteriana (MB em amostra das crian\u00e7as com idade entre 2 e 59 meses, em Salvador, Nordeste do Brasil, com \u00eanfase na freq\u00fc\u00eancia de MB de etiologia indeterminada (MBEI, antes, e a rotineira de lactentes com vacina para [Aproximaci\u00f3n al uso de hongos entomopat\u00f3genos y vacunas para el control sostenible de garrapatas en sistemas ganaderos: revisi\u00f3n](http://www.redalyc.org/articulo.oa?id=83743886006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Ana Carolina Moncada Gonz\u00e1lez 2015-01-01 Full Text Available La resistencia desarrollada por las garrapatas frente a los acaricidas de s\u00edntesis, hace necesario replantear las estrategias utilizadas actualmen - te para su control. Los programas de manejo integrado de par\u00e1sitos se presentan como una alternativa que, al promover estrategias de con - trol basadas en la ecolog\u00eda y la epidemiolog\u00eda de cada especie de par\u00e1sito, reducen el riesgo de desarrollo de resistencia. Dichas estrategias incluyen la aplicaci\u00f3n de vacunas antigarrapata y hongos entomopat\u00f3genos que afectan la viabi - lidad y la reproducci\u00f3n en las garrapatas. Sin embargo, la informaci\u00f3n obtenida entre estudios sobre hongos y vacunas ha sido inconsistente, por lo que hoy en d\u00eda ambas representan \u00e1reas de investigaci\u00f3n bastante activas. El prop\u00f3sito de este trabajo consisti\u00f3 en realizar una revisi\u00f3n descriptiva sobre los mecanismos de acci\u00f3n de la vacuna antigarrapata y los hongos entomopat\u00f3genos, en la b\u00fasqueda de una po - sible complementariedad que permita el dise\u00f1o de planes de aplicaci\u00f3n conjunta, con miras a mejorar los resultados de control en sistemas ganaderos. En la primera parte del documento se revisa la actual problem\u00e1tica asociada al uso y abuso de los acaricidas de s\u00edntesis, haciendo un \u00e9nfasis particular en el tema de resistencia; posteriormente, se describen los mecanismos de acci\u00f3n de hongos y vacunas que afectan la re - producci\u00f3n y supervivencia en garrapatas, y se incluye informaci\u00f3n relevante sobre su eficacia. Se espera que la informaci\u00f3n aqu\u00ed recolectada, sirva como base para elaborar estudios que permitan identificar la utilidad de los hongos entomopat\u00f3genos y las vacunas antigarrapata al interior de los programas de manejo integrado de par\u00e1sitos en ganader\u00eda. [Anti-Hemagglutinin Antibody Journals Henry Memczak Full Available Antibodies against spike proteins of influenza are used as a tool for characterization of viruses and therapeutic approaches. However, development, production and quality control of antibodies is expensive and time consuming. determining regions of an antibody chain spike glycoprotein. Their binding properties were studied prevented binding to and infection of target micromolar region without any cytotoxic effect. PeB by substitutional analysis. The their are of great potential for to receive control vaccine at age 2/4/6 and Of these, 2,000 with AOM symptoms; surveillance was enhanced approximately 2 y into the study through regular telephone calls or home visits by study personnel, who advised parents to visit healthcare physician; 649 cases were C-AOM cases as per protocol definition. From the 503 MEF samples collected, 158 (1990-2005 Mortality due to influenza and pneumonia in Mexico between 1990 and 2005](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342006000500004) [Directory of Open Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Pablo Kuri-Morales 2006-10-01 Full Text Available OBJETIVO: Estimar el impacto de la vacuna contra la influenza en personas menores de dos a\u00f1os y mayores de 65, a trav\u00e9s del an\u00e1lisis de la mortalidad por influenza y neumon\u00eda en la Rep\u00fablica mexicana entre 1990 y 2005, y determinar el patr\u00f3n estacional de comportamiento de la mortalidad, la tendencia de mortalidad por volumen de defunciones por periodo estacional y la velocidad de mortalidad. MATERIAL Y M\u00c9TODOS: Los datos se tomaron del Sistema Epidemiol\u00f3gico y Estad\u00edstico de Defunciones (SEED-SSA. RESULTADOS: El an\u00e1lisis mostr\u00f3 una tendencia de defunciones a la baja con una rapidez respectiva de 509 y 29 defunciones menos por a\u00f1o, as\u00ed como una interrupci\u00f3n de la tendencia ascendente de la mortalidad por la vacunaci\u00f3n. CONCLUSIONES: La intervenci\u00f3n por vacunaci\u00f3n tiene costos positivos, tanto econ\u00f3micos como de calidad de vida, por lo que su implementaci\u00f3n debe considerarse en un contexto que refleje una menor incidencia de hospitalizaciones y muertes.OBJECTIVE: To estimate the impact of influenza vaccine in infants less than two years of age and in elders more than sixty-five years of age, through the analysis of mortality due to influenza and pneumonia in Mexico, between 1990 and 2005. To determine the seasonal pattern of mortality, the tendency of mortality by volume of deaths per seasonal period, and the speed rate of mortality. MATERIAL AND METHODS: Data were taken from the Epidemiological and Statistical Mortality System (SEED-SSA per its abbreviation in Spanish. RESULTS AND CONCLUSIONS: The analysis showed there is a tendency deaths decrease at a rate of 509 deaths less per year in the infants group and 29 less in the lower admissions and deaths. [Un caso de Osteocondritis costal t\u00edfica tratado vacunas y antivirus](https://revistas.unal.edu.co/index.php/revfacmed/article/view/22140) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) F. Lleras Acosta 1932-05-01 Full Text Available Por considerala de importancia pr\u00e1ctica, presentamos la historia cl\u00ednica de una enferma afectada de osteocondritis costal de origen Eberthiano, tratada con \u00e9xito completo por las autovacunas y antivirus, Debemos esta interesante observaci\u00f3n al Dr. Juan N. Carpas y al interno de su servicio de mujeres, Sr. Azuero, quienes galantemente nos suministraron los datos cl\u00ednicos y las observaciones relativas a los efectos producidos por las vacunas. [Genetic Reassortment Among the Influenza Viruses (Avian Influenza, Human Influenza in Open Ayu Hewajuli Full Text Available Influenza A virus is a hazardous virus and harm to respiratory tract. The virus infect pigs, horses, humans. Pigs hosts in ecology of two receptors, NeuAc 2,3Gal and which make the pigs are sensitive to infection of influenza virus from birds and humans and genetic reassortment can be occurred. viruses had been circulated in pigs in North America and other countries for 80 years. In 1998, triple reassortant H3N2 swine influenza viruses that contains genes of human A virus (H3N2, swine influenza virus (H1N1 and avian influenza are reported as cause an outbreaks in pigs in North America. Furthermore, the by triple reassortant swine influenza A virus (H1N1 usually made direct contact with pigs. Although without any symptoms, pigs (H1N1 can transmit infection to the humans around them. In June 2009, WHO declared that pandemic influenza of reassortant H1N1 influenza A virus (novel H1N1 has reached phase 6. In Indonesia until 2009, there were 1005 people were infected by H1N1 influenza A and 5 of them died. Novel H1N1 and H5N1 viruses have reassortant that infect pigs together. [Vacunaci\u00f3n contra influenza para adultos mayores en M\u00e9xico: consideraciones econ\u00f3micas Influenza vaccination in the elderly population economic considerations](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342005000300007) Open Juan Pablo Guti\u00e9rrez 2005-06-01 Full Text Available OBJETIVO: Presentar una estimaci\u00f3n de los costos y resultados de salud que podr\u00edan obtenerse en M\u00e9xico con la introducci\u00f3n de un programa de vacunaci\u00f3n contra influenza en los adultos de 65 a\u00f1os de edad y m\u00e1s. MATERIAL Y M\u00c9TODOS: Entre junio y octubre de 2004, en Cuernavaca, Morelos, M\u00e9xico, se elabor\u00f3 un modelo para estimar el n\u00famero de a\u00f1os de vida que se pierden por problemas de salud ocasionados por la influenza y el porcentaje de los que podr\u00edan salvarse mediante la vacunaci\u00f3n por influenza en adultos de 65 a\u00f1os de edad y m\u00e1s, as\u00ed como el costo asociado a la atenci\u00f3n de casos de influenza y el costo potencial de la vacunaci\u00f3n, para obtener el costo neto por a\u00f1o de vida salvado. RESULTADOS: Utilizando dos escenarios de efectividad de la vacuna, se estim\u00f3 un total de entre 7 454 y 11 169 a\u00f1os de vida que podr\u00edan salvarse mediante la vacunaci\u00f3n de todos los adultos mayores en M\u00e9xico a un costo de entre 13 301 y 21 037 pesos por a\u00f1o. DISCUSI\u00d3N: Si bien no se compar\u00f3 con otros usos alternativos de los recursos, la intervenci\u00f3n evaluada tiene un costo por a\u00f1o de vida ganado significativamente menor al producto interno bruto per c\u00e1pita de M\u00e9xico, lo que sugiere que es costo efectivo llevar a cabo la vacunaci\u00f3n contra influenza en adultos de 65 a\u00f1os de edad en M\u00e9xico.OBJECTIVE: To estimate costs and health outcomes that could be attained by an influenza vaccination program in adults 65 years of age and older in Mexico. MATERIAL AND METHODS: Between June and October 2004, a model was constructed to estimate the number of life years lost due to influenza and the fraction that could be prevented by vaccination among adults 65 years of age and older. The model also allowed the estimation of the net cost of a vaccination program, including both the cost of delivering the vaccine and savings from prevented infections and costs. RESULTS: Using two scenarios of vaccine effectiveness, between 7 454 and 11 [Vacunas para la prevenci\u00f3n de la gripe en personas de edad avanzada](http://www.sciencedirect.com/science/article/pii/S0716864010706088) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Tom Jefferson 2010-09-01 Conclusiones de los autores: Las pruebas disponibles son de calidad deficiente y no proporcionan orientaci\u00f3n con respecto a la seguridad, la eficacia o la efectividad de las vacunas contra la gripe en las personas de 65 a\u00f1os de edad o m\u00e1s. Para resolver la incertidumbre se debe realizar un ensayo aleatorio controlado con placebo, con financiamiento p\u00fablico y con poder estad\u00edstico adecuado, durante varias estaciones. [Using Complementary and Alternative Medicines to Target the 2010-01-01 Full Text now accepted that an overwhelming inflammatory response is the cause of human deaths from avian H5N1 influenza infection. With this in mind we sought to examine the literature for examples of complementary and alternative medicines that reduce inflammation, and to place the results of this search in the context of our own work in a mouse model of influenza disease, using a pharmaceutical agent with anti-inflammatory properties. of the cytokine High Mobility Group Box 1 protein and Trifolium pratense (red clover, has anti-inflammatory properties, and thus could be used as an influenza treatment. This is of great interest since we have recently shown abilities of these natural agents should be considered in light of what is now known about the mechanisms of fatal influenza, and tested as potential candidates for influenza treatments in their own or as adjunct treatments to antivirals. [Reactogenicidad e inmunogenicidad de una nueva vacuna de toxoide tet\u00e1nico y dift\u00e9rico con concentraci\u00f3n reducida en adolescentes cubanos](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200003&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Rolando Felipe Ochoa. 2006-08-01 Full Text Available Se realiz\u00f3 un estudio aleatorizado, controlado y a doble ciegas en 225 adolescentes cubanos entre 13 y 16 a\u00f1os de edad, con el objetivo de evaluar la reactogenicidad y la inmunogenicidad de una nueva vacuna de toxoide tet\u00e1nico y toxoide dift\u00e9rico con concentraci\u00f3n reducida, producida en el Instituto Finlay, con respecto a su similar comercial IMOVAX dT adult de Aventis Pasteur. Se tomaron muestras de suero antes y 21 d\u00edas despu\u00e9s de la vacunaci\u00f3n. La reactogenicidad de ambas vacunas fue similar. Los s\u00edntomas y signos, tanto locales como generales fueron moderados y aparecieron principalmente durante las primeras 72 h despu\u00e9s de la vacunaci\u00f3n. Todos los voluntarios vacunados alcanzaron niveles protectores (\u00b30,1 UI/mL de antitoxina contra el t\u00e9tanos y la difteria. El 99,25% de los inmunizados con la vacuna experimental y el 98,36% de los voluntarios del grupo control presentaron niveles de antitoxina tet\u00e1nica correspondientes a una protecci\u00f3n de larga duraci\u00f3n (\u00b31,0 UI/mL; para la antitoxina dift\u00e9rica se alcanzaron estos niveles en el 81,20% y 80,33% de los voluntarios en cada grupo. Los t\u00edtulos medios geom\u00e9tricos de antitoxina tet\u00e1nica (21,73 UI/mL y antitoxina dift\u00e9rica (2,55 UI/mL inducidos por la nueva vacuna fueron superiores (p<0,05 a los del Jin-Qiu; Jiang, Li, Yu-Huan 2015-01-01 Influenza is still a serious threat to human health with significant morbidity and mortality. The emergence of drug-resistant influenza to existing antiviral drugs. Traditional Chinese medicines (TCMs) may be an alternative to overcome the challenge. Here, 10 oral proprietary Chinese medicines influenza B virus. Importantly, they demonstrate potent antiviral activities against drug-resistant strains. we found that in by real-time PCR method sugar chain-immobilized gold Yasuo Available A highly Viral detected patients or inpatients who had been considered influenza-free by of nasal swabs. Furthermore, the method viruses in saliva of the L-92 group was found to be significantly lower compared to the control group. Thus, this method was useful for monitoring the against nosocomial infection. [A-equi-2 influenza in horses in the Republic of South Africa.](https://www.ncbi.nlm.nih.gov/pubmed/2839681) Rogers, A L 1988-06-01 In early December 1986 A-equi-2 influenza virus was isolated for the first time in the Republic of South Africa. All horses were susceptible to the DE of epithelial cells from COPD patients and have (n = 7) and controls (n = 5). PBEC were cultured at the air-liquid interface (ALI) to achieve mucociliary differentiation. ALI-PBECs were apically for 1 h to a stream of freshly generated whole DE or air. Exposure was followed by 3 h incubation in presence or absence of UV-inactivated NTHi before analysis of epithelial gene markers of integrated stress response to a similar extent in from the expression of that DE exposure may cause adverse health effects in part by [Vigilancia epidemiol\u00f3gica centinela de Haemophilus influenzae y Streptococcus pneumoniae en menores de 5 a\u00f1os el Per\u00fa](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342003000300007&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) 2003-07-01 Full Text Available Objetivo: Determinar la frecuencia, serotipos y perfil de resistencia antimicrobiana de Haemophilus influenzae (Hi y Streptococcus pneumoniae (Spn en casos de neumon\u00eda y meningitis en ni\u00f1os menores de 5 a\u00f1os en el Per\u00fa. Materiales y m\u00e9todos: Entre octubre de 2000 y diciembre de 2001, se implement\u00f3 la vigilancia centinela de Hi y Spn en dos hospitales de Lima y tres hospitales de otros departamentos (Cusco, Arequipa y Puno. La identificaci\u00f3n de serotipos y el estudio de la resistencia antimicrobiana se realizaron en el Instituto Nacional de Salud de Lima, Per\u00fa. La susceptibilidad antimicrobiana por la concentraci\u00f3n inhibitoria m\u00ednima (CIM se realiz\u00f3 por el m\u00e9todo de microdiluci\u00f3n en placa, siguiendo las pautas del Comit\u00e9 Nacional de Est\u00e1ndares de Laboratorios Cl\u00ednicos (NCCLS. Resultados: Ingresaron 1 283 casos. Se aislaron 59 cepas (31 de Hi y 28 de Spn, de ellos, 2,3% de las neumon\u00edas y 42,5% de las meningitis tuvieron aislamiento bacteriol\u00f3gico. En 10/1210 (0,8% pacientes con neumon\u00eda se aisl\u00f3 Hi y Spn en 18/1210 (1,5%. En 21/73 (28,8% de los casos de meningitis se aislaron Hi y Spn en 10/73 (13,7%. Se identificaron los serotipos de Spn: 1, 5, 6A, 11, 14, 19, 19F y 20. Los cepas aislados de Hi fueron del serotipo B. Se identificaron cepas de Spn con resistencia alta a penicilina resistentes a cotrimoxazol (4/20 y ampicilina (1/20. Conclusiones: Las tasas de aislamiento de Spn y Hi en menores de 5 a\u00f1os fueron bastante bajas. Se hallaron serotipos ya encontrados en Latinoam\u00e9rica, y se identificaron algunas cepas de Spn y Hi con resistencia a los antibi\u00f3ticos utilizados en los esquemas de tratamiento para neumon\u00eda y meningitis. Recomendamos continuar con este sistema de vigilancia, basado en hospitales centinela. [La construcci\u00f3 de fets cient\u00edfics : La vacuna SPf66](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::69504224a67a1db5cf7f4eafc85160f1) Naspleda Pardo, Joan 2015-01-01 En aquest treball, a partir de la teoria de l'actor-xarxa i la Sociologia del Coneixement Cient\u00edfic (SCC), analitzem la creaci\u00f3 i evoluci\u00f3 de la vacuna contra la mal\u00e0ria de l'equip del Dr. Manuel Elkin Patarroyo, durant els anys 80 i 90 del passat segle, per mostrar com les interaccions socials participen de manera decisiva en l'acceptaci\u00f3 o rebuig d'una proposta cient\u00edfica. En este trabajo, a partir de la teor\u00eda del actor-red y la Sociolog\u00eda del Conocimiento Cient\u00edfico (SCC), analizamos l... [La segunda expedici\u00f3n de Balmis, revoluci\u00f3n y vacuna](https://www.openaire.eu/search/publication?articleId=od_______935::d513a40dc09e50440853f4ad3258003a) Tuells Hern\u00e1ndez, Jos\u00e9; Duro Torrijos, Jos\u00e9 Luis 2013-01-01 Cuatro a\u00f1os despu\u00e9s de concluir la Real Expedici\u00f3n Filantr\u00f3pica de la Vacuna (REFV) (1803-1806) en calidad de director, Francisco Xavier Balmis emprendi\u00f3 una nueva comisi\u00f3n con destino a M\u00e9xico que le mantuvo all\u00ed desde 1810 a 1813. El objetivo inicial para el que fue comisionado pasaba por verificar si la estrategia de vacunaci\u00f3n implantada a trav\u00e9s de las Juntas era eficaz y, asimismo, encontrar una fuente de fluido vacuno aut\u00f3ctona que permitiera continuar la acci\u00f3n vacunadora. Balmis ejer... [Rheumatoid arthritis Text Patients with rheumatoid arthritis (RA are known to be at risk particularly if they are taking drugs with immunomodulatory effects. There is a need for more information on the risk of influenza in patients with RA. Methods A retrospective cohort study was carried out using data gathered from a large US commercial health insurance database (Thomson Reuters Medstat MarketScan from 1 January 2000 to 31 December 2007. Patients were 18 years of age, with at least two RA claims diagnoses. The database was scanned for incidence of seasonal influenza and its complications on or up to 30 days after an influenza diagnosis in RA patients and matched controls. Other factors in patients with RA. Results 46,030 patients with RA and a matching number of controls had a median age of 57 years. The incidence of influenza was higher in RA patients than in controls (409.33 vs 306.12 cases per 100,000 patient-years, and there was a 2.75-fold increase in incidence of complications in RA. Presence biologics had no of influenza observed in women and in both genders combined (but not in men only when all age groups were combined. In general, the risk of influenza complications was similar in RA patients not receiving DMARDs or biologics to patients. rates were higher in infarction higher in vaccines meta-analyses. Overall, MenC-CRM in a 2 or 3 that the main driver of variability in Hib responses, and challenge current perspectives on this Laboratory; Alamos Jurgen G [Los Alamos National Laboratory 2008-01-01 M2 is one of the most conserved influenza proteins, and has been widely prospected as a universal vaccine target, with protection predominantly mediated by antibodies. In this paper we describe the creation of a humanized single chain Fv from 14C2, a potent monoclonal that humanized scFv demonstrates similar activity to the parental mAb: recognize M2 in its native on able to intervention in influenza. [Que hay en el horizonte sobre el virus del papiloma humano, vacunas y el control del c\u00e1ncer](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342007000300011&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Patricia J. Garc\u00eda 2007-07-01 Full Text Available Esta revisi\u00f3n provee una visi\u00f3n general sobre las infecciones genitales producidas por el virus del papiloma humano (VPH y de las neoplasias relacionadas con \u00e9ste y la informaci\u00f3n sobre las expectativas crecientes de la vacunaci\u00f3n como medio de prevenci\u00f3n. Se explora como se han desarrollado las vacunas contra el VPH y que aspectos hay que tener en cuenta para una posible implementaci\u00f3n de un programa de vacunaci\u00f3n para prevenir el c\u00e1ncer cervical, como los costos, el p\u00fablico objetivo (varones, mujeres o ambos, grupos de riesgo, a que edad vacunarlos, consideraciones que debemos tener en cuenta en la promoci\u00f3n de la vacuna, que pasar\u00eda con los programas de detecci\u00f3n precoz de c\u00e1ncer cervical y cuales son los potenciales problemas que tendr\u00eda en pa\u00edses en desarrollo. [Efic\u00e1cia e seguran\u00e7a da vacina brasileira contra hepatite B em rec\u00e9m-nascidos Eficiencia y seguridad de la vacuna brasilera contra hepatitis B en reci\u00e9n-nacidos Efficacy and safety of the Brazilian vaccine against Hepatitis B in newborns](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102009000600013) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Expedito Jos\u00e9 de Luna 2009-12-01 Full geral do Guarulhos, entre 2002 e 2005. A vacina contra os rec\u00e9m-nascidos foram alocados aleatoriamente ao grupo refer\u00eancia. Os rec\u00e9m-nascidos receberam tr\u00eas doses das vacinas, uma em at\u00e9 24 h ap\u00f3s o nascimento e as subseq\u00fcentes 30 e 180 dias ap\u00f3s. No primeiro ensaio 538 rec\u00e9m-nascidos completaram o Considerou-se crit\u00e9rio de equival\u00eancia a diferen\u00e7a grupo experimental, comparada a 98,5% (267/271 no grupo controle (p = 0,001. Com este VrHB-IB n\u00e3o atingiu 25\u00bcg, a soroprote\u00e7\u00e3o no segundo ensaio foi de 100% no grupo experimental e 99,2% no grupo controle. Nenhum evento adverso grave foi registrado. A foi considerada seu uso recomendado \u00e0 vacina\u00e7\u00e3o de rec\u00e9m-nascidos.OBJETIVO: Analizar la eficiencia y seguridad de vacuna recombinante contra hepatitis B en reci\u00e9n-nacidos. M\u00c9TODOS: El estudio fue conducido en hospital general del municipio de Guarulhos, Sureste de Brasil, entre 2002 y 2005. La vacuna recombinante contra hepatitis B del Instituto Butantan (VrHB-IB fue analizada en dos ensayos cl\u00ednicos. En ambos ensayos, los reci\u00e9n-nacidos fueron distribuidos aleatoriamente en el grupo experimental o control (vacuna de referencia. Los reci\u00e9n-nacidos recibieron tres dosis de las vacunas, una en m\u00e1ximo 24 h posterior al nacimiento y las subsecuentes 30 y 180 d [Activities of two novel macrolides, GW 773546 and GW MIC at which 50% of strains are inhibited (MIC(50)) and the MIC(90) of GW 773546, a novel macrolide, were 1.0 and novel macrolide, and telithromycin, an established ketolide, were 2.0 and respectively, while the MIC(50) and MIC(90) of azithromycin 2.0 microg/ml, respectively. The MIC(50) and MIC(90) of erythromycin were 4.0 and 8.0 microg/ml, respectively; and those of clarithromycin were 4.0 All were bactericidal (99.9% killing) against nine strains at two times the MIC after 24 h. Telithromycin was bactericidal against eight of the nine strains. In addition, both novel macrolides and telithromycin at two times the MIC showed 99% killing of all nine strains after 12 h and 90% killing of all strains after 6 h. After 24 h, all drugs were bactericidal against four to seven strains when they were tested at the MIC. Ten of 11 strains tested by multistep selection analysis yielded resistant 43 with erythromycin. Azithromycin gave resistant clones of 50 passages, and clarithromycin gave resistant clones of 9 of 11 strains after to 41 passages. By comparison, GW 708408 gave resistant clones of 9 of 11 strains after 14 to 44 passages, and GW 773546 gave resistant clones of 10 of strains after 14 to 45 passages. Telithromycin gave resistant clones of 7 of 11 strains after 18 to 45 passages. Mutations mostly in the and frequencies 1.5 x 10(-9) to 2.2 x 10(-6) with [Vacunaci\u00f3n de la poblaci\u00f3n de 65 a\u00f1os en Castilla-La Mancha con la vacuna antineumoc\u00f3cica conjugada Available La estrategia de vacunaci\u00f3n antineumoc\u00f3cica en adultos a partir de los 65 a\u00f1os de edad ha ido modific\u00e1ndose, tras la aprobaci\u00f3n de la vacuna 13valente conjugada (VNC13 para adultos y la recomendaci\u00f3n de los Centros de Control y Prevenci\u00f3n de enfermedad de EEUU (CDC en el a\u00f1o 2014 de incluir la vacuna VNC13 a la poblaci\u00f3n a partir de 65 a\u00f1os de edad, a partir de los resultados del estudio CAPiTA. Diversos pa\u00edses, y en Espa\u00f1a varias Comunidades Auto- n\u00f3micas, ya han incluido la vacuna VNC13 en los calendarios vacunales de adultos a partir de los 65 a\u00f1os. En este documento, las sociedades: Sociedad de M\u00e9dicos Generales y de Familia de Castilla-La Mancha, Sociedad Castellano Manchega de Patolog\u00eda Respiratoria, Sociedad Castellano Manchega de M\u00e9dicos Preventivistas, Sociedad Castellano Manchega de Geriatr\u00eda, Sociedad Castellano Manchega de M\u00e9dicos Internistas (Secci\u00f3n Infecciosas, Socie- dad Castellano Manchega de Farmacia Familiar y Comunitaria presentamos a la Direcci\u00f3n General de Salud P\u00fablica de la Junta de Comunidades de Castilla-La Mancha nuestra propuesta y justificaci\u00f3n para la inclusi\u00f3n de la vacuna VNC13 en cohorte de 65 a\u00f1os de edad de Castilla-La Mancha [A randomised trial to evaluate the receive the Phase III Clinical (Clin) or the Commercial (Com) lot of PHiD-CV at 2, 3, and 5 months of age. In the booster vaccination phase, Singapore non-inferior to Com respectively. antibody 0.2 g/mL, in the Clin and Com groups, respectively. All children, except one, had measurable anti-protein D antibodies and the primary and [Streptococcus Montoya 2007-03-01 Full Text Available Las meningoencefalitis bacterianas constituyen una enfermedad invasiva importante, quiz\u00e1s no tanto por su frecuencia, como por la gravedad de su cuadro. Los cambios en la epidemiolog\u00eda de los s\u00edndromes neurol\u00f3gicos infecciosos en Cuba a partir de la vacunaci\u00f3n contra meningococo BC y Haemophilus influenzae b han hecho que el Streptococcus pneumoniae constituya el agente causal m\u00e1s frecuente. Debido al incremento de la resistencia de este microorganismo a los antibi\u00f3ticos habituales, se realizaron modificaciones al r\u00e9gimen terap\u00e9utico convencional, fundamentalmente en las meningitis pedi\u00e1tricas. Es necesario lograr el aislamiento en cultivo de este agente para conocer los serotipos m\u00e1s frecuentes en el pa\u00eds, y lograr una vacuna neumoc\u00f3cica conjugada, as\u00ed como para la vigilancia de las cepas frente a los antimicrobianos.The bacterial meningoencephalitis is an important invasive frequency, but because of the severity of its picture. changes in the epidemiology of the neurological infectious syndromes in vaccination against and Haemophilus infuenzae b have Streptococcus pneumoniae be the most frequent causal agent. Due to the increase of the resistance of this microorganism to habitual antibiotics, modifications were made in the conventional therapeutic regimen, mainly in the pediatric meningitis. It is to achieve the isolation in culture of this agent to know the most common serotypes in the country, to attain a conjugated pneumococcal vaccine, and to keep the surveillance of the strains against the antimicrobials. [Vacunas y autoinmunidad: una rara asociaci\u00f3n bajo debate Vaccines and autoimmunity: a strange association under debate](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342012000200017) [Directory of Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70) Alexander Batista-Duharte 2012-06-01 Full Text Available La posible asociaci\u00f3n entre vacunas y enfermedades autoinmunes es un tema controversial. Existen elementos a favor de esta relaci\u00f3n basados en modelos te\u00f3ricos, ensayos de laboratorio y varios casos cl\u00ednicos publicados. En cambio, los estudios epidemiol\u00f3gicos no han confirmado esta asociaci\u00f3n y, de ellos, puede inferirse que las vacunas no constituyen una causa demostrada de enfermedades autoinmunes. En este trabajo se analizan las evidencias a favor y en contra de esta controversial asociaci\u00f3n, adem\u00e1s, se aborda un nuevo s\u00edndrome asociado con la administraci\u00f3n continuada de adyuvantes vacunales. Se concluye que debido al gran impacto en beneficio de la salud logrado con las vacunas, es necesario continuar desarrollando esta tecnolog\u00eda, pero tambi\u00e9n se debe seguir perfeccionando los dise\u00f1os de las nuevas formulaciones y profundizando estudios b\u00e1sicos, precl\u00ednicos, ensayos cl\u00ednicos y farmacovigilancia de los nuevos candidatos vacunales para establecer el riesgo real de desarrollo de un evento autoinmune posvacunaci\u00f3n.The occurrence sources including theoretical contrast, several epidemiological studies don't and at least indicates that vaccines are not a major cause of autoimmune diseases. We analyzed current scientific data concluded that vaccines bring a positive impact on public health, this an anti-parasitic agent, but has recently been repurposed for the treatment influenza virus infections. Thought to its III clinical trials. Here, we the susceptibility of seasonal viruses to A(H1N1)pdm09, and influenza B viruses circulating in the southern hemisphere from the period March 2014 to August 2016. Tizoxanide showed potent in tested. report on the susceptibility of circulating viruses to tizoxanide. The Irene robust inflammation that is usually more pronounced in the case of avian influenza. It is becoming clearer that the morbidity and immune the It agents have animal models at reducing IAV pathology as a proof of principle. The injury while maintaining the ability of the host cells to mount an antiviral response to control virus replication. However, the dissection of is very of players involved in this regulation, some of which may be undescribed or unknown. This article provides a comprehensive review of the current knowledge regarding the innate immune responses associated with tissue damage by IAV infection, the understanding of which is essential drugs. Furthermore, and effective agents for prevention and treatment. At present, influenza neuraminidase (NA), a key enzyme in viral replication, spread, and pathogenesis, is considered to be one of most promising targets for combating influenza. Despite the substantial medical inhibitors (NAIs), only three of these drugs comprising chemical scaffolds of high diversity, which present an infinite pool of chemical entities for target-oriented drug discovery in the battle against this contagious pathogen. This review illuminates the increasing research decade (2000-2011), focusing on the structure, function and druggability of influenza as well as its inhibition by natural products. Following a critical of publications plant metabolites tested for their inhibitory potential against influenza NA, the impact of three different strategies to identify and develop novel NAIs is presented: screening of herbal extracts, (ii) exploitation of empirical knowledge, and (iii) computational approaches. This work addresses the latest developments in theoretical and experimental research on properties of NA that are and will be driving anti-influenza drug development now and in the near future. [IMPLICACIONES \u00c9TICAS Y SOCIALES DE LA INTRODUCCI\u00d3N DE LA VACUNA CONTRA EL VIRUS DEL PAPILOMA HUMANO EN M\u00c9XICO: REFLEXIONES SOBRE UNA PROPUESTA DE INTERVENCI\u00d3N](https://www.openaire.eu/search/publication?articleId=od______3056::d4191acb1173d7dbea934cb8c961809f) Prieto de Guti\u00e9rrez Delgado,Cristina; Feinholz Klip,Dafna; Morales Gonz\u00e1lez,Gisela; Witlen,Renee 2008-01-01 El objetivo de este trabajo es identificar aspectos \u00e9ticos y sociales relacionados con la introducci\u00f3n de la vacuna contra el virus del papiloma humano (VPH) en M\u00e9xico para una decisi\u00f3n informada y justa que considere no s\u00f3lo los aspectos financieros. De acuerdo con la informaci\u00f3n sobre eficiencia y costo de la vacuna, su introducci\u00f3n al sistema p\u00fablico mexicano puede acarrear consecuencias no previstas para las participantes y para toda la sociedad, por lo que debe examinarse en el "}